AGREEMENT AND PLAN OF MERGER among ALBERTSON’S, INC., NEW ALOHA CORPORATION, NEW DIAMOND SUB, INC., SUPERVALU INC., and EMERALD ACQUISITION SUB, INC. Dated as of January 22, 2006
Exhibit 2.01
among
XXXXXXXXX’X, INC.,
NEW ALOHA CORPORATION,
NEW DIAMOND SUB, INC.,
SUPERVALU INC.,
and
EMERALD ACQUISITION SUB, INC.
Dated as of January 22, 2006
TABLE OF CONTENTS
Page | ||||
ARTICLE I DEFINITIONS |
2 | |||
SECTION 1.1 Certain Defined Terms |
2 | |||
SECTION 1.2 Other Defined Terms |
8 | |||
ARTICLE II MERGERS |
12 | |||
SECTION 2.1 The Diamond Merger |
12 | |||
SECTION 2.2 The Emerald Merger |
12 | |||
SECTION 2.3 Closing; Effective Time |
12 | |||
SECTION 2.4 Effects of the Mergers |
13 | |||
SECTION 2.5 Certificate of Incorporation; By-Laws |
13 | |||
SECTION 2.6 Directors and Officers |
14 | |||
ARTICLE III EFFECT OF THE MERGERS ON CAPITAL STOCK OF THE CONSTITUENT CORPORATIONS |
14 | |||
SECTION 3.1 Effect of the Diamond Merger on Capital Stock |
14 | |||
SECTION 3.2 Effect of the Emerald Merger on Capital Stock |
15 | |||
SECTION 3.3 Treatment of Options and Other Equity Awards |
15 | |||
SECTION 3.4 Adjustment of Merger Consideration |
17 | |||
SECTION 3.5 Dissenting Shares |
18 | |||
SECTION 3.6 Payment and Exchange of Certificates |
19 | |||
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY, NEW DIAMOND, AND NEW DIAMOND
MERGER SUB |
21 | |||
SECTION 4.1 Organization |
22 | |||
SECTION 4.2 Authority; Enforceability |
23 | |||
SECTION 4.3 Non-Contravention |
24 |
-i-
Page | ||||
SECTION 4.4 Governmental Consents |
24 | |||
SECTION 4.5 Capitalization of the Company |
25 | |||
SECTION 4.6 Company Subsidiaries |
26 | |||
SECTION 4.7 SEC Reports; Financial Information |
26 | |||
SECTION 4.8 No Undisclosed Liabilities |
28 | |||
SECTION 4.9 Absence of Certain Changes or Events |
29 | |||
SECTION 4.10 Contracts |
29 | |||
SECTION 4.11 Compliance with Law and Reporting Requirements |
30 | |||
SECTION 4.12 Litigation |
31 | |||
SECTION 4.13 Employee Compensation and Benefit Plans; ERISA |
31 | |||
SECTION 4.14 Labor Matters |
33 | |||
SECTION 4.15 Properties |
33 | |||
SECTION 4.16 Tangible Personal Property |
34 | |||
SECTION 4.17 Intellectual Property; IT Systems |
34 | |||
SECTION 4.18 Environmental Laws |
35 | |||
SECTION 4.19 Taxes |
36 | |||
SECTION 4.20 Insurance |
37 | |||
SECTION 4.21 Rights Plan |
37 | |||
SECTION 4.22 HITS |
37 | |||
SECTION 4.23 Affiliate Transactions |
38 | |||
SECTION 4.24 Brokers |
39 | |||
SECTION 4.25 State Takeover Statutes |
39 | |||
SECTION 4.26 Fairness Opinion |
39 | |||
ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT AND ACQUISITION SUB |
39 | |||
SECTION 5.1 Organization |
40 |
-ii-
Page | ||||
SECTION 5.2 Authority; Enforceability |
40 | |||
SECTION 5.3 Non-Contravention |
41 | |||
SECTION 5.4 Governmental Consents |
41 | |||
SECTION 5.5 Capitalization |
41 | |||
SECTION 5.6 SEC Reports; Financial Information |
42 | |||
SECTION 5.7 No Undisclosed Liabilities |
43 | |||
SECTION 5.8 Absence of Certain Changes or Events |
44 | |||
SECTION 5.9 Compliance with Law and Reporting Requirements |
44 | |||
SECTION 5.10 Litigation |
44 | |||
SECTION 5.11 Financing |
44 | |||
SECTION 5.12 Brokers |
44 | |||
SECTION 5.13 Company Stock |
45 | |||
SECTION 5.14 Acquisition Sub |
45 | |||
SECTION 5.15 Fairness Opinion |
45 | |||
SECTION 5.16 Cub Stores Divestiture |
45 | |||
ARTICLE VI ADDITIONAL AGREEMENTS |
45 | |||
SECTION 6.1 Conduct of Business Prior to the Closing |
45 | |||
SECTION 6.2 Stockholders Meetings |
50 | |||
SECTION 6.3 Proxy Statement |
52 | |||
SECTION 6.4 Access to Information |
53 | |||
SECTION 6.5 Acquisition Proposals |
54 | |||
SECTION 6.6 Further Action; Reasonable Best Efforts |
57 | |||
SECTION 6.7 Resignations |
59 | |||
SECTION 6.8 Directors’ and Officers’ Indemnification and Insurance |
59 | |||
SECTION 6.9 Public Announcements |
61 |
-iii-
Page | ||||
SECTION 6.10 Cooperation |
62 | |||
SECTION 6.11 Notification |
62 | |||
SECTION 6.12 Third-Party Consents |
63 | |||
SECTION 6.13 Employment and Employee Benefits Matters; Section 16 |
63 | |||
SECTION 6.14 Board Representation |
65 | |||
SECTION 6.15 Available Cash |
65 | |||
SECTION 6.16 Coordination of Dividends |
65 | |||
SECTION 6.17 The Diamond Reorganization |
66 | |||
SECTION 6.18 Boise Operations and Community Involvement |
66 | |||
ARTICLE VII CONDITIONS OF MERGER |
66 | |||
SECTION 7.1 Mutual Conditions to Effect the Mergers |
66 | |||
SECTION 7.2 Conditions to Obligations of Parent and Acquisition Sub |
67 | |||
SECTION 7.3 Conditions to Obligations of the Company, New Diamond and New Diamond
Merger Sub |
67 | |||
ARTICLE VIII TERMINATION, AMENDMENT AND WAIVER |
68 | |||
SECTION 8.1 Termination |
68 | |||
SECTION 8.2 Effect of Termination |
70 | |||
SECTION 8.3 Expenses |
73 | |||
SECTION 8.4 Amendment |
73 | |||
SECTION 8.5 Waiver |
73 | |||
ARTICLE IX GENERAL PROVISIONS |
73 | |||
SECTION 9.1 Non-Survival of Representations, Warranties and
Agreements |
73 | |||
SECTION 9.1 Company Disclosure Letter; Parent Disclosure Letter |
73 | |||
SECTION 9.3 Notices |
74 | |||
SECTION 9.4 Severability |
75 | |||
SECTION 9.5 Entire Agreement |
75 |
-iv-
Page | ||||
SECTION 9.6 Assignment |
76 | |||
SECTION 9.7 No Third Party Beneficiaries |
76 | |||
SECTION 9.8 No Responsibility for Other Parties |
76 | |||
SECTION 9.9 Governing Law |
76 | |||
SECTION 9.10 Specific Performance; Jurisdiction |
76 | |||
SECTION 9.11 Waiver of Jury Trial |
77 | |||
SECTION 9.12 Interpretation |
77 | |||
SECTION 9.13 Counterparts |
77 |
INDEX OF EXHIBITS
Exhibit A-1
|
Form of Restated Certificate of Incorporation of Old Xxxxxxxxx’x, Inc. | |
Exhibit A-2
|
Form of By-Laws of Old Xxxxxxxxx’x, Inc. | |
Exhibit B
|
Form of Amended and Restated Certificate of Incorporation of New Aloha Corporation | |
Exhibit C
|
Form of By-Laws of New Aloha Corporation | |
Exhibit D
|
Form of Amended and Restated Certificate of Incorporation of New Xxxxxxxxx’x Inc. | |
Exhibit E
|
Form of By-Laws of New Xxxxxxxxx’x Inc. | |
Exhibit F
|
Separation Agreement | |
Exhibit G
|
Standalone Drug Sale Agreement | |
Exhibit H
|
Separate Operations Data | |
Exhibit I
|
Separate Balance Sheet Data |
-v-
This AGREEMENT AND PLAN OF MERGER, dated as of January 22, 2006 (this “Agreement”), is
entered into by and among SUPERVALU INC., a Delaware corporation (“Parent”), Emerald
Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent
(“Acquisition Sub”), Xxxxxxxxx’x, Inc., a Delaware corporation (the “Company”), New
Aloha Corporation, a Delaware corporation and a wholly owned subsidiary of the Company (“New
Diamond”), and New Diamond Sub, Inc., a Delaware corporation and a wholly owned subsidiary of
New Diamond (“New Diamond Merger Sub”).
W I T N E S S E T H:
WHEREAS, the Board of Directors of the Company (the “Company Board of Directors”) has
(i) determined that it is in the best interests of the Company and the stockholders of the Company,
and declared it advisable, to enter into this Agreement providing for the merger (the “Diamond
Merger”) of New Diamond Merger Sub with and into the Company, with the Company as the surviving
corporation, in accordance with the General Corporation Law of the State of Delaware (the
“DGCL”) and upon the terms and subject to the conditions set forth herein, (ii) determined
that it is in the best interests of the Company, New Diamond and the stockholders thereof, and
declared it advisable, to enter into this Agreement providing for the merger (the “Emerald
Merger,” and together with the Diamond Merger, the “Mergers”) of Acquisition Sub with
and into New Diamond, with New Diamond as the surviving corporation, in accordance with the DGCL
and upon the terms and conditions set forth herein, (iii) approved this Agreement in accordance
with the DGCL, and (iv) resolved to recommend adoption of this Agreement by the stockholders of the
Company;
WHEREAS, (i) the Board of Directors of Parent (the “Parent Board of Directors”), the
Board of Directors of Acquisition Sub, the Board of Directors of New Diamond, and the Board of
Directors of New Diamond Merger Sub have each determined that it is in the best interests of
Parent, Acquisition Sub, New Diamond and New Diamond Merger Sub and their respective stockholders,
and declared it advisable, to enter into this Agreement, and have approved this Agreement in
accordance with the DGCL, and (ii) Parent, as the sole stockholder of Acquisition Sub, will adopt
this Agreement in accordance with the DGCL;
WHEREAS, concurrently with the execution of this Agreement, (i) the Company, New Diamond,
Parent and AB Acquisition LLC are entering into that certain Purchase and Separation Agreement,
dated as of the date hereof and attached as Exhibit F hereto (the “Separation
Agreement”), and (ii) the Company, New Diamond, Parent, CVS Corporation (“CVS”) and
certain additional parties are entering into that certain Asset Purchase Agreement, dated as of the
date hereof and attached as Exhibit G hereto (the “Standalone Drug Sale
Agreement”);
WHEREAS, it is intended that, after the Diamond Merger, the Company will convert into a
Delaware limited liability company (such limited liability company, “Diamond LLC,” and such
conversion, the “Diamond LLC Conversion”), and that Diamond LLC will then distribute its
core business to New Diamond, pursuant to the terms of the Separation Agreement; and
WHEREAS, for federal income tax purposes, it is intended that the Diamond Merger and the
Diamond LLC Conversion, taken together, will qualify as a reorganization under the
-1-
provisions of Section 368(a)(1)(F) of the Code, and that this Agreement shall constitute a
“plan of reorganization” with respect thereto.
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements
herein contained, and intending to be legally bound hereby, New Diamond, New Diamond Merger Sub,
Parent, Acquisition Sub and the Company hereby agree as follows:
ARTICLE I
DEFINITIONS
SECTION 1.1 Certain Defined Terms . As used in this Agreement, the following terms
have the following meanings:
“Action” means any claim, action, suit, proceeding or investigation by or before any
Governmental Authority.
“Affiliate” means, with respect to any specified Person, any other Person that
directly, or indirectly through one or more intermediaries, Controls, is Controlled by, or is under
common Control with, such specified Person.
“ASC” means American Stores Company LLC.
“Average Closing Price” means the average of the closing prices for a Parent Share as
reported on the NYSE Composite Transactions Reports (as reported in The Wall Street Journal
or, if not reported thereby, any other authoritative source) for the ten trading days prior to, but
not including, the Closing Date.
“Business Day” means any day that is not a Saturday, a Sunday or other day that is a
statutory holiday under the federal Laws of the United States.
“Cash Consideration” means $20.35 in cash, without interest, per New Diamond Share.
“Code” means the Internal Revenue Code of 1986, as amended, and the rules and
regulations promulgated thereunder.
“Company Material Adverse Effect” means any effect that is materially adverse to the
business, financial condition or results of operations of the Company and the Company Subsidiaries
(or, following the Separation, New Diamond and its Subsidiaries) taken as a whole in relation to
the New Diamond Business, other than any effect to the extent resulting proximately from (i)
general economic conditions or developments or changes therein, (ii) conditions in the industries
in which the Company and the Company Subsidiaries operate or developments or changes therein,
except to the extent that such conditions, developments or changes impact the Company in a
materially disproportionate adverse manner relative to similarly situated competitors of the
Company, (iii) conditions in the stock markets or other capital markets or developments or changes
therein, (iv) the announcement of the Transaction Agreements or the Transactions, (v) the
performance by the Company of its obligations pursuant
to the Transaction Agreements (except the obligations of the Company to obtain the consents
-2-
contemplated by Section 4.3 and Section 4.4), (vi) the announcement, consummation, termination or
abandonment of the Standalone Drug Sale, (vii) any actions taken or omitted to be taken by or at
the request or with the written consent of Parent or Acquisition Sub, (viii) any changes in any
Laws or any accounting regulations or principles, (ix) any union organizing activities, labor
disputes, strikes, work stoppages or similar labor unrest or disruption, or (x) any acts of God,
war or terrorism, except to the extent that such acts impact the Company in a materially
disproportionate adverse manner relative to similarly situated competitors of the Company. A
failure by the Company to meet any projections, estimates or budgets for any period prior to, on or
after the date of this Agreement shall not in itself constitute a Company Material Adverse Effect.
“Company Proposal” means any Acquisition Proposal relating to the acquisition of, or a
business combination transaction with, the Company, any of its Subsidiaries or some or all of their
respective assets, securities or other ownership interests.
“Company Subsidiaries” means the Subsidiaries of the Company.
“Confidentiality Agreements” means the reciprocal confidentiality agreements dated
September 22, 2005 and November 17, 2005, between Parent and the Company.
“Control” (including the terms “Controlled by” and “under common Control
with”), with respect to the relationship between or among two or more Persons, means the
possession, directly or indirectly, of the power to direct or cause the direction of the affairs or
management of a Person, whether through the ownership of voting securities, by contract or
otherwise, including the ownership, directly or indirectly, of securities having the power to elect
a majority of the board of directors or similar body governing the affairs of such Person.
“Coordination Agreement” means that certain Coordination Agreement by and among the
Company, Parent, AB Acquisition LLC, and CVS, dated as of the date hereof.
“Cub Sale Agreement” means that certain Asset Purchase Agreement by and among Parent
and Hawk Acquisition LLC, dated as of the date hereof.
“Data” means all information and data, whether in printed or electronic form and
whether contained in a database or otherwise, that is used in or held for use in the operation of
the respective businesses of the Company or the Company Subsidiaries, or that is otherwise material
to or necessary for the operation of the respective businesses of the Company or the Company
Subsidiaries.
“Deferred Compensation Plans” means the Company’s 2000 Deferred Compensation Plan; the
Company’s 1990 Deferred Compensation Plan; the Company’s Executive Deferred Compensation Plan; the
Company’s Senior Executive Deferred Compensation Plan; any supplemental retirement benefit provided
in any employment agreement; the Company’s Non-Employees Directors’ Deferred Compensation Plan;
Xxxx’x Supermarkets, Inc. Deferred Compensation Plan; the Company’s Executive ASRE Makeup Plan; the
Company’s Executive Pension Makeup Plan; Xxxx’x Supermarkets, Inc. Supplemental Savings Plan;
Xxxx’x Supermarkets, Inc. Supplemental Executive Retirement Plan; American Stores Company
Supplemental Executive Retirement Plan; American Stores Company
Retirement Plan for Non-
-3-
Employee Directors; and American Stores Company Supplemental Long Range Retirement Plan, as any
of the foregoing may have been amended or restated, and any other plan, program, agreement or
arrangement providing substantially similar benefits to the Company’s current or former directors,
officers or employees.
“Encumbrance” means any security interest, pledge, mortgage, lien, charge,
hypothecation, option or right of first refusal to purchase or lease or otherwise acquire any
interest, conditional sales agreement, adverse claim of ownership or use, title defect, easement,
right of way, or other encumbrance of any kind, other than any obligation to accept returns of
inventory in the ordinary course of business consistent with past practice and other than those
arising by reason of restrictions on transfers under federal, state and foreign securities Laws.
“Equity Interest” means (a) with respect to a corporation, any and all classes or
series of shares of capital stock, (b) with respect to a partnership, limited liability company,
trust or similar Person, any and all classes or series of partnership, limited liability company,
trust or similar interests or units, and (c) with respect to any other Person, any other security
representing any direct equity ownership or participation in such Person.
“ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and the
rules and regulations promulgated thereunder.
“Exchange Act” means the Securities Exchange Act of 1934 and the rules and regulations
promulgated thereunder.
“GAAP” means United States generally accepted accounting principles.
“Governmental Authority” means any federal, state, local or foreign government
(including any political or other subdivision or judicial, legislative, executive or administrative
branch, agency, commission, authority or other body of any of the foregoing).
“Governmental Order” means any order, writ, judgment, injunction, decree or award
entered by or with any Governmental Authority.
“HSR Act” means the Xxxx-Xxxxx-Xxxxxx Antitrust Improvements Act of 1976, as amended,
and the rules and regulations promulgated thereunder.
“Indebtedness” means, with respect to any Person, (i) indebtedness of such Person for
borrowed money, (ii) other indebtedness of such Person evidenced by notes, bonds or debentures,
(iii) capitalized leases classified as indebtedness of such Person under GAAP, (iv) all
indebtedness created or arising under any conditional sale or other title retention agreement with
respect to property acquired by such Person (even though the rights and remedies of the seller or
lender under such agreement in the event of default are limited to repossession or sale of such
property), (v) any obligation of such Person for the deferred purchase price of property or
services (other than trade payables and other current liabilities), (vi) all Indebtedness of
another Person referred to in clauses (i) through (v) above guaranteed directly or indirectly,
jointly or severally, in any manner by such Person, (vii) all Indebtedness referred to in clauses
(i) through (v) above secured by (or for which the holder of such Indebtedness has an existing
right,
contingent or otherwise, to be secured by) any Encumbrance on property (including, without
-4-
limitation, accounts and contract rights) owned by such Person, even though such Person has not
assumed or become liable for the payment of such Indebtedness, and (viii) all reimbursement
obligations of such Person with respect to letters of credit, bankers’ acceptance or similar
facilities issued for the account of such Person. Notwithstanding anything to the contrary herein,
the Indebtedness of the Company and the Company Subsidiaries shall not include (a) any indebtedness
or obligation owed by the Company to any Company Subsidiary, by any Company Subsidiary to the
Company, or between any Company Subsidiaries, or (b) any guarantee by the Company or any Company
Subsidiary of any indebtedness or obligation described in clause (a) of this sentence.
“Intellectual Property” means United States or foreign intellectual property,
including (i) patents and patent applications, together with all reissues, continuations,
continuations-in-part, divisionals, extensions and reexaminations thereof, (ii) trademarks, service
marks, logos, trade names, corporate names, Internet domain names, trade dress, including all
goodwill associated therewith, and all applications, registrations and renewals in connection
therewith, (iii) copyrights and copyrightable works and all applications and registrations in
connection with any of the foregoing, (iv) inventions and discoveries (whether patentable or not),
industrial designs, trade secrets, confidential information and know-how, (v) computer software
(including databases and related documentation), (vi) moral and economic rights of authors and
inventors, and (vii) all other proprietary rights whether now known or hereafter recognized in any
jurisdiction.
“IT Systems” means all electronic data processing, information, recordkeeping,
communications, telecommunications, account management, inventory management and other computer
systems (including all computer programs, software, databases, firmware, hardware and related
documentation) and Internet websites.
“Knowledge” means (i) with respect to Parent, the actual knowledge after reasonable
inquiry of the officers of Parent listed in Section 1.1 of the Parent Disclosure Letter and (ii)
with respect to the Company, the actual knowledge after reasonable inquiry of the officers of the
Company listed in Section 1.1 of the Company Disclosure Letter.
“Law” means any statute, law, ordinance, regulation, rule, code or other requirement
of law of a Governmental Authority or any Governmental Order.
“Material Company Subsidiary” shall mean a Company Subsidiary that qualifies as a
“significant subsidiary” of the Company as such term is defined in Rule 1-02(w) of Regulation S-X
promulgated under the Securities Act.
“New Diamond Business” has the meaning given to it in the Separation Agreement.
“New Diamond Employee” has the meaning given to it in the Separation Agreement.
“New Diamond Entities” has the meaning given to it in the Separation Agreement.
“NYSE” means the New York Stock Exchange.
-5-
“Option” means, subject to Section 3.3(a), each option granted by the Company to
purchase Company Shares pursuant to any of the Stock Plans.
“Parent Material Adverse Effect” means any effect that is materially adverse to the
business, financial condition or results of operations of Parent and its Subsidiaries taken as a
whole, other than any effect to the extent resulting proximately from (i) general economic
conditions or developments or changes therein, (ii) conditions in the industries in which Parent
operates or developments or changes therein, except to the extent that such conditions,
developments or changes impact Parent in a materially disproportionate adverse manner relative to
similarly situated competitors of Parent, (iii) conditions in the stock markets or other capital
markets or developments or changes therein, (iv) the announcement of the Transaction Agreements or
the Transactions, (v) the performance by the Parent of its obligations pursuant to the Transaction
Agreements (except the obligations of Parent to obtain the consents contemplated by Section 5.3 and
Section 5.4), (vi) any actions taken or omitted to be taken by or at the request or with the
written consent of the Company or (vii) any changes in any Laws or any accounting regulations or
principles, any union organizing activities, labor disputes, strikes, work stoppages or similar
labor unrest or disruption, or (ix) any acts of God, war or terrorism, except to the extent that
such acts impact Parent in a materially disproportionate adverse manner relative to similarly
situated competitors of Parent. A failure by Parent to meet any projections, estimates or budgets
for any period prior to, on or after the date of this Agreement shall not in itself constitute a
Parent Material Adverse Effect.
“Parent Proposal” means any Acquisition Proposal relating to the acquisition of, or a
business combination transaction with, Parent, any of its Subsidiaries or some or all of their
respective assets, securities or other ownership interests.
“PCX” means the Pacific Stock Exchange.
“Per Share Merger Consideration” means the Cash Consideration and the Stock
Consideration.
“Permitted Encumbrances” means: (i) Encumbrances that relate to taxes, assessments
and governmental charges or levies imposed upon the Company or a Company Subsidiary that are not
yet due and payable or that are being contested in good faith by appropriate proceedings and for
which reserves have been established in accordance with GAAP on the most recent financial
statements included in the Company SEC Reports filed prior to the date hereof, (ii) Encumbrances
imposed by Law that relate to obligations that are not yet due and have arisen in the ordinary
course of business and consistent with past practice, (iii) pledges or deposits to secure
obligations under workers’ compensation laws or similar legislation or to secure public or
statutory obligations, (iv) mechanics’, carriers’, workers’, repairers’ and similar Encumbrances
imposed upon the Company or a Company Subsidiary arising or incurred in the ordinary course of
business and consistent with past practice and (v) other Encumbrances on assets which, in the case
of each of clause (iv) and (v) above are, either individually or in the aggregate, not material in
amount and would not reasonably be expected to materially impair the continued use, utility or
value of the property to which they relate in the conduct of the business currently conducted
thereon.
-6-
“Person” means any individual, partnership, firm, corporation, association, trust,
unincorporated organization, Governmental Authority, joint venture, limited liability company or
other entity.
“Public Proposal” means an Acquisition Proposal (provided that all percentages
included in the definition of “Acquisition Proposal” shall be increased to 50%) that shall have
been publicly announced and not publicly withdrawn.
“Qualifying Parent Proposal” means any Parent Proposal that contemplates, and would
not materially delay, the consummation of the Transactions and the Standalone Drug Sale and that is
not otherwise inconsistent with the provisions of the Transaction Agreements and the Standalone
Drug Sale Agreement.
“Reorganization” has the meaning given to it in the Separation Agreement.
“Retained Business” has the meaning given to it in the Separation Agreement.
“Retained Business Purchase” has the meaning given to it in the Separation Agreement.
“Securities Act” means the Securities Act of 1933 and the rules and regulations
promulgated thereunder.
“Separation” has the meaning given to it in the Separation Agreement.
“Site” means each location where the Company or any Company Subsidiary conducts
business, including each Owned Real Property and Leased Real Property.
“Standalone Drug Business” has the meaning given to the term “Business” in the
Standalone Drug Sale Agreement.
“Standalone Drug Employee” has the meaning given to the word “Employee” in the
Standalone Drug Sale Agreement.
“Standalone Drug RE Purchase” has the meaning given to it in the Separation Agreement.
“Standalone Drug Sale” means the sale of the Standalone Drug Business pursuant to the
Standalone Drug Sale Agreement.
“Stock Consideration” means 0.182 Parent Shares for each New Diamond Share.
“Stock Plans” means the following plans, in each case as amended through the date
hereof: (i) the Xxxxxxxxx’x, Inc. 1995 Amended and Restated Stock-Based Incentive Plan, (ii) the
Xxxxxxxxx’x, Inc. 2004 Equity and Performance Incentive Plan, (iii) the Xxxxxxxxx’x, Inc. 1995
Stock Option Plan for Non-Employee Directors, (iv) the ASC 1997 Stock Option and Stock Award Plan,
(v) the ASC 1997 Stock Plan for Non-Employee Directors, (vi) the ASC 1997A Stock Option and Stock
Award Plan, (vii) the ASC Amended and Restated 1989 Stock Option
-7-
and Stock Award Plan, and (viii) the ASC Amended and Restated 1985 Stock Option and Stock
Award Plan.
“Stock Unit” means, subject to Section 3.3(d), a right to receive Company Shares
pursuant to a stock unit award under any of the Stock Plans.
“Subsidiaries” of a Person means any and all corporations, partnerships, limited
liability companies, trusts and other entities, whether incorporated or unincorporated, with
respect to which such Person, directly or indirectly, legally or beneficially, owns (i) a right to
a majority of the profits of such entity or (ii) securities having the power to elect a majority of
the board of directors or similar body governing the affairs of such entity.
“Tax” or “Taxes” means all federal, state, provincial, local, territorial and
foreign income, profits, franchise, license, capital, capital gains, transfer, ad valorem, wage,
severance, occupation, import, custom, gross receipts, payroll, sales, employment, use, property,
real estate, excise, value added, goods and services, stamp, alternative or add-on minimum,
environmental, withholding and any other like governmental tax charges, together with all interest,
penalties and additions imposed with respect to such amounts, whether disputed or not and including
any obligations to indemnify or otherwise assume or succeed to the Tax liability of any other
Person.
“Tax Authority” and “Taxing Authority” means any Governmental Authority
responsible for the administration or imposition of any Tax.
“Tax Return” or “Tax Returns” means all returns, declarations, reports, claims
for refund or statements relating to Taxes, including any schedule or attachment thereto, and
including any amendment thereof filed or to be filed with any Tax Authority in connection with the
determination, assessment or collection of Taxes.
“Transaction Agreements” means this Agreement and the Separation Agreement.
“Transactions” means the transactions contemplated by the Transaction Agreements,
including the Mergers, the Reorganization, the Separation and the Retained Business Purchase.
SECTION 1.2 Other Defined Terms. The following terms have the meanings defined for
such terms in the Sections set forth below:
Term | Section | |
ACM |
4.18(a) | |
Acquisition Proposal |
6.5(a) | |
Acquisition Sub |
Preamble | |
Adjusted Option |
3.3(c) | |
Advance Contract |
4.10(c) | |
Agreement |
Preamble | |
Benefits Continuation Period |
6.13(a) |
-8-
Term | Section | |
Blackstone |
4.24 | |
Board of Directors |
6.5(a) | |
Capitalization Date |
4.5(a) | |
Cash Fraction |
3.3(b) | |
Cash-Out Amount |
3.3(b) | |
Cash-Out Price |
3.3(b) | |
Certificate |
3.6(b) | |
Charter Amendment |
6.2(a)(i) | |
Closing |
2.3(d) | |
Closing Date |
2.3(d) | |
Company |
Preamble | |
Company Balance Sheet Date |
4.8 | |
Company Board of Directors |
Recitals | |
Company Board Recommendation |
6.2(a)(ii) | |
Company Disclosure Letter |
Article IV | |
Company Employees |
4.13(a) | |
Company Form 10-K |
Article IV | |
Company Intellectual Property |
4.17(a)(i) | |
Company Plans |
4.13(a) | |
Company SEC Reports |
4.7(a) | |
Company Shares |
3.1(a) | |
Company Stockholders Meeting |
6.2(a)(i) | |
Company Termination Fee |
8.2(b) | |
Compensation |
6.13(c) | |
Current Employee |
6.13(c) | |
CVS |
Recitals | |
Debt and Purchase Contract Assumption |
6.6(h)(ii) | |
Deferred Compensation Distribution |
6.13(b) | |
DGCL |
Recitals | |
Diamond Certificate of Merger |
2.3(b) | |
Diamond LLC |
Recitals |
-9-
Term | Section | |
Diamond LLC Conversion |
Recitals | |
Diamond Merger |
Recitals | |
Diamond Reorganization |
6.17 | |
Dissenting Shares |
3.5(b) | |
Effective Time |
2.3(e) | |
Emerald Certificate of Merger |
2.3(e) | |
Emerald Merger |
Recitals | |
Environmental Laws |
4.18(c) | |
Environmental Permits |
4.18(c) | |
Financing |
5.11 | |
Financing Commitment |
5.11 | |
First Operating Year |
4.10(c) | |
Form S-4 |
6.3(a) | |
F Reorg |
6.17 | |
Xxxxxxx Xxxxx |
4.24 | |
HITS |
4.5(a) | |
HITS Indenture |
4.22(a) | |
HITS Purchase Contract Agreement |
4.22(a) | |
HSR Clearance |
6.6(d) | |
Indemnified Directors and Officers |
6.8(a) | |
Initial Closing |
2.3(a) | |
Initial Closing Date |
2.3(a) | |
Initial Effective Time |
2.3(b) | |
IRS |
4.13(b) | |
Leased Real Property |
4.15(b) | |
Lucky Delaware |
6.17 | |
XXXXx |
5.5(a) | |
Material Contract |
4.10(a) | |
Materials of Environmental Concern |
4.18(c) | |
Mergers |
Recitals | |
Multiemployer Plan |
4.13(a) |
-10-
Term | Section | |
New Diamond |
Preamble | |
New Diamond Merger Sub |
Preamble | |
New Diamond Shares |
3.1(a) | |
Objection |
6.6(d) | |
Owned Real Property |
4.15(a) | |
Parent |
Preamble | |
Parent Balance Sheet Date |
5.7 | |
Parent Board of Directors |
Recitals | |
Parent Board Recommendation |
6.2(b) | |
Parent Disclosure Letter |
Article V | |
Parent Form 10-K |
Article V | |
Parent Plan |
6.13(d) | |
Parent Rights Plan |
5.5(a) | |
Parent SEC Reports |
5.6(a) | |
Parent Shares |
5.5(a) | |
Parent Stockholders Meeting |
6.2(b) | |
Parent Termination Fee |
8.2(c) | |
Paying Agent |
3.6(a) | |
PBGC |
4.13(b) | |
Pledge Agreement |
6.6(h) | |
Proxy Statement/Prospectus |
6.3(a) | |
Real Property Lease |
4.15(b) | |
Regulatory Termination Fee |
8.2(d) | |
Remarketing Agreement |
6.6(h) | |
Representatives |
6.5(a) | |
Requisite Company Stockholder Vote |
4.2(a) | |
Requisite Parent Stockholder Vote |
5.2(a) | |
Rights Plan |
4.5(a) | |
SEC |
4.7(a) | |
Separate Balance Sheet Data |
4.7(b) | |
Separate Operations Data |
4.7(b) |
-11-
Term | Section | |
Separation Agreement |
Recitals | |
Share Issuance |
5.2(a) | |
Standalone Drug Sale Agreement |
Recitals | |
Superior Proposal |
6.5(a) | |
Surviving Corporation |
2.2 | |
Termination Date |
8.1(c) | |
Third Party Use and Occupancy Agreement |
4.15(c) | |
Withdrawal Liability |
4.13(d) |
ARTICLE II
MERGERS
SECTION 2.1 The Diamond Merger. Upon the terms and subject to the conditions of this
Agreement and in accordance with the DGCL, at the Initial Effective Time (as defined below), New
Diamond Merger Sub shall be merged with and into the Company. As a result of the Diamond Merger,
the separate corporate existence of New Diamond Merger Sub shall cease and the Company shall
continue as the surviving corporation in the Diamond Merger and as a wholly owned subsidiary of New
Diamond.
SECTION 2.2 The Emerald Merger. Upon the terms and subject to the conditions of this
Agreement and in accordance with the DGCL, at the Effective Time (as defined below), Acquisition
Sub shall be merged with and into New Diamond. As a result of the Emerald Merger, the separate
corporate existence of Acquisition Sub shall cease and New Diamond shall continue as the surviving
corporation in the Emerald Merger (the “Surviving Corporation”) and as a wholly owned
subsidiary of Parent.
SECTION 2.3 Closing; Effective Time.
(a) Subject to the provisions of Article VII, the closing of the Diamond Merger (the
“Initial Closing”) shall take place at the offices of Xxxxx Day, 000 Xxxx 00xx Xxxxxx, Xxx
Xxxx, Xxx Xxxx 00000, at 9:00 a.m. local time, as soon as practicable, but in no event later than
the second Business Day after the satisfaction or waiver of the conditions set forth in Article VII
(excluding conditions that, by their terms, cannot be satisfied until the Closing, as defined
below, but the Closing shall be subject to the satisfaction or waiver of those conditions), or at
such other place or at such other date or time as Parent and the Company may mutually agree. The
date on which the Initial Closing actually occurs is hereinafter referred to as the “Initial
Closing Date.”
(b) Subject to the provisions of this Agreement, as soon as practicable after 9:00 a.m. local
time on the Initial Closing Date, the parties hereto shall cause the Diamond Merger to be
consummated by filing a certificate of merger (the “Diamond Certificate of Merger”) with
the Secretary of State of the State of Delaware, in such form as required by, and executed in
-12-
accordance with, the relevant provisions of the DGCL (the date and time of the filing of the
Diamond Certificate of Merger
with the Secretary of State of the State of Delaware, or such later
time as is specified in the Diamond Certificate of Merger and as is agreed to by Parent and the
Company, being the “Initial Effective Time”) and shall make all other filings or recordings
required under the DGCL in connection with the Diamond Merger.
(c) As soon as practicable after the Initial Effective Time, but in any event before the
Effective Time (as defined below), the parties hereto shall effect the Diamond LLC Conversion and
then shall effect the other transactions set forth in the Separation Agreement.
(d) Subject to the provisions of Article VII, the closing of the Emerald Merger (the
“Closing”) shall take place at the offices of Xxxxx Day, 000 Xxxx 00xx Xxxxxx, Xxx Xxxx,
Xxx Xxxx 00000, at 10:00 a.m. local time, on the Initial Closing Date or as promptly as practicable
thereafter (and in no case more than two Business Days thereafter), or at such other place or at
such other date or time as Parent and the Company may mutually agree. The date on which the
Closing actually occurs is hereinafter referred to as the “Closing Date.”
(e) Subject to the provisions of this Agreement, as soon as practicable after 10:00 a.m. local
time on the Closing Date, the parties hereto shall cause the Emerald Merger to be consummated by
filing a certificate of merger (the “Emerald Certificate of Merger”) with the Secretary of
State of the State of Delaware, in such form as required by, and executed in accordance with, the
relevant provisions of the DGCL (the date and time of the filing of the Emerald Certificate of
Merger with the Secretary of State of the State of Delaware, or such later time as is specified in
the Emerald Certificate of Merger and as is agreed to by Parent and New Diamond, being the
“Effective Time”) and shall make all other filings or recordings required under the DGCL in
connection with the Emerald Merger.
SECTION 2.4 Effects of the Mergers. The Mergers shall have the effects set forth in
this Agreement and the applicable provisions of the DGCL. Without limiting the generality of the
foregoing and subject thereto, (i) at the Initial Effective Time, all the property, rights,
privileges, immunities, powers and franchises of the Company and New Diamond Merger Sub shall vest
in the Company as the surviving corporation in the Diamond Merger and all debts, liabilities and
duties of the Company and New Diamond Merger Sub shall become the debts, liabilities and duties of
the Company as the surviving corporation in the Diamond Merger, and (ii) at the Effective Time, all
the property, rights, privileges, immunities, powers and franchises of New Diamond and Acquisition
Sub shall vest in the Surviving Corporation and all debts, liabilities and duties of New Diamond
and Acquisition Sub shall become the debts, liabilities and duties of the Surviving Corporation.
SECTION 2.5 Certificate of Incorporation; By-Laws.
(a) At the Initial Effective Time, (i) the restated certificate of incorporation of the
Company, as in effect immediately prior to the Initial Effective Time, shall be amended in its
entirety in the form attached hereto as Exhibit A-1 and as so amended shall be the restated
certificate of incorporation of the Company, as the surviving corporation in the Diamond Merger,
and (ii) the by-laws of the Company shall be amended and
restated to read in their entirety in the
form attached hereto as Exhibit A-2 and, as so amended, shall be the amended and
-13-
restated
by-laws of the Company until thereafter amended in accordance with their terms, the restated
certificate of incorporation of the Company and applicable law.
(b) Immediately prior to the Initial Effective Time, the certificate of incorporation and the
by-laws of New Diamond shall be amended and restated to read in their entirety in the form attached
hereto as Exhibits B and C, respectively.
(c) At the Effective Time, (i) the amended and restated certificate of incorporation of New
Diamond shall be amended so as to read in its entirety in the form annexed hereto as Exhibit
D, and, as so amended, shall be the amended and restated certificate of incorporation of the
Surviving Corporation until thereafter amended in accordance with its terms and applicable Law, and
(ii) the restated by-laws of New Diamond shall be amended so as to read in their entirety in the
form annexed hereto as Exhibit E, and, as so amended, shall be the amended and restated
by-laws of the Surviving Corporation until thereafter amended in accordance with their terms, the
amended and restated certificate of incorporation of the Surviving Corporation and applicable Law.
SECTION 2.6 Directors and Officers.
(a) The Company and New Diamond shall take the necessary actions to cause the directors and
officers of the Company immediately prior to the Initial Effective Time to be the directors and
officers of New Diamond from and after the Initial Effective Time. Immediately prior to the
Retained Business Purchase, the directors of the Company shall submit resignations to be effective
as of the consummation of the Retained Business Purchase.
(b) Immediately prior to the Effective Time, the directors of New Diamond shall submit their
resignations to be effective as of the Effective Time. Parent shall take the necessary actions to
cause the directors of Acquisition Sub immediately prior to the Effective Time to be the directors
of the Surviving Corporation from and after the Effective Time, each to hold office in accordance
with the restated certificate of incorporation and by-laws of the Surviving Corporation.
(c) The officers of New Diamond immediately prior to the Effective Time shall be the officers
of the Surviving Corporation, each to hold office until the earlier of his or her resignation or
removal.
ARTICLE III
EFFECT OF THE MERGERS ON CAPITAL STOCK OF THE CONSTITUENT
CORPORATIONS
CORPORATIONS
SECTION 3.1 Effect of the Diamond Merger on Capital Stock. At the Initial Effective
Time, by virtue of the Diamond Merger and without any action on the part of any party hereto or any
holder of any of the following securities:
(a) Each share (or fraction of a share) of Common Stock, par value $1.00 per share, of the
Company (the “Company Shares”) issued and outstanding immediately prior to the Initial
Effective Time (other than any Company Shares to be canceled pursuant to Section 3.1(b) and
-14-
any
Dissenting Shares (as defined in Section 3.5(b))) shall be converted into the right to receive one
(1) fully paid and nonassessable share (or an equal fraction of a share, if applicable) of Common
Stock, par value $0.01 per share, of New Diamond (the “New Diamond Shares”).
(b) Each Company Share held in the treasury of the Company immediately prior to the Initial
Effective Time shall be canceled without any conversion thereof.
(c) Each New Diamond Share held by the Company immediately prior to the Initial Effective Time
shall be canceled.
(d) Each share of common stock of New Diamond Merger Sub issued and outstanding immediately
prior to the Initial Effective Time shall be converted into one share of Common Stock of the
Company as the surviving corporation of the Diamond Merger.
SECTION 3.2 Effect of the Emerald Merger on Capital Stock. At the Effective Time, by
virtue of the Emerald Merger and without any action on the part of Parent, Acquisition Sub, New
Diamond or the holders of any of the following securities:
(a) Each New Diamond Share issued and outstanding immediately prior to the Effective Time
(other than any Shares to be canceled pursuant to Section 3.2(b)) shall be converted into the right
to receive the Per Share Merger Consideration from Parent.
(b) Each New Diamond Share held in the treasury of New Diamond, or owned by Parent, the
Company, New Diamond or any wholly owned direct or indirect Subsidiary of the Company, Parent or
New Diamond, in each case immediately prior to the Effective Time, shall be canceled without any
conversion thereof and no consideration shall be paid with respect thereto.
(c) Each share of common stock of Acquisition Sub issued and outstanding immediately prior to
the Effective Time shall be converted into one share of common stock of the Surviving Corporation.
SECTION 3.3 Treatment of Options and Other Equity Awards. Prior to the Initial
Effective Time, the Company and New Diamond, and the Company Board
of Directors and the New Diamond Board of Directors, as applicable, shall take all action
necessary, including a resolution of such boards (or a committee thereof), such that:
(a) Each Option that is outstanding and unexercised as of immediately prior to the Initial
Effective Time shall be assumed by New Diamond at the Initial Effective Time, and shall continue to
have, and be subject to, the same terms and conditions (and shall have the same date of grant) as
were applicable under the Stock Plans and any applicable agreements thereunder immediately before
the Initial Effective Time, except that each Option will be exercisable for a number of New Diamond
Shares equal to the number of Company Shares that were issuable upon exercise of such option
immediately prior to the Initial Effective Time. For the avoidance of doubt, the term “Option”
after the Initial Effective Time shall mean an option to purchase New Diamond Shares pursuant to
any of the Stock Plans, as assumed by New Diamond at the Initial Effective Time.
-15-
(b) Each Option that is outstanding and unexercised as of immediately prior to the Effective
Time, whether or not vested or exercisable, and that is not held by a New Diamond Employee shall be
canceled by New Diamond, and the holder of such Option shall receive, in full settlement thereof,
an amount of cash (the “Cash-Out Amount”), without interest, equal to the product of (i)
the total number of New Diamond Shares subject to such Option multiplied by (ii) the excess, if
any, of the sum of (x) (A) the number of Parent Shares represented by the Stock Consideration
multiplied by (B) the Average Closing Price plus (y) the Cash Consideration (such sum, the
“Cash-Out Price”) over the exercise price per New Diamond Share subject to such Option
(with the aggregate amount of such payment to the holder to be rounded to the nearest cent), less
applicable Taxes, if any, required to be withheld with respect to such payment; provided,
however, that if the holder of such Option is a non-employee director of New Diamond, such
holder shall not receive the full Cash-Out Amount in cash, but shall instead receive (x) an amount
in cash (rounded to the nearest cent) equal to the product of (1) the Cash-Out Amount multiplied by
(2) a fraction (the “Cash Fraction”), the numerator of which is the Cash Consideration and
the denominator of which is the sum of (a) the Cash Consideration plus (b) the product of (i) the
Stock Consideration multiplied by (ii) the Average Closing Price, and (y) a number of Parent Shares
(rounded to the nearest share) equal to a fraction, the numerator of which is the product of (1)
the Cash-Out Amount multiplied by (2) (a) 1.0 minus (b) the Cash Fraction, and the denominator of
which is the Average Closing Price.
(c) Each Option that is outstanding and unexercised as of immediately prior to the Effective
Time and that is held by a New Diamond Employee (whether or not vested or exercisable) shall be
assumed by Parent at the Effective Time. To the extent permitted under the Stock Plans, all such
outstanding Options shall accelerate and become immediately exercisable in connection with the
Mergers in accordance with the terms of the Stock Plans and any applicable agreements thereunder.
Except for the acceleration of the Options in accordance with the terms of the Stock Plans and any
applicable agreements thereunder, at the Effective Time, each Option so assumed by Parent under
this Agreement (an “Adjusted Option”) shall continue to have, and be subject to, the same
terms and conditions as were applicable under the Stock Plans and any applicable agreements
thereunder immediately before the Initial Effective Time, except that (i) each Adjusted Option will
be exercisable for that number of Parent Shares (rounded up or down to the nearest share, and
rounded up in the case of half a share) equal to the product of (x) the number of New Diamond
Shares that were issuable upon exercise of such
option immediately prior to the Effective Time multiplied by (y) the sum of (A) the Stock
Consideration, plus (B) (1) the Cash Consideration divided by (2) the Average Closing Price, and
(ii) the per share exercise price for the Parent Shares issuable upon exercise of such Adjusted
Option will be equal to the quotient (rounded up or down to the nearest cent) determined by
dividing (x) the per share exercise price of such Option immediately prior to the Effective Time by
(y) the sum of (A) the Stock Consideration plus (B) (1) the Cash Consideration, divided by (2) the
Average Closing Price. The date of grant of each Adjusted Option will be the date on which the
corresponding Option was granted. In the event that the holder of an Adjusted Option would be
precluded by applicable securities laws from disposing of Parent Shares acquired upon exercise of
such option during the 60-day period beginning on the Closing Date, Parent will (to the extent
permitted by applicable Law) make available a “cashless exercise” opportunity to such holder during
such period unless such cashless exercise would result in an accounting impact for Parent that is
both adverse to Parent and likely to continue beyond the 60-day period beginning on the Closing
Date.
-16-
(d) Each Stock Unit that is outstanding as of immediately prior to the Initial Effective Time
shall be assumed by New Diamond at the Initial Effective Time, and shall continue to have, and be
subject to, the same terms and conditions as were applicable immediately before the Initial
Effective Time, except that each Stock Unit will become a right to receive a number of New Diamond
Shares equal to the number of Company Shares that would be received for such Stock Unit immediately
prior to the Initial Effective Time. Each Stock Unit that is outstanding as of immediately prior
to the Effective Time (other than Stock Units granted pursuant to the exception provided in Section
6.1 of the Company Disclosure Letter), whether or not vested, will, as of the Effective Time,
entitle the holder thereof to receive the Per Share Merger Consideration and shall continue to
have, and be subject to, the same terms and conditions as were applicable immediately before the
Effective Time, provided that each holder of a Stock Unit that is outstanding as of immediately
prior to the Effective Time, whether or not vested, may elect, prior to the Effective Time, to
receive payment of such Stock Unit upon the earlier of (1) the existing payment date under the
current terms of the Stock Units (subject to any change in the existing payment date that is
required to comply with Section 409A of the Code) or (2) the later of (x) the Effective Time or (y)
January 1, 2007. The Company may adopt such amendments to the Stock Units as it deems necessary or
appropriate to effectuate the transactions contemplated hereby.
(e) Prior to the Initial Effective Time, the Company shall use its reasonable best efforts to
take or cause to be taken all actions necessary to effectuate the foregoing treatment in this
Section 3.3 to the extent such treatment is not expressly provided for by the terms of the
applicable equity compensation plans and related award agreements. All payments under this Section
3.3 shall be made no later than five (5) Business Days following the Closing Date.
(f) Parent shall take all corporate action necessary to reserve for issuance a sufficient
number of Parent Shares for delivery upon exercise of Adjusted Options pursuant to the terms set
forth in Section 3.3(c). As soon as practicable following the Effective Time, Parent shall cause
the Parent Shares subject to the Adjusted Options to be covered by an effective registration
statement on Form S-8 (or any successor form) or another appropriate form and Parent shall use its
reasonable best efforts to maintain the effectiveness of such registration statement for so long
as any Adjusted Options remain outstanding. In addition, Parent shall use its reasonable best
efforts to cause the Parent Shares subject to the Adjusted Options to be listed on the NYSE.
(g) The parties will make good faith efforts to make equitable adjustments if necessary to
ensure that the provisions of this Section 3.3 comply with Section 409A of the Code.
SECTION 3.4 Adjustment of Merger Consideration. Notwithstanding anything in this
Agreement to the contrary, if, (a) between the date of this Agreement and the Closing Date, the
issued and outstanding Company Shares (prior to the Initial Effective Time) or New Diamond Shares
(after the Initial Effective Time), or the issued and outstanding Parent Shares, shall have been
changed into a different number of shares or a different class by reason of any stock split,
reverse stock split, stock dividend (other than dividend equivalents paid to members of the Company
Board of Directors under the terms of Stock Units outstanding on the date hereof),
reclassification, or redenomination, or (b) at the Initial Effective Time, the Company’s
representation and warranties in Section 4.5 (Capitalization of the Company) or Parent’s
-17-
representations and warranties in Section 5.5 (Capitalization) are not true in any non-de minimis
respect relating to the number of fully diluted shares outstanding, then the Per Share Merger
Consideration, the Cash-Out Price and any other dependent items (1) shall be appropriately
adjusted, in the case of (a) above, to provide to the holders of New Diamond Shares the same
economic effect as contemplated by this Agreement prior to such action and as so adjusted shall,
from and after the date of such event, be the Per Share Merger Consideration, the Cash-Out Price or
other dependent item, subject to further adjustment in accordance with this sentence, and/or (2)
shall be appropriately adjusted, in the case of (b) above, to provide to New Diamond and Parent and
their respective stockholders the same economic effect as contemplated by this Agreement assuming
such representations and warranties are true and correct in all such respects as written and as so
adjusted shall be the Per Share Merger Consideration, the Cash-Out Price or other dependent item,
subject to further adjustment in accordance with this sentence.
SECTION 3.5 Dissenting Shares.
(a) No appraisal rights shall be available to holders of New Diamond Shares in connection with
the Emerald Merger.
(b) In the event the Charter Amendment is approved and the Effective Time occurs, Company
Shares that are issued and outstanding immediately prior to the Initial Effective Time and which
are held by holders of Company Shares who have not voted in favor of or consented to the adoption
of this Agreement and who have properly taken the steps required in order to demand and perfect
their rights to appraisal in connection with the Diamond Merger, in accordance with Section 262 of
the DGCL (the “Dissenting Shares”) shall not be converted into the right to receive New
Diamond shares in accordance with Section 3.1(a), and the holders thereof instead shall be entitled
to only such rights as are granted by Section 262 of the DGCL and the restated certificate of
incorporation of the Company; provided, however, that if any such stockholder of
the Company shall fail to perfect or shall effectively waive, withdraw or lose such stockholder’s
rights under Section 262 of the DGCL, such stockholder’s Company Shares in
respect of which the stockholder would otherwise be entitled to receive fair value under
Section 262 of the DGCL shall thereupon be deemed to have been converted, at the Initial Effective
Time, into New Diamond Shares in accordance with Section 3.1(a) (which New Diamond Shares shall be
converted into the Per Share Merger Consideration in the Emerald Merger in accordance with Section
3.2(a)). In the event the Charter Amendment is not approved or the Effective Time does not occur,
no appraisal rights shall be available to holders of Company Shares in connection with the Diamond
Merger.
(c) Company shall give Parent (i) prompt notice of any notice received by Company of the
intent of any holder of Company Shares to demand the fair value of any Company Shares in the
Diamond Merger, any written demand for appraisal, any withdrawals thereof and any instruments
served pursuant to Section 262 of the DGCL and received by the Company, and (ii) the opportunity to
direct all negotiations and proceedings with respect to the exercise of dissenters’ rights under
Section 262 of the DGCL. The Company shall not, except with the prior written consent of Parent or
as otherwise required by an order, decree, ruling or injunction of a court of competent
jurisdiction, make any payment with respect to any such exercise of dissenters’ rights or offer to
settle or settle any such rights.
-18-
(d) The parties shall cooperate to take any reasonable steps requested by another party that
may be necessary to (i) provide appraisal rights to holders of Company Shares as contemplated by
Section 3.5(b), and (ii) ensure that no appraisal rights are available in connection with the
Emerald Merger.
SECTION 3.6 Payment and Exchange of Certificates.
(a) Following the date of this Agreement and in any event not less than three Business Days
prior to the mailing of the Proxy Statement/Prospectus to the stockholders of the Company, Parent
or Acquisition Sub shall designate a bank or trust company reasonably acceptable to the Company to
act as Paying Agent in connection with the Mergers (the “Paying Agent”). At or prior to
the Effective Time, Parent will cause to be deposited in trust with the Paying Agent the aggregate
consideration to which stockholders of the Company are contemplated to become entitled under this
Article III. Until used for that purpose, the portion of such aggregate consideration consisting
of cash shall be invested by the Paying Agent, as directed by Parent or the Surviving Corporation,
in obligations of or guaranteed by the United States of America or obligations of an agency of the
United States of America which are backed by the full faith and credit of the United States of
America, or in commercial paper obligations rated A-1 or P-1 or better by Xxxxx’x Investors
Service, Inc. or Standard & Poor’s Corporation; provided that no such investment or losses
thereon shall affect the Per Share Merger Consideration payable to former stockholders of New
Diamond, and Parent shall promptly provide, or shall cause the Surviving Corporation to promptly
provide, additional funds to the Paying Agent for the benefit of the former stockholders of New
Diamond in the amount of any shortfall in funds payable to the former stockholders of New Diamond
pursuant to this Article III.
(b) From and after the Initial Effective Time, (i) each stock certificate which immediately
prior to the Initial Effective Time represented Company Shares (other than
Dissenting Shares) shall be deemed to represent an equal number of New Diamond Shares (each
such stock certificate, a “Certificate”), and (ii) each holder of record of Company Shares
(other than Dissenting Shares) immediately prior to the Initial Effective Time shall be deemed to
be a holder of record of the same number of New Diamond Shares.
(c) Promptly after the Effective Time (and in any event within two Business Days following the
Effective Time), the Surviving Corporation shall cause the Paying Agent to mail to each Person who
was a record holder of New Diamond Shares immediately prior to the Effective Time, whose New
Diamond Shares were converted pursuant to this Article III into the right to receive the Per Share
Merger Consideration, (i) a form of letter of transmittal for use in effecting the surrender of
Certificates in order to receive payment of the Per Share Merger Consideration (which shall specify
that delivery shall be effected, and risk of loss and title to the Certificate shall pass, only
upon actual delivery of the Certificates to the Paying Agent, and shall otherwise be in customary
form), and (ii) instructions for use in effecting the surrender of the Certificates in exchange for
payment of the Per Share Merger Consideration. When the Paying Agent receives a Certificate,
together with a properly completed and executed letter of transmittal and any other required
documents, the Paying Agent shall deliver to the holder of the New Diamond Shares represented by
the Certificate, or as otherwise directed in the letter of transmittal, (A) a cash amount in
immediately available funds equal to the aggregate Cash Consideration into
-19-
which all of the New
Diamond Shares represented by such Certificate shall have been converted pursuant to the Emerald
Merger, (B) a certificate representing that number of whole Parent Shares into which the New
Diamond Shares represented by such Certificate shall have been converted pursuant to the Emerald
Merger, (C) any cash in lieu of a fractional Parent Share to which such holder shall be entitled
pursuant to Section 3.6(h), and (D) any dividends or other distributions to which such holder shall
be entitled pursuant to Section 3.6(i). Any payment hereunder shall be less any required Tax
withholdings in accordance with Section 3.6(d) below, and the Certificate shall be canceled. No
interest shall be paid or accrued on the Per Share Merger Consideration payable upon the surrender
of Certificates. If payment is to be made to a Person other than the Person in whose name a
surrendered Certificate is registered, it shall be a condition of payment that the Certificate so
surrendered must be properly endorsed or otherwise be in proper form for transfer, and the Person
who surrenders the Certificate must provide funds for payment of any transfer or other Taxes
required by reason of the payment to a Person other than the registered holder of the surrendered
Certificate or establish to the satisfaction of the Surviving Corporation that the Tax has been
paid or is not applicable. After the Effective Time, a Certificate shall represent only the right
to receive the Per Share Merger Consideration in respect of the New Diamond Shares represented by
such Certificate, without any interest thereon.
(d) The Paying Agent may withhold from the sum payable to any Person as a result of the
Emerald Merger, and pay to the appropriate Taxing Authorities, any amounts that the Paying Agent or
the Surviving Corporation may be required (or may reasonably believe it is required) to withhold
under the Code, or any provision of state, local or foreign Tax Law. Any sum that is withheld and
paid to a Taxing Authority as permitted by this Section will be deemed to have been paid to the
Person from whom it is withheld.
(e) In the event that any Certificate shall have been lost, stolen or destroyed, upon the
holder’s compliance with the reasonable replacement requirements established by the Paying
Agent, the Paying Agent shall deliver in exchange for the lost, stolen or destroyed
Certificate the applicable Per Share Merger Consideration payable in respect of the New Diamond
Shares represented by the Certificate pursuant to this Article III.
(f) At any time which is more than 180 days after the Effective Time, Parent shall be entitled
to require the Paying Agent to deliver to it any funds and shares which had been deposited with the
Paying Agent and have not been disbursed in accordance with this Article III (including interest
and other income received by the Paying Agent in respect of the funds made available to it), and
after the funds and shares have been delivered to Parent, Persons entitled to payment in accordance
with this Article III shall be entitled to look solely to Parent (subject to abandoned property,
escheat or other similar Laws) for payment of the Per Share Merger Consideration upon surrender of
the Certificates held by them, without any interest thereon. Any Per Share Merger Consideration
remaining unclaimed as of a date which is immediately prior to such time as such amounts would
otherwise escheat to or become property of any government entity shall, to the extent permitted by
applicable Law, become the property of Parent free and clear of any claims or interest of any
Person previously entitled thereto. Neither the Surviving Corporation, Parent nor the Paying Agent
will be liable to any Person entitled to payment under this Article III for any consideration which
is properly delivered to a public official pursuant to any abandoned property, escheat or similar
Law.
-20-
(g) At the Effective Time, the stock transfer books of New Diamond shall be closed and
thereafter there shall be no further registration of transfers of New Diamond Shares that were
outstanding prior to the Effective Time. After the Effective Time, Certificates presented to the
Surviving Corporation for transfer shall be canceled and exchanged for the Per Share Merger
Consideration in respect of the New Diamond Shares represented thereby.
(h) No certificates or scrip representing fractional Parent Shares will be issued upon the
surrender for exchange of Certificates, no dividend or distribution of Parent will relate to such
fractional share interests and such fractional share interests will not entitle the owner thereof
to vote or to any rights of a stockholder of Parent. Notwithstanding any other provision of this
Agreement, each holder of New Diamond Shares converted pursuant to the Emerald Merger who would
otherwise be entitled to receive a fraction of a Parent Share (after taking into account all New
Diamond Shares held at the Effective Time by such holder) shall receive, in lieu thereof and in
accordance with Section 3.6(i), an amount in cash (without interest), rounded to the nearest cent,
equal to the product obtained by multiplying (i) the fractional share interest to which such former
holder would otherwise be entitled by (ii) the Average Closing Price.
(i) No cash payment in lieu of fractional shares and no dividends or other distributions with
respect to Parent Shares with a record date after the Effective Time will be paid to any holder of
an unsurrendered Certificate until the surrender of such Certificate in accordance with this
Article III. Subject to the effect of applicable escheat or similar Laws, following the surrender
of any such Certificate in accordance herewith, there will be paid to the holder of the New Diamond
Shares represented by such Certificate or as otherwise directed by the related letter of
transmittal, without interest, (i) at the time of such surrender, the amount of any cash payable in
lieu of a fractional Parent Share to which such holder is entitled pursuant to Section 3.6(h) and
the amount of dividends or other distributions with a record date after the Effective Time
theretofore paid with respect to whole Parent Shares to which such holder is
entitled pursuant to Section 3.6(c), and (ii) at the appropriate payment date, the amount of
dividends or other distributions with a record date after the Effective Time but prior to such
surrender and with a payment date subsequent to such surrender payable with respect to such whole
Parent Shares. Pending such payment, all such amounts shall be deposited by Parent, as promptly as
practicable, with the Paying Agent, to be held in trust by the Paying Agent for the benefit of the
applicable holders of unsurrendered Certificates.
(j) Holders of unsurrendered Certificates shall be entitled to vote after the Effective Time
at any meeting of Parent stockholders the number of whole Parent Shares the holder of such
Certificates would be entitled to receive in the Emerald Merger, regardless of whether such holders
have exchanged their Certificates.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF THE COMPANY, NEW DIAMOND, AND NEW DIAMOND MERGER SUB
Except as set forth in the corresponding sections of the disclosure letter (subject to the
provisions of Section 9.2) delivered by the Company to Parent on or prior to the execution of this
Agreement (the “Company Disclosure Letter”) and except as disclosed in the Form 10-K of the
-21-
Company for the fiscal period ended February 3, 2005, as amended through the date hereof (as
amended, the “Company Form 10-K”), the Proxy Statement for the Company’s 2005 Annual
Meeting of Shareholders, and the Form 10-Qs and Form 8-Ks filed or furnished from the date of the
filing of the Company Form 10-K to the date of this Agreement (and any amendments to any such
filings which amendments are filed with the SEC prior to the date hereof) to the extent such
qualifications are reasonably apparent (and which in no event shall include risk factors or other
factors identified in general cautionary statements regarding reliance on forward looking
statements in either case included in the Company SEC Reports); and provided that in this
Article IV, except for this sentence and the representations and warranties contained in Section
4.1 (Organization), Section 4.2(a) and (c) (Authority; Enforceability), Section 4.5 (Capitalization
of the Company), Section 4.7 (SEC Reports; Financial Information), Section 4.10(a)(iv), (x) and
(xi) (Contracts), Section 4.13 (Employee Compensation and Benefit Plans; ERISA), Section 4.14
(Labor Matters), Section 4.19 (Tax) and Section 4.20 (Insurance), all references to the “Company”
or to the “Company Subsidiaries” shall (1) prior to the Separation, be deemed to refer to the
Company or to the Company Subsidiaries, as applicable, in relation to the New Diamond Business, and
(2) following the Separation, be deemed to refer to New Diamond or to its Subsidiaries, as
applicable, in relation to the New Diamond Business; the Company hereby represents and warrants to
Parent and Acquisition Sub that:
SECTION 4.1 Organization.
(a) Each of the Company and the Company Subsidiaries is duly organized, validly existing and
in good standing under the laws of its respective jurisdiction of organization, and has the
requisite corporate or similar power and authority to own its properties and to carry on its
business as presently conducted and is duly qualified to do business and is in good standing
(where such concept exists) as a foreign corporation or other entity in each jurisdiction in
which the nature of its business or the ownership or leasing of its properties makes such
qualification necessary, except where the failure to be so organized, qualified or in good standing
or have such power or authority would not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect. Complete and correct copies of the certificate of
incorporation and by-laws of the Company and of the certificate of incorporation and the by-laws or
the equivalent organizational documents of each of the Material Company Subsidiaries as currently
in effect have been made available to Parent and, as so made available, are in full force and
effect, and no other organizational documents are applicable to or binding upon the Company or such
Material Company Subsidiaries.
(b) New Diamond is a Delaware corporation and, as of the date hereof, a wholly owned
subsidiary of the Company. It was formed solely for the purpose of engaging in the Transactions
and, prior to the Initial Effective Time, has engaged in no business activities and has conducted
no operations.
(c) New Diamond Merger Sub is a Delaware corporation and, as of the date hereof, a wholly
owned subsidiary of New Diamond. It was formed solely for the purpose of engaging in the
transactions contemplated hereby and, prior to the Initial Effective Time, has engaged in no
business activities and has conducted no operations.
-22-
SECTION 4.2 Authority; Enforceability.
(a) The Company has all necessary corporate power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the transactions contemplated
hereby. The execution, delivery and performance by the Company of this Agreement and the
consummation by the Company of the transactions contemplated hereby have been duly and validly
authorized by all necessary corporate action on the part of the Company and no other corporate
proceedings on the part of the Company are necessary pursuant to its governing documents or the
DGCL to authorize this Agreement or to consummate the transactions contemplated hereby (other than,
with respect to the Diamond Merger, the adoption of this Agreement and the Charter Amendment by the
holders of a majority of the outstanding Company Shares) (the “Requisite Company Stockholder
Vote”)). The Company Board of Directors has (i) approved this Agreement and the transactions
contemplated hereby, (ii) determined that the terms of this Agreement are fair to and in the best
interests of the Company and its stockholders, and (iii) declared the advisability of this
Agreement. This Agreement has been duly executed and delivered by the Company and, assuming due
authorization, execution and delivery by the other parties hereto, constitutes a legal, valid and
binding agreement of the Company enforceable against the Company in accordance with its terms,
subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium
and other similar Laws relating to or affecting creditors’ rights generally and general equitable
principles (whether considered in a proceeding in equity or at law).
(b) Attached as Exhibit G hereto is a true and correct copy of the Standalone Drug
Sale Agreement. The Company has all requisite power and authority to enter into the Standalone
Drug Sale Agreement and consummate the Standalone Drug Sale, and such agreement has been
duly and validly executed by the Company and, to the Company’s Knowledge (without any inquiry
by any officers of the Company), any other party thereto, and constitutes the valid and binding
obligation of the Company and, to the Company’s Knowledge (without any inquiry by any officers of
the Company), each party thereto, enforceable against such party in accordance with its terms,
subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium
and other similar Laws relating to or affecting creditors’ rights generally and general equitable
principles (whether considered in a proceeding in equity or at law).
(c) Attached as Exhibit F hereto is a true and correct copy of the Separation
Agreement. The Company has all requisite power and authority to enter into the Separation
Agreement and consummate the transactions contemplated thereby, and such agreement has been duly
and validly executed by the Company and, to the Company’s Knowledge (without any inquiry by any
officers of the Company), any other party thereto, and constitutes the valid and binding obligation
of the Company and, to the Company’s Knowledge (without any inquiry by any officers of the
Company), each party thereto, enforceable against such party in accordance with its terms, subject
to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and
other similar Laws relating to or affecting creditors’ rights generally and general equitable
principles (whether considered in a proceeding in equity or at law).
-23-
(d) Each of New Diamond and New Diamond Merger Sub has all necessary corporate power and
authority to execute and deliver this Agreement, to perform its obligations hereunder and to
consummate the transactions contemplated hereby. The execution, delivery and performance by New
Diamond and New Diamond Merger Sub of this Agreement and the consummation of the transactions
contemplated hereby have been duly and validly authorized by all necessary corporate action on the
part of New Diamond and New Diamond Merger Sub, and no other corporate proceedings on the part of
New Diamond or New Diamond Merger Sub are necessary pursuant to their governing documents or the
DGCL to authorize this Agreement or to consummate the transactions contemplated hereby (other than,
with respect to the Diamond Merger, the adoption of this Agreement by New Diamond as the sole
stockholder of New Diamond Merger Sub and, with respect to the Emerald Merger, the adoption of this
Agreement by the Company as the sole stockholder of New Diamond). The Company has caused the
directors of each of New Diamond and New Diamond Merger Sub to approve and declare advisable, and
such directors have approved and declared advisable, this Agreement and the transactions
contemplated hereby. This Agreement has been duly executed and delivered by New Diamond and New
Diamond Merger Sub and, assuming due authorization, execution and delivery by the other parties
hereto, constitutes a legal, valid and binding agreement of each of New Diamond and New Diamond
Merger Sub enforceable against New Diamond and New Diamond Merger Sub in accordance with its terms,
subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium
and other similar Laws relating to or affecting creditors’ rights generally and general equitable
principles (whether considered in a proceeding in equity or at law).
SECTION 4.3 Non-Contravention. The execution, delivery and performance of the
Transaction Agreements by each of the Company, New Diamond, and New Diamond Merger Sub does not and
will not (a) conflict with
or violate its respective organizational documents, (b) conflict with or violate the
organizational documents of any Company Subsidiary, (c) assuming that all consents, approvals and
authorizations contemplated by Section 4.4 have been obtained and all filings described therein
have been made, conflict with or violate any Law applicable to the Company or any of the Company
Subsidiaries or by which its or any of their respective properties are bound, or (d) result in any
breach or violation of or constitute a default (or an event which with notice or lapse of time or
both would become a default) or result in the loss of a benefit under, or give rise to any right of
termination, cancellation, recapture, amendment or acceleration of, or performance under, any note,
bond, mortgage, indenture, contract, agreement, lease, license, permit or other instrument or
obligation (which, in any case, is not a contract, agreement or other arrangement pursuant to which
the Company or any Company Subsidiary leases real property, including the Real Property Leases) to
which the Company or any of the Company Subsidiaries is a party or by which the Company or any of
the Company Subsidiaries or its or any of their respective properties are bound, except in the case
of clauses (b), (c) and (d) of this Section 4.3, for any such conflict, violation, breach, default,
loss, right or other occurrence which would not (i) prevent or materially delay the Company from
performing its obligations under this Agreement in any material respect, or (ii) reasonably be
expected to have, individually or in the aggregate, a Company Material Adverse Effect.
SECTION 4.4 Governmental Consents. The execution, delivery and performance of the
Transaction Agreements by the Company, New Diamond, and New Diamond Merger Sub and the consummation
of the Transactions does not and will not require any consent, approval,
-24-
authorization or permit
of, action by, filing with or notification to, any Governmental Authority, except as required under
or pursuant to (a) the HSR Act, (b) the Securities Act and the Exchange Act, (c) state securities,
takeover and “blue sky” Laws, (d) the rules and regulations of the NYSE or the PCX, (e) the DGCL,
(f) the applicable requirements of antitrust or other competition Laws of other jurisdictions or
investment Laws relating to foreign ownership, and (g) any other consent, approval, authorization,
permit, action, filing or notification the failure of which to be made or obtained would not (i)
prevent or materially delay the Company from performing its obligations under this Agreement in any
material respect, or (ii) reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect.
SECTION 4.5 Capitalization of the Company.
(a) The authorized capital stock of the Company consists of 1,200,000,000 Company Shares and
10,000,000 shares of preferred stock. As of the close of business on January 19, 2006 (the
“Capitalization Date”), (i) 368,970,767 Company Shares were issued and outstanding, (ii) no
Company Shares were held in the treasury of the Company or by Company Subsidiaries, (iii)
49,868,600 Company Shares were reserved for issuance upon or otherwise deliverable in connection
with the conversion of the Company’s 7.25% Hybrid Income Term Security Units (“HITS”), (iv)
62,300,123 Company Shares were reserved for issuance upon or otherwise deliverable in connection
with the grant of equity-based awards (including Stock Units) or the exercise of outstanding
Options issued pursuant to the Company Plans and (v) no shares of preferred stock were outstanding.
Section 4.5 of the Company Disclosure Letter sets forth, as of the date specified thereon, a
complete and accurate list of the Options granted under each Stock
Plan and the exercise price of each such Option and the number of underlying Shares. As of
the Capitalization Date, the Company had outstanding (1) Options to purchase 35,840,443 Company
Shares, (2) 6,051,892 Company Shares underlying Stock Units, and (3) 46,000,000 HITS obligating the
holders thereof to purchase Company Shares in accordance with the terms thereof. From the close of
business on the Capitalization Date until the date of this Agreement, no Company Shares, Options,
Stock Units or HITS have been granted or issued except for Company Shares issued pursuant to the
exercise of Options, the settlement of Stock Units (and dividend equivalents thereon) or the
settlement of HITS in accordance with their present terms. All of the outstanding securities of
the Company are duly authorized and validly issued, and, to the extent such concepts are applicable
thereto, fully paid and nonassessable. Except for the Rights Agreement, dated as of December 9,
1996, between the Company and American Stock Transfer & Trust Company, as successor to ChaseMellon
Shareholder Services, LLC, as subsequently amended on August 2, 1998, March 16, 1999 and September
26, 2003 (as so amended, the “Rights Plan”) and the Rights (as defined in the Rights Plan)
and except as set forth above, there are no outstanding shares, options, warrants, calls, stock
appreciation rights, or other Equity Interests, rights or commitments or any other agreements of
any character relating to dividend rights or to the sale, issuance or voting of, or the granting of
rights to acquire, any shares of capital stock or securities of the Company, or any securities or
obligations convertible into, exchangeable for or evidencing the right to purchase any shares of
capital stock or securities of the Company.
(b) Except as set forth in Section 4.5(a), (i) there are no preemptive rights of any kind
which obligate the Company or any Company Subsidiary to issue or deliver any shares of capital
stock or securities of the Company or any securities or obligations convertible or exchangeable
-25-
into or exercisable for, or giving any Person a right to subscribe for or acquire from the Company
or any Company Subsidiary, any shares of capital stock or securities of the Company, and (ii) there
is no agreement, contract, commitment or arrangement pursuant to which the Company or any Company
Subsidiary is or may become obligated to repurchase or redeem any shares of capital stock or
securities of the Company or any securities or obligations convertible or exchangeable into or
exercisable for any shares of capital stock or securities of the Company. Except for the HITS,
neither the Company nor any Company Subsidiary has outstanding any bonds, debentures, notes or
other obligations the holders of which have the right to vote (or which are convertible,
exchangeable, exercisable or can be settled for or into securities having the right to vote) with
the stockholders of the Company on any matter.
(c) As of the date hereof, the authorized capital stock of New Diamond consists of 1,000 New
Diamond Shares. Immediately prior to the Initial Effective Time, the certificate of incorporation
of New Diamond will be amended to provide that the authorized capital stock of New Diamond will
consist of 1,200,000,000 New Diamond Shares. As of the date hereof, 100 New Diamond Shares are
issued and outstanding, all of which New Diamond Shares have been issued to and are held by the
Company. Except for the New Diamond Shares, there are no securities of New Diamond authorized,
issued or outstanding.
(d) The authorized capital stock of New Diamond Merger Sub consists of 1,000 shares of Common
Stock, 100 of which shares have been issued to and are held by New Diamond. Except for such shares
of Common Stock, there are no securities of New Diamond Merger Sub authorized, issued or
outstanding.
SECTION 4.6 Company Subsidiaries. All of the outstanding Equity Interests, as
applicable, of each Company Subsidiary are validly issued, fully paid and nonassessable and are
owned, directly or indirectly, by the Company free and clear of any Encumbrances. There are no
outstanding options, warrants, calls, stock appreciation rights, or other rights or commitments or
any other agreements of any character (other than agreements between the Company and any Company
Subsidiary) relating to the sale, issuance or voting of, or the granting of rights to acquire any
Equity Interests of any such Company Subsidiary, or any securities or other instruments convertible
into, exchangeable for or evidencing the right to purchase any Equity Interests of any such Company
Subsidiary. Section 4.6 of the Company Disclosure Letter sets forth each Company Subsidiary. No
Subsidiary of the Company owns any stock, or any option or other instrument convertible into or
calculated by reference to any stock, in the Company or any HITS.
SECTION 4.7 SEC Reports; Financial Information.
(a) The Company has timely filed or furnished, as applicable, all forms, reports, statements,
certifications and other documents (including all exhibits, supplements and amendments thereto)
required to be filed or furnished by it with the Securities and Exchange Commission (“SEC”)
since January 1, 2003 (collectively, with any amendments thereto, the “Company SEC
Reports”), each of which, including any financial statements or schedules included therein, as
finally amended prior to the date hereof, has complied as to form in all material respects with the
applicable requirements of the Securities Act and the Exchange Act, each as in effect on the date
so filed. None of the Company SEC Reports contained, when filed
-26-
as finally amended prior to the
date hereof, any untrue statement of a material fact or omitted to state a material fact required
to be stated or incorporated by reference therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. Each of (i)
the consolidated balance sheets included in the Company SEC Reports (including the related notes
and schedules) was prepared in accordance with GAAP in all material respects applied on a
consistent basis throughout the periods covered and fairly presents, in all material respects, the
consolidated financial position of the Company and the Company Subsidiaries at the respective dates
thereof and (ii) the related consolidated statements of earnings, cash flows and stockholders’
equity included in the Company SEC Reports (including the related notes and schedules) were
prepared in accordance with GAAP in all material respects applied on a consistent basis throughout
the periods covered and fairly present, in all material respects, the results of operations and
cash flows of the Company and the Company Subsidiaries for the periods indicated (subject, in the
case of each of clause (i) and (ii), to normal and/or recurring year-end adjustments and the
absence of full footnote disclosure in the case of unaudited financial statements).
(b) Attached hereto are (i) unaudited selected results of operations data for each of the New
Diamond Business, the Standalone Drug Business and the Retained Business for the 52 weeks ended
January 29, 2004, the 53 weeks ended February 3, 2005 and the 39 weeks ended November 3, 2005
(collectively, the “Separate Operations Data,” attached hereto as Exhibit H) and
(ii) unaudited selected balance sheet data for the Company and each of the Company’s operating
regions as of February 3, 2005 (the “Separate Balance Sheet Data,” attached hereto as
Exhibit I). The Separate Operations Data and the Separate Balance Sheet Data have been
compiled from source books, records and financial reports of the Company and its Subsidiaries.
Such source books, records and financial reports were prepared by the Company in the ordinary
course of its business, are accurate in all material respects and were subject to the Company’s
internal controls. The allocations of the Separate Operations Data among the New Diamond Business,
the Standalone Drug Business and the Retained Business are consistent with Section 4.7(b)(i) of the
Company Disclosure Letter and the allocations of the Separate Balance Sheet Data are allocated in
the manner described in Section 4.7(b)(ii) of the Company Disclosure Letter. The Separate Balance
Sheet Data and the Separate Operations Data reconcile to the Company’s historical financial
statements filed with the SEC and, in the Company’s opinion, present fairly, in all material
respects, the information presented in the Separate Balance Sheet Data and the Separate Operations
Data, respectively. Subject to the changes in accounting principles and methodologies effected by
the Company as described in the Company SEC Reports, the accounting principles and methodologies
used in the preparation of the Separate Operations Data were applied on a consistent basis, in all
material respects, for each of the periods presented therein.
(c) The Company has designed and maintains a system of internal control over financial
reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) sufficient to provide
reasonable assurances regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with GAAP. The Company (i) has designed
and maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of
the Exchange Act) that provide reasonable assurance that material information required to be
disclosed by the Company in the reports that it files or submits under the Exchange Act is
recorded, processed, summarized and reported within the time periods
-27-
specified in the SEC’s rules
and forms, and (ii) has disclosed and reported, based on its most recent evaluation of its internal
control over financial reporting prior to the date hereof, to the Company’s auditors and the audit
committee of the Company Board of Directors (A) any significant deficiencies and material
weaknesses in the design or operation of its internal control over financial reporting that are
reasonably likely to adversely affect in any material respect the Company’s ability to record,
process, summarize and report financial information and (B) any fraud, whether or not material,
that involves management or other employees who have a significant role in the Company’s internal
control over financial reporting. The Company has heretofore furnished to Parent complete and
correct copies of the Company’s final report to the audit committee of the Company Board of
Directors for fiscal 2004 and all subsequent regular quarterly updates, in each case in respect of
the matters described in clause (ii) of the immediately preceding sentence.
(d) Except for matters resolved prior to the date hereof, since January 1, 2003, (i) to the
Knowledge of the Company neither the Company nor any Company Subsidiary nor any director, officer,
employee, auditor, accountant or representative of the Company or of any Company Subsidiary has
received or otherwise had or obtained Knowledge of any material complaint, allegation, assertion or
claim, whether written or oral, regarding the accounting or auditing practices, procedures,
methodologies or methods of the Company or any Company Subsidiary or their respective internal
accounting controls, including any material complaint, allegation, assertion or claim that the
Company or any Company Subsidiary has engaged in questionable accounting or auditing practices, and
(ii) no attorney representing the Company or any Company Subsidiary, whether or not employed by the
Company or any Company
Subsidiary, has reported evidence of a material violation of securities Laws, breach of
fiduciary duty or similar violation by the Company or any of its officers, directors, employees or
agents to the Company Board of Directors or any committee thereof or to the General Counsel or
Chief Executive Officer of the Company.
SECTION 4.8 No Undisclosed Liabilities. Neither the Company nor any of the Company
Subsidiaries has any liabilities, claims or indebtedness of any kind whatsoever, whether accrued,
contingent, absolute, determined, determinable or otherwise, whether due or to become due, in each
case, that are required by GAAP to be accrued, reserved against, or disclosed in a consolidated
balance sheet or the notes thereto, except liabilities that (i) are accrued or reserved against in
the financial statements included in the Company Form 10-K or Quarterly Report on Form 10-Q most
recently filed prior to the date hereof or are disclosed in the notes thereto, (ii) were incurred
in the ordinary course of business and consistent with past practice since the date of the most
recent balance sheet included in the most recent quarterly report on Form 10-Q filed by the Company
with the SEC prior to the date of this Agreement (the “Company Balance Sheet Date”) and
would not reasonably be expected to have, individually or in the aggregate, (A) a Company Material
Adverse Effect or (B) a Material Adverse Effect as that term is defined in the Standalone Drug Sale
Agreement, (iii) are incurred pursuant to the transactions contemplated by this Agreement, (iv)
have been discharged or paid in full prior to the date of this Agreement in the ordinary course of
business consistent with past practice or (v) were incurred outside the ordinary course of business
since the Company Balance Sheet Date, but which are, and would reasonably be expected to be,
individually or in the aggregate, immaterial in amount or nature.
-28-
SECTION 4.9 Absence of Certain Changes or Events. Since the Company Balance Sheet
Date, except as expressly contemplated by this Agreement, the Company and the Company Subsidiaries
have conducted their businesses in the ordinary course in all material respects consistent with
past practice, and, since such date, there has not been any change, event or occurrence which has
had or would reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect. Except as set forth in Section 4.9 of the Company Disclosure Letter, since the
Company Balance Sheet Date to the date hereof, neither the Company nor any Company Subsidiary has
taken any action that, if taken after the date of this Agreement, would constitute a breach of the
covenants set forth in Sections 6.1(a)(i), (ii), (iv)(B), (v)(A), (v)(B), (v)(C), (v)(D) (other
than any Real Property Leases), (viii) or (xi) hereof.
SECTION 4.10 Contracts.
(a) As of the date hereof, none of the Company nor any Company Subsidiary is a party to or
bound by any: (i) contract (other than this Agreement) that would be required to be filed by the
Company as a material contract pursuant to Item 601(b)(10) of Regulation S-K of the SEC; (ii)
except as contemplated by this Agreement, contract containing covenants of the Company or any
Company Subsidiary not to compete in any line of business, industry or geographical area (in each
case, other than agreements with respect to real property) in any manner that is material to the
Company and the Company Subsidiaries, taken as a whole; (iii) contract which creates a partnership
or joint venture or similar arrangement that is material to the
Company and the Company Subsidiaries, taken as a whole; (iv) contract (other than purchase
orders) for the purchase of merchandise for resale with the Company’s top ten suppliers of
merchandise for resale (measured by dollar volume during the fiscal year ended February 3, 2005),
or requirements or output contract or any contract containing an exclusive arrangement or agreement
with a Company supplier under which, in each case, the Company and the Company Subsidiaries have
made or reasonably expect to make $20,000,000 of payments in any 12 month period; (v) indenture,
credit agreement, loan agreement, security agreement, note, mortgage or other evidence of
Indebtedness or agreement providing for Indebtedness, or capital lease or sublease of real or
personal property (including synthetic leases and similar financing arrangements), in excess of
$25,000,000; (vi) contract (other than the Transaction Agreements and the Standalone Drug Sale
Agreement) for the sale of any of its assets after the date hereof in excess of $35,000,000 (other
than in the ordinary course of business consistent with past practice); (vii) collective bargaining
or employee association agreement covering in excess of 50 employees; (viii) except for HITS,
contract that contains a put, call, right of first refusal or similar right pursuant to which the
Company or any Company Subsidiary would be required to purchase or sell, as applicable, any Equity
Interests of any Person (other than a Company Subsidiary); (ix) settlement or conciliation
agreement or similar agreement with a Governmental Authority or order or consent of a Governmental
Authority to which the Company or any of the Company Subsidiaries is a party involving future
performance by the Company or any Company Subsidiary which is material to the Company and Company
Subsidiaries taken as a whole; (x) distribution, supply, inventory purchase or private label
products purchase contract under which the Company and the Company Subsidiaries are obligated to
make payments in the future in excess of $10,000,000 per annum during the life of the contract and
which is not cancelable (without material penalty, cost or other liability) within one year; and
(xi) other contract (other than the Transaction Agreements, the Standalone Drug Sale Agreement,
purchase orders for the purchase of inventory or supplies or agreements with respect to real
property made in the
-29-
ordinary course of business consistent with past practice) under which the
Company and the Company Subsidiaries have made payments in the past 12 months or are obligated to
make payments in the future in excess of (A) $5,000,000 per annum or $10,000,000 during the life of
the contract in the case of licenses or contracts for the provision of agency, advisory or
consulting services, and (B) $20,000,000 per annum or $50,000,000 during the life of the contract
in the case of any other contracts. Each such contract described in clauses (i)-(xi), together
with any contract of the type described in clauses (i)-(xi) above and entered into on or after the
date hereof and prior to the Closing Date, is referred to herein as a “Material Contract.”
(b) (i) Neither the Company nor any Company Subsidiary is (and, to the Company’s Knowledge, no
other party is) in default under any Material Contract in any material respect, (ii) each of the
Material Contracts is, in all material respects, in full force and effect, and is the valid,
binding and enforceable obligation of the Company and the Company Subsidiaries, and to the
Company’s Knowledge, of the other parties thereto, and (iii) the Company and the Company
Subsidiaries have performed all respective material obligations required to be performed by them to
date under the Material Contracts and are not (with or without the lapse of time or the giving of
notice, or both) in material breach thereunder. The Company has made available to Parent true and
complete copies of each Material Contract, including all material amendments thereto, except to the
extent such disclosure would violate the confidentiality provisions of such Material Contract.
(c) Section 4.10(c) of the Company Disclosure Letter is a complete and correct list of all
distribution, supply, inventory purchase or private label products purchase contracts under which
the Company has received any advance of money in excess of $10,000,000 (including advances
characterized as advance payments, inducements, incentives, rebates, fees or promotional funds)
subject to repayment, in whole or in part, for reasons relating to purchase volume (including
minimum volume requirements, minimum number of participating stores, or repayment for early
cancellation) (such contracts, “Advance Contracts”). The consummation of the Transactions
and the Standalone Drug Sale will not cause any advances under the Advance Contracts to be
repayable within one year of the Closing Date (the “First Operating Year”), assuming the
Company’s and its Subsidiaries’ business consisted only of the New Diamond Business and generated a
sales volume during the course of the First Operating Year that is consistent with the sales volume
of the New Diamond Business over that past year.
SECTION 4.11 Compliance with Law and Reporting Requirements.
(a) The Company and the Company Subsidiaries are not (and have not been since the Company
Balance Sheet Date) in material violation of any Law, and have not received any written notice of
any material violation of Law. The Company and the Company Subsidiaries have, and are (and have
been since the Company Balance Sheet Date) in compliance with, all permits, licenses,
authorizations, exemptions, orders, consents, approvals and franchises from Governmental
Authorities required to conduct their respective businesses as now being conducted, except for any
such permit, license, authorization, exemption, order, consent, approval or franchise the absence
of, or the non-compliance with which, would not reasonably be expected to have, individually or in
the aggregate, a Company Material Adverse Effect.
-30-
(b) None of the Company Subsidiaries is, or has at any time since January 1, 2003 been,
subject to the reporting requirements of Sections 13(a) or 15(d) under the Exchange Act.
SECTION 4.12 Litigation. There are no Actions pending or, to the Knowledge of the
Company, threatened against the Company or any Company Subsidiary or, to the Knowledge of the
Company, any officer, director or employee of the Company or any Company Subsidiary in such
capacity, which would reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect. Neither the Company nor any Company Subsidiary is a party or subject to
or in default under any material Governmental Order.
SECTION 4.13 Employee Compensation and Benefit Plans; ERISA.
(a) Section 4.13(a) of the Company Disclosure Letter sets forth a correct and complete list of
each material “employee benefit plan” (within the meaning of Section 3(3) of ERISA but excluding
any plan that is a “multiemployer plan,” as defined in Section 3(37) of ERISA (“Multiemployer
Plan”)) and each other material director and employee plan, program, agreement or arrangement,
vacation or sick pay policy, fringe benefit plan, compensation,
severance or employment agreement, stock bonus, stock purchase, stock option, restricted
stock, stock appreciation right or other equity-based plan, and bonus or other incentive
compensation or salary continuation plan or policy contributed to, sponsored or maintained by or
with respect to which the Company or any Company Subsidiary has any liability (contingent or
otherwise) as of the date hereof for the benefit of any current, former or retired employee,
officer, consultant, independent contractor or director of the Company or any Company Subsidiary
(collectively, the “Company Employees”; such plans, programs, policies, agreements and
arrangements, collectively, being the “Company Plans”).
(b) With respect to each Company Plan, the Company has made available to the Parent a current,
accurate and complete copy thereof (or, if a plan is not written, a written description thereof)
and, to the extent applicable, (i) any related trust or custodial agreement or other funding
instrument, (ii) the most recent determination letter, if any, received from the Internal Revenue
Service (“IRS”), (iii) any current summary plan description or employee handbook, (iv) for
the most recent year (A) the Form 5500 and attached schedules, (B) audited financial statements,
and (C) actuarial valuation reports, if any, and (v) copies of any correspondence from the IRS,
SEC, Pension Benefit Guaranty Corporation (the “PBGC”) or Department of Labor (or any
agency thereof) relating to any material compliance issues with respect to any Company Plan.
(c) Except as would not, individually or in the aggregate, reasonably be expected to result in
a Company Material Adverse Effect, each Company Plan has been established and is being administered
in accordance with its terms and in compliance with the applicable provisions of ERISA, the Code,
and other Laws.
(d) With respect to any Multiemployer Plan with respect to which the Company or any Company
Subsidiary has any liability or contributes (or has at any time contributed) or has an obligation
to make a contribution, (i) neither the Company nor any Company Subsidiary has incurred any
withdrawal liability under Subtitle E of Title IV of ERISA (“Withdrawal Liability”) that
remains unsatisfied as would reasonably be expected to have, individually or in the
-31-
aggregate, a
Company Material Adverse Effect, and (ii) neither the Company nor any Company Subsidiary has
received any notification, nor has any reason to believe, that any such Multiemployer Plan is in
reorganization, has been terminated, is insolvent, or prior to the Effective Time is reasonably
likely to be in reorganization, to be insolvent, or to be terminated.
(e) Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, no actions, suits or claims (other than routine claims for
benefits in the ordinary course) are pending or, to the Knowledge of the Company, threatened with
respect to any Company Plan.
(f) Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, (i) neither the Company nor any Company Subsidiary has incurred
any liability under Subtitle C or D of Title IV of ERISA that has not been satisfied in full, and
(ii) no condition exists that presents a risk to the Company or any Company Subsidiary of incurring
any such liability other than liability for premiums due the PBGC. With respect to each Company
Plan that is subject to Title IV or Section 302 of ERISA or Section 412 or 4971 of the Code: (A)
there does not exist any accumulated funding
deficiency within the meaning of Section 412 of the Code or Section 302 of ERISA, whether or
not waived, (B) the fair market value of the assets of such plan equals or exceeds the actuarial
present value of all accrued benefits under such plan (whether or not vested), (C) since January 1,
2003, no reportable event within the meaning of Section 4043(c) of ERISA for which the 30-day
notice requirement has not been waived has occurred, and the consummation of the transactions
contemplated by this agreement will not result in the occurrence of any such reportable event, (D)
all premiums to the PBGC have been timely paid in full, and (E) the PBGC has not instituted
proceedings to terminate any such plan and, to the Company’s Knowledge, no condition exists that
presents a risk that such proceedings will be instituted or which would constitute grounds under
Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any
such plan and the Company has not received any notice from the PBGC regarding the Transactions
and/or the funded status of any Company Plan subject to Title IV of ERISA.
(g) Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, each Company Plan which is intended to be qualified under Section
401(a) of the Code is so qualified and has received a determination letter to that effect from the
IRS and, to the Knowledge of the Company, no circumstances exist which would reasonably be expected
to materially adversely affect such qualification or exemption.
(h) The Company and the Company Subsidiaries have reserved the right to amend, terminate or
modify at any time all plans or arrangements providing for retiree health or life insurance
coverage, and there has been no communication to current or former employees of the Company and
Company Subsidiaries which could reasonably be interpreted to promise or guarantee such individuals
or their dependents retiree health or life insurance or other retiree death benefits on a permanent
basis.
(i) All Company Plans subject to the laws of any jurisdiction outside of the United States (i)
have been maintained in accordance with all applicable requirements, (ii) if
-32-
they are intended to
qualify for special tax treatment, meet all requirements for such treatment, and (iii) if they are
intended to be funded and/or book-reserved, are fully funded and/or book-reserved, as appropriate,
based upon reasonable actuarial assumptions.
SECTION 4.14 Labor Matters. Except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect, neither the Company nor any
Company Subsidiary has received notice during the past two years of the intent of any Governmental
Authority responsible for the enforcement of labor, employment, occupational health and safety or
workplace safety and insurance/workers compensation laws to conduct an investigation of or
affecting the Company or a Company Subsidiary and, to the Knowledge of the Company, no such
investigation is in progress. Except as would not reasonably be expected to have, individually or
in the aggregate, a Company Material Adverse Effect, there are no (and have not since June 30, 2003
been any) labor disputes, strikes, organizing activities or work stoppages against the Company or
Company Subsidiaries pending, or to the Knowledge of the Company, threatened. No labor
organization or group of 50 or more employees of the Company or any Company Subsidiary has made a
pending formal demand for recognition or certification, and there are no representation or
certification proceedings or petitions seeking a representation
proceeding presently pending or, to the Company’s Knowledge, threatened to be brought. The
Company and each of the Company Subsidiaries is in compliance with all collective bargaining
agreements respecting employment and employment practices, terms and conditions of employment,
wages and hours and occupational safety and health (including, without limitation, classifications
of service providers as employees and/or independent contractors).
SECTION 4.15 Properties.
(a) Section 4.15(a) of the Company Disclosure Letter contains a true and complete list of all
real property owned by the Company or any Company Subsidiary (other than immaterial real property
that is not currently used (or currently identified for future use) in connection with the
operation of a grocery store, drug store and/or distribution center) (each, an “Owned Real
Property,” and collectively, the “Owned Real Properties”).
(b) Section 4.15(b) of the Company Disclosure Letter contains a true and complete list of all
real property leased or subleased (whether as tenant or subtenant) by the Company or any Company
Subsidiary (other than immaterial real property that is not currently used (or currently identified
for future use) in connection with the operation of a grocery store, drug store and/or distribution
center) (each, including the improvements thereon, a “Leased Real Property,” and
collectively, the “Leased Real Properties”). With respect to the Leased Real Properties and
the Real Property Leases (as defined below), there are no non-disturbance agreements and
declarations of covenants, restrictions, reciprocal and/or operating easements, development
agreements, or agreements with municipal authorities with respect to zoning or planning, including
amendments relating thereto, that would reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect. Substantially accurate (to the Company’s Knowledge)
summaries prepared in the ordinary course of business of the principal economic terms of each of
the leases pursuant to which the Company leases (as a lessee) real property for the operation of a
grocery or drug store, distribution center, or other material operation center, as such leases have
been amended to date (each lease, including all amendments thereto, a “Real Property
Lease”) have been made available to Parent.
-33-
(c) Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, the Company or one of the Company Subsidiaries has good and
marketable fee simple title to all Owned Real Properties and valid leasehold estates in all Leased
Real Properties free and clear of all Encumbrances. The Company or one of the Company Subsidiaries
has exclusive use and possession of each Leased Real Property and Owned Real Property, other than
any use or occupancy rights granted to third-party owners, tenants or licensees pursuant to
agreements with respect to such real property entered in the ordinary course of business (each
agreement, including all amendments thereto, a “Third Party Use and Occupancy Agreement”),
none of which would reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect.
(d) Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, each Real Property Lease and each Third Party Use and Occupancy
Agreement is in full force and effect and is valid and enforceable in accordance with its terms,
and there is no material default under any Real Property Lease or any Third Party Use and Occupancy
Agreement either by the Company or the Company Subsidiaries
party thereto or, to the Company’s Knowledge, by any other party thereto, and no event has
occurred that, with the lapse of time or the giving of notice or both, would constitute a default
by the Company or the Company Subsidiaries thereunder.
(e) Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, there are no pending or, to the Company’s Knowledge, threatened
condemnation or eminent domain proceedings that affect any Owned Real Property or Leased Real
Property, and neither the Company nor the Company Subsidiaries have received any written notice of
the intention of any Governmental Authority or other Person to take any Owned Real Property or
Leased Real Property.
SECTION 4.16 Tangible Personal Property. Other than with respect to the Owned Real
Properties and the Leased Real Properties and except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect, the Company or one of the
Company Subsidiaries has good, valid and indefeasible title to or, in the case of leased assets, a
valid, binding and enforceable leasehold interest in, all tangible assets reflected on the most
recent consolidated balance sheet included in Company SEC Reports filed prior to the date hereof as
being owned by the Company or one of the Company Subsidiaries or purchased or acquired by the
Company or a Company Subsidiary after the date of such most recent balance sheet, in each case free
and clear of any Encumbrance other than Permitted Encumbrances.
SECTION 4.17 Intellectual Property; IT Systems.
(a) Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, (i) the Company and the Company Subsidiaries own all right, title,
and interest in, or have the right to use, pursuant to a license or otherwise, in each case, free
and clear of all Encumbrances, all Intellectual Property required to operate their respective
businesses as presently conducted (the “Company Intellectual Property”), (ii) Section 4.17
of the Company Disclosure Letter lists all registrations and applications for Intellectual Property
owned by the Company and/or any of the Company Subsidiaries and material to the Company’s business,
and (iii) as of the date hereof, (x) neither the Company nor any Company
-34-
Subsidiary has received
any written notice of any actual or threatened Actions alleging a violation, misappropriation or
infringement of the Intellectual Property of any other Person, except for any of the foregoing that
have since been resolved, (y) to the Company’s Knowledge, the operation of the business of the
Company and each Company Subsidiary does not violate, misappropriate or infringe and has not
previously violated, misappropriated or infringed the Intellectual Property of any other Person
(except for any previous violation, misappropriation or infringement which has been fully and
conclusively resolved with such other Person), and (z) to the Company’s Knowledge, no other Person
has violated, misappropriated or infringed any Intellectual Property owned by the Company or any
Company Subsidiary.
(b) Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, (i) the IT Systems of the Company and the Company Subsidiaries are
adequate for the operation of their respective businesses as presently conducted and (ii) there has
not been any material malfunction with respect to any of the material
IT Systems of the Company or the Company Subsidiaries since January 31, 2002 that has not been
remedied or replaced in all material respects.
(c) Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, (i) the use of the Data by the Company or the Company Subsidiaries
in the operation of their business does not infringe or violate the privacy rights of any Person or
otherwise violate any Law or regulation, (ii) the Company and the Company Subsidiaries have taken
reasonable and customary measures consistent with generally accepted industry practices to protect
the privacy of the Data of their respective customers, and (iii) to the Company’s Knowledge, since
January 31, 2002 there have been no security breaches with respect to the privacy of such Data.
SECTION 4.18 Environmental Laws.
(a) (i) Except as would not reasonably be expected to have a Company Material Adverse Effect,
to the Company’s Knowledge, the Company and each Company Subsidiary comply and have complied with
all applicable Environmental Laws (as defined below), and possess and comply, and have complied,
with all applicable Environmental Permits (as defined below) required under such laws to operate as
it currently operates; (ii) except as would not reasonably be expected to have a Company Material
Adverse Effect, to the Company’s Knowledge, there are no, and there have not been any, Materials of
Environmental Concern (as defined below) at any property currently or formerly owned or operated by
the Company or a Company Subsidiary, under circumstances that have resulted in or are reasonably
likely to result in liability of the Company or a Company Subsidiary under any applicable
Environmental Laws; (iii) except as would not reasonably be expected to have a Company Material
Adverse Effect, neither the Company nor any Company Subsidiary has received any written
notification alleging that it is liable for, or request for information pursuant to section 104(e)
of the Comprehensive Environmental Response, Compensation and Liability Act or similar foreign,
state or local Law concerning, any release or threatened release of Materials of Environmental
Concern at any location except, with respect to any such notification or request for information
concerning any such release or threatened release, to the extent such matter has been fully
resolved such that no further action is required with the appropriate foreign, federal, state or
local regulatory authority or otherwise; and (iv) the reports of environmental assessments, audits
and similar investigations
-35-
previously made available to Parent are all material such reports in the
possession of the Company and conducted since January 30, 2003 on any property currently or
formerly owned or operated by the Company or any Company Subsidiary. There are no Actions arising
under Environmental Laws pending or, to the Knowledge of the Company, threatened against the
Company or any Company Subsidiary which would reasonably be expected to have, individually or in
the aggregate, a Company Material Adverse Effect. Except as would not reasonably be expected to
have a Company Material Adverse Effect, at each property where Asbestos-Containing Material
(“ACM”) has been identified, all ACM is non-friable, encapsulated or abated and no ACM is
present in any property where the Company has not implemented an Asbestos Operation and Management
Plan.
(b) Notwithstanding any other representations and warranties in this Agreement, the
representations and warranties in this Section 4.18 are the only representations and warranties in
this Agreement with respect to Environmental Laws, Environmental Permits or Materials of
Environmental Concern.
(c) For purposes of this Agreement, the following terms have the meanings assigned below:
“Environmental Laws” means all Laws relating to the protection of the environment,
including the ambient air, soil, surface water or groundwater, or relating to the protection of
human health from exposure to Materials of Environmental Concern.
“Environmental Permits” means all permits, licenses, registrations, and other
authorizations required under applicable Environmental Laws.
“Materials of Environmental Concern” means any hazardous, acutely hazardous, or toxic
substance or waste defined or regulated as such under Environmental Laws, including the federal
Comprehensive Environmental Response, Compensation and Liability Act and the federal Resource
Conservation and Recovery Act.
SECTION 4.19 Taxes. (a) Except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect, (1) all Tax Returns required
to be filed by, or with respect to any activities of, the Company and the Company Subsidiaries have
been filed (except those under valid extension), (2) all Taxes of the Company and the Company
Subsidiaries have been paid or adequately provided for on the most recent financial statements
included in the Company SEC Reports filed prior to the date hereof other than those Taxes accrued
in the ordinary course of business since February 3, 2005, (3) neither the Company nor any Company
Subsidiary has received notice in writing of any action, suit, proceeding, investigation, claim or
audit against, or with respect to, any Taxes of the Company or any Company Subsidiary, (4) there
are no liens for Taxes (other than Taxes not yet due and payable) upon any of the assets of the
Company or any Company Subsidiary, (5) the Company and each Company Subsidiary has withheld and
paid all Taxes required to have been withheld and paid in connection with amounts paid or owing to
any employee, independent contractor, creditor, stockholder, or other third party, (6) neither the
Company nor any Company Subsidiary (A) has been a member of an affiliated group filing a
consolidated federal income tax return (other than a group the common parent of which was the
Company) or (A) has any liability for
-36-
the Taxes of any Person (other than the Company, or any
Company Subsidiary) under Treasury Regulation Section 1.1502-6 (or any similar provision of state,
local or foreign law), (7) neither the Company nor any Company Subsidiary has engaged in any
“listed transaction” for purposes of Treasury Regulation Sections 1.6011-4(b)(2) and (c)(3), and
(8) neither the Company nor any Company Subsidiary has waived any statute of limitations with
respect to Taxes which has not since expired or agreed to any extension of time with respect to a
Tax assessment or deficiency which has not since expired.
(b) Neither the Company nor any Company Subsidiary has distributed the stock of another
company in a transaction (occurring within the past two years or that otherwise is part of the same
plan or series of transactions, within the meaning of Section 355 of the Code, as the Mergers) that
was purported or intended to be governed by Section 355 or Section 361 of the Code.
(c) Each of American Stores Company, LLC and American Stores Realty Company, LLC is a
“disregarded” entity within the meaning of Treasury Regulation Section 301.7701-3. American
Partners, LP is a partnership within the meaning of the Code. Except as set forth in Section
4.19(c) of the Company Disclosure Letter, each other Subsidiary of the Company is a corporation
within the meaning of the Code.
SECTION 4.20 Insurance. All material insurance policies maintained by the Company and
the Company Subsidiaries are listed in Section 4.20 of the Company Disclosure Letter. Except as
would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect, all such insurance policies are in full force and effect, all premiums due and
payable thereon have been paid, and no written notice of cancellation or termination has been
received with respect to such policy.
SECTION 4.21 Rights Plan. The Company Board of Directors has amended the Rights Plan
so that (a) neither the execution, delivery or performance of this Agreement nor the consummation
of the transactions contemplated hereby will (i) cause the Rights to become exercisable, (ii) cause
New Diamond, Parent or any of its Affiliates or Associates (as each such term is defined in the
Rights Plan) to become an Acquiring Person (as such term is defined in the Rights Plan) or (iii)
give rise to a Stock Acquisition Date or a Distribution Date (as each such term is defined in the
Rights Plan), and (b) the Rights will expire immediately prior to the Initial Effective Time
without any payment being made in respect thereof. The Company has made available to Parent a true
and complete copy of such amendment.
SECTION 4.22 HITS.
(a) Complete and correct copies of the following documents relating to the HITS have been made
available to the Parent and, as so made available, are in full force and effect: (i) the Purchase
Contract Agreement dated May 7, 2004 and relating to the HITS, between the Company and U.S. Bank
Trust National Association, as Purchase Contract Agent (the “HITS Purchase Contract
Agreement”); (ii) the Pledge Agreement; (iii) the Remarketing Agreement; and (iv) the
Indenture, dated as of May 1, 1992, between the Company and U.S. Bank Trust National Association,
as successor Trustee, as supplemented by Supplemental Indenture No. 1, dated May 7, 2004, between
the Company and U.S. Bank Trust National Association, as Trustee
-37-
(as supplemented, the “HITS
Indenture”). For purposes of this Section 4.22, all capitalized terms not defined in this
Agreement shall have the meaning given to them in the HITS Purchase Contract Agreement.
(b) If the Surviving Corporation enters into such supplemental agreements in form reasonably
satisfactory to the Purchase Contract Agent and Collateral Agent, so as to cause all obligations of
the Company under the HITS Purchase Contract Agreement, the Purchase Contracts, the HITS Pledge
Agreement, the HITS Remarketing Agreement, and the HITS Indenture, to become obligations of the
Surviving Corporation upon consummation of the Mergers (which supplemental agreements to the HITS
Purchase Contract Agreement shall provide that each Holder of a Purchase Contract shall have the
rights provided by Section 5.04(b)(i) of the HITS Purchase Agreement), then the consummation of the
Transactions shall
not cause a breach of the covenant contained in Section 9.01 of the HITS Purchase Contract
Agreement.
(c) Neither the Company nor the Surviving Corporation shall, immediately after any of the
Transactions, (i) be in default of payment obligations under the HITS Purchase Contract Agreement,
the Purchase Contracts, the HITS Pledge Agreement, the HITS Remarketing Agreement or the HITS
Indenture, or (ii) be in material default in the performance of any other covenants under any of
the foregoing agreements.
(d) If the Transactions are consummated and on the Purchase Contract Settlement Date, the
Surviving Corporation, in exchange for the Purchase Price, delivers or causes the Collateral Agent
to deliver to a Holder of a Purchase Contract on such date with respect to each Purchase Contract,
utilizing the Settlement Rate in effect at such time based upon the Applicable Market Value of the
Per Share Merger Consideration, (i) an amount in cash equal to the product obtained by multiplying
the Cash Consideration by such Settlement Rate and (ii) a number of Parent Shares equal to the
product obtained by multiplying the Stock Consideration by such Settlement Rate, such delivery
shall be in compliance with Article 5 of the HITS Purchase Contract Agreement.
(e) If the Transactions are consummated and any Holder of a Purchase Contract effects a Cash
Merger Early Settlement with respect to any Purchase Contract in accordance with Section
5.04(b)(ii) of the HITS Purchase Contract Agreement, and if the Surviving Corporation delivers or
causes the Collateral Agent to deliver with respect to each Purchase Contract on the Cash Merger
Early Settlement Date utilizing the Settlement Rate in effect at such time based upon the
Applicable Market Value of the Per Share Merger Consideration: (i) (x) an amount in cash equal to
the product obtained by multiplying the Cash Consideration by such Settlement Rate and (y) a number
of Parent Shares equal to the product obtained by multiplying the Stock Consideration by such
Settlement Rate; (ii) the Senior Notes, the Applicable Ownership Interests in the Treasury
Portfolio or Treasury Securities, as the case may be, related to such Purchase Contract; and (iii)
any prospectus required to be delivered by Section 5.04(b)(ii) of the HITS Purchase Contract
Agreement, then such delivery shall be in compliance with Section 5.04(b)(ii) of the HITS Purchase
Contract Agreement.
SECTION 4.23 Affiliate Transactions. There are no transactions, agreements,
arrangements or understandings between (i) the Company or any of the Company Subsidiaries,
-38-
on the
one hand, and (ii) any Affiliate, stockholder, officer or director of the Company (other than the
Company Subsidiaries), on the other hand, of the type that would be required to be disclosed under
Item 404 of Regulation S-K under the Securities Act.
SECTION 4.24 Brokers. Except for Xxxxxxx, Xxxxx & Co. (“Xxxxxxx Sachs”) and
The Blackstone Group, L.P. (“Blackstone”), no agent, broker, finder or investment banker is
entitled to any brokerage, finder’s or other fee or commission from the Company in connection with
the Transactions. The amount of such fees and commissions payable to each of Xxxxxxx Xxxxx and
Blackstone is set forth in Section 4.24 of the Company Disclosure Letter.
SECTION 4.25 State Takeover Statutes. No “fair price”, “moratorium”, “control share
acquisition” or other similar antitakeover statute or regulation enacted under state or federal
laws in the United States (with the exception of Section 203 of the DGCL) applicable to the
Company, New Diamond or New Diamond Merger Sub is applicable to the transactions contemplated by
this Agreement. Assuming the accuracy of the representations and warranties set forth in Section
5.13, the action of the Company Board of Directors in approving this Agreement (and the
transactions contemplated hereby) is sufficient to render inapplicable to this Agreement (and the
transactions contemplated hereby) the restrictions on “business combinations” (as defined in
Section 203 of the DGCL) as set forth in Section 203 of the DGCL. The Company has delivered to
Parent a true and complete copy of all resolutions of the Company Board of Directors relating to
the applicability of such antitakeover statute or regulation to the Company or to this Agreement or
the other transactions contemplated hereby. The original certificate of incorporation of each of
New Diamond and New Diamond Merger Sub contains a provision expressly electing not to be governed
by Section 203 of the DGCL.
SECTION 4.26 Fairness Opinion. Xxxxxxx Sachs, Blackstone and Xxxxxxxx Xxxxx Xxxxxx &
Xxxxx have each delivered to the Company Board of Directors its written opinion (or oral opinion to
be confirmed in writing), dated as of the date hereof, that, as of such date, the Per Share Merger
Consideration is fair, from a financial point of view, to the holders of New Diamond Shares (as the
former holders of Company Shares).
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF PARENT AND ACQUISITION SUB
Except as set forth in the corresponding sections of the disclosure letter (subject to the
provisions of Section 9.2) delivered by Parent to the Company on or prior to the execution of this
Agreement (the “Parent Disclosure Letter”) and except as disclosed in the Form 10-K of
Parent for the fiscal period ended December 31, 2004, as amended through the date hereof (as
amended, the “Parent Form 10-K”), the Proxy Statement for the Parent’s 2005 Annual Meeting
of Stockholders, and the Form 10-Qs and Form 8-Ks filed or furnished from the date of the filing of
the Parent Form 10-K to the date of this Agreement (and any amendments to any such filings which
amendments are filed with the SEC prior to the date hereof) to the extent such qualifications are
reasonably apparent (and which in no event shall include risk factors or other factors identified
in general cautionary statements regarding reliance on forward looking statements in either case
included in the Parent SEC Reports), Parent and Acquisition Sub hereby, jointly and severally,
represent and warrant to the Company that:
-39-
SECTION 5.1 Organization. Each of Parent and Acquisition Sub is duly organized,
validly existing and in good standing under the laws of its respective jurisdiction of
organization, and has the requisite corporate or similar power and authority to own its properties
and to carry on its business as presently conducted and is duly qualified to do business and is in
good standing (where such concept exists) as a foreign
corporation in each jurisdiction in which the nature of its business or the ownership or
leasing of its properties makes such qualification necessary. Complete and correct copies of the
certificate of incorporation and by-laws (or equivalent organizational documents) of Parent and
Acquisition Sub as currently in effect, have been made available to the Company, and as so made
available, are in full force and effect and no other organizational documents are applicable to or
binding upon Parent and Acquisition Sub. Acquisition Sub is a direct wholly owned Subsidiary of
Parent.
SECTION 5.2 Authority; Enforceability.
(a) Each of Parent and Acquisition Sub has the corporate or other power and authority to
execute and deliver this Agreement, to perform its obligations hereunder and to consummate the
transactions contemplated hereby. The execution, delivery and performance by each of Parent and
Acquisition Sub of this Agreement and the consummation by each of Parent and Acquisition Sub of the
transactions contemplated hereunder have been duly authorized by all necessary action on the part
of each of Parent and Acquisition Sub, and no other corporate proceedings on the part of Parent or
Acquisition Sub are necessary pursuant to its governing documents or the DGCL to authorize this
Agreement or to consummate the transactions contemplated hereby (other than (i) the adoption of
this Agreement by Parent as the sole stockholder of Acquisition Sub and (ii) the approval of the
issuance of Parent Shares in connection with the consummation of the Merger (the “Share
Issuance”) by the holders of a majority of the votes cast by the holders of outstanding Parent
Shares present (in person or by proxy) and entitled to vote on such matter at the Parent
Stockholder Meeting, where a quorum is present (the “Requisite Parent Stockholder Vote”)).
The boards of directors of Parent and Acquisition Sub have determined that it is in the best
interests of Parent and Acquisition Sub and their respective stockholders, and declared it
advisable, to enter into this Agreement, and have approved this Agreement in accordance with the
DGCL. This Agreement has been duly executed and delivered by each of Parent and Acquisition Sub
and, assuming due authorization, execution and delivery by the other parties hereto, constitutes a
legal, valid and binding agreement of each of Parent and Acquisition Sub, enforceable against each
of them in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other similar Laws relating to or affecting creditors’
rights generally and general equitable principles (whether considered in a proceeding in equity or
at law).
(b) Parent has all requisite power and authority to enter into the Separation Agreement and to
consummate the transactions contemplated thereby, and such agreement has been duly and validly
executed by Parent and, to Parent’s Knowledge (without any inquiry by any officers of Parent), any
other party thereto, and constitutes the valid and binding obligation of Parent and, to Parent’s
Knowledge (without any inquiry by any officers of Parent), each party thereto, enforceable against
such party in accordance with its terms, subject to the effects of bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and other similar
-40-
Laws relating to or affecting
creditors’ rights generally and general equitable principles (whether considered in a proceeding in
equity or at law).
SECTION 5.3 Non-Contravention. The execution, delivery and performance of the
Transaction Agreements, as applicable, by each of Parent and Acquisition Sub does not and will not
(a) conflict with or violate its certificate of incorporation or by-laws or comparable governing
documents, (b) conflict with or violate the governing documents of any other Subsidiary of Parent,
(c) assuming that all consents, approvals and authorizations contemplated by Section 5.4 have been
obtained and all filings described therein have been made, conflict with or violate any Law
applicable to Parent, Acquisition Sub or any of their Subsidiaries or by which it or any of its
properties are bound or (d) result in any breach or violation of or constitute a default (or an
event which with notice or lapse of time or both would become a default) or result in the loss of a
benefit under, or give rise to any right of termination, cancellation, recapture, amendment or
acceleration of, or performance under, any note, bond, mortgage, indenture, contract, agreement,
lease, license, permit or other instrument or obligation to which Parent, Acquisition Sub or any of
their Subsidiaries is a party or by which Parent, Acquisition Sub or any of their Subsidiaries or
its or any of their properties are bound, except, in the case of clauses (b), (c), and (d) of this
Section 5.3 for any such conflict, violation, breach, default, loss, right or other occurrence
which would not (i) prevent or materially delay the consummation of the transactions contemplated
by the Transaction Agreements, or (ii) reasonably be expected to have, individually or in the
aggregate, a Parent Material Adverse Effect.
SECTION 5.4 Governmental Consents. The execution, delivery and performance of this
Agreement by each of Parent and Acquisition Sub and the consummation by each of Parent and
Acquisition Sub of the Transactions do not and will not require any consent, approval,
authorization or permit of, action by, filing with or notification to, any Governmental Authority,
except as required under or pursuant to (a) the HSR Act, (b) the Exchange Act, (c) state
securities, takeover and “blue sky” Laws, (d) the rules and regulations of the NYSE and the PCX,
(e) the DGCL, (f) the applicable requirements of antitrust or other competition Laws of other
jurisdictions or investment Laws relating to foreign ownership, and (g) any other consent,
approval, authorization, permit, action, filing or notification the failure of which to be made or
obtained would not reasonably be expected to have, individually or in the aggregate, a Parent
Material Adverse Effect.
SECTION 5.5 Capitalization. (a) The authorized capital stock of Parent consists of
400,000,000 shares of Common Stock, par value $1.00 per share (“Parent Shares”), and
1,000,000 shares of preferred stock. As of the close of business on the Capitalization Date, (i)
136,318,661 Parent Shares were issued and outstanding, (ii) 14,312,549 Parent Shares were held in
the treasury of Parent or by Parent Subsidiaries, (iii) 10,159,743 Parent Shares were reserved for
issuance upon or otherwise deliverable in connection with the grant of equity-based awards
(including Retention Stock Units) or the exercise of outstanding stock options and (iv) 1,341
shares of preferred stock were outstanding. As of the Capitalization Date, Parent had outstanding
(1) options to purchase 12,088,125 Parent Shares at a weighted average exercise price of $26.74 per
share and (2) 810,750 Liquid Yield Option Notes (“XXXXx”) which may be convertible into
Parent Shares under certain circumstances in accordance with the terms thereof. From the close of
business on the Capitalization Date until the date of this Agreement, no Parent Shares have been
issued except for Parent Shares issued pursuant to the exercise of Options or to
-41-
the settlement of
the XXXXx in accordance with their terms. Except for the Rights Agreement, dated as of April 12,
2000, between Parent and Xxxxx
Fargo Bank Minnesota, N.A. (formerly Norwest Bank Minnesota, N.A.) as Rights Agent (the
“Parent Rights Plan”) and the Rights (as defined in the Parent Rights Plan) and except as
set forth above, there are no outstanding shares, options, warrants, calls, stock appreciation
rights, or other Equity Interests, rights or commitments or any other agreements of any character
relating to dividend rights or to the sale, issuance or voting of, or the granting of rights to
acquire, any shares of capital stock or voting securities of Parent, or any securities or
obligations convertible into, exchangeable for or evidencing the right to purchase any shares of
capital stock or voting securities of Parent.
(b) Except as set forth in Section 5.5(a), (i) there are no preemptive rights of any kind
which obligate Parent or any Subsidiary of Parent to issue or deliver any shares of capital stock
or voting securities of Parent or any securities or obligations convertible or exchangeable into or
exercisable for, or giving any Person a right to subscribe for or acquire from Parent or any
Subsidiary of Parent, any shares of capital stock or voting securities of Parent, and (ii) there is
no agreement, contract, commitment or arrangement pursuant to which Parent or any Subsidiary of
Parent is or may become obligated to repurchase or redeem any shares of capital stock or voting
securities of Parent or any securities or obligations convertible or exchangeable into or
exercisable for, any shares of capital stock or voting securities of Parent. Parent does not have
outstanding any bonds, debentures, notes or other obligations the holders of which have the right
to vote (or which are convertible, exchangeable or exercisable for or into securities having the
right to vote) with the stockholders of the Parent on any matter.
SECTION 5.6 SEC Reports; Financial Information.
(a) Parent has timely filed or furnished, as applicable, all forms, reports, statements,
certifications and other documents (including all exhibits, supplements and amendments thereto)
required to be filed or furnished by it with the SEC since January 1, 2003 (collectively, with any
amendments thereto, the “Parent SEC Reports”), each of which, including any financial
statements or schedules included therein, as finally amended prior to the date hereof, has complied
as to form in all material respects with the applicable requirements of the Securities Act and the
Exchange Act, each as in effect on the date so filed. None of the Parent SEC Reports contained,
when filed as finally amended prior to the date hereof, any untrue statement of a material fact or
omitted to state a material fact required to be stated or incorporated by reference therein or
necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. Each of (i) the consolidated balance sheets included in the Parent
SEC Reports (including the related notes and schedules) was prepared in accordance with GAAP in all
material respects applied on a consistent basis throughout the periods covered and fairly presents,
in all material respects, the consolidated financial position of Parent and the Parent Subsidiaries
at the respective dates thereof and (ii) the related consolidated statements of earnings, cash
flows and stockholders’ equity included in the Parent SEC Reports (including the related notes and
schedules) were prepared in accordance with GAAP in all material respects applied on a consistent
basis throughout the periods covered and fairly present in all material respects the results of
operations and cash flows of Parent and the Parent Subsidiaries for the periods indicated (subject,
in the case of each of clause (i) and (ii), to normal and/or recurring year-end adjustments and the
absence of full footnote disclosure in the case of unaudited financial statements).
-42-
(b) Parent has designed and maintains a system of internal controls over financial reporting
(as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) sufficient to provide reasonable
assurances regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with GAAP. Parent (i) has designed and maintains
disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange
Act) that provide reasonable assurance that material information required to be disclosed by Parent
in the reports that it files or submits under the Exchange Act is recorded, processed, summarized
and reported within the time periods specified in the SEC’s rules and forms, and (ii) has disclosed
and reported, based on its most recent evaluation of such internal control over financial reporting
prior to the date hereof, to Parent’s auditors and the audit committee of the Parent Board of
Directors (A) any significant deficiencies and material weaknesses in the design or operation of
its internal control over financial reporting which are reasonably likely to adversely affect in
any material respect Parent’s ability to record, process, summarize and report financial
information and (B) any fraud, whether or not material, that involves management or other employees
who have a significant role in Parent’s internal control over financial reporting. Parent has
heretofore furnished to the Company complete and correct copies of all such reports (if any).
(c) Except for matters resolved prior to the date hereof, since January 1, 2003, (i) to the
Knowledge of Parent neither Parent nor any Parent Subsidiary nor any director, officer, employee,
auditor, accountant or representative of Parent or of any Parent Subsidiary has received or
otherwise had or obtained Knowledge of any material complaint, allegation, assertion or claim,
whether written or oral, regarding the accounting or auditing practices, procedures, methodologies
or methods of Parent or any Parent Subsidiary or their respective internal accounting controls,
including any material complaint, allegation, assertion or claim that the Parent or any Parent
Subsidiary has engaged in questionable accounting or auditing practices, and (ii) no attorney
representing the Parent or any Parent Subsidiary, whether or not employed by Parent or any Parent
Subsidiary, has reported evidence of a material violation of securities Laws, breach of fiduciary
duty or similar violation by Parent or any of its officers, directors, employees or agents to the
Parent Board of Directors or any committee thereof or to the General Counsel or Chief Executive
Officer of Parent.
SECTION 5.7 No Undisclosed Liabilities. Neither Parent nor any of the Parent
Subsidiaries has any liabilities, claims or indebtedness of any kind whatsoever, whether accrued,
contingent, absolute, determined, determinable or otherwise, whether due or to become due, in each
case, that are required by GAAP to be accrued, reserved against or disclosed in a consolidated
balance sheet or the notes thereto, except liabilities that (i) are accrued or reserved against in
the most recent financial statements included in the Parent Form 10-K or Quarterly Report on Form
10-Q most recently filed prior to the date hereof or are disclosed in the notes thereto, (ii) were
incurred in the ordinary course of business and consistent with past practice since the date of the
most recent balance sheet included in the most recent quarterly report on Form 10-Q filed by Parent
with the SEC prior to the date of this Agreement (the “Parent Balance Sheet Date”) and
would not reasonably be expected to have, individually or in the aggregate, a Parent Material
Adverse Effect, (iii) are incurred pursuant to the transactions contemplated by this Agreement,
(iv) have been discharged or paid in full prior to the date of this Agreement in the ordinary
course of business consistent with past practice or (v) were incurred outside the
-43-
ordinary course
of business since the Company Balance Sheet Date, but which are, and would reasonably be expected
to be, individually or in the aggregate, immaterial in amount or nature.
SECTION 5.8 Absence of Certain Changes or Events. Since the Parent Balance Sheet
Date, except as contemplated by this Agreement, Parent and the Parent Subsidiaries have conducted
their businesses in the ordinary course in all material respects consistent with past practice,
and, since such date, there has not been any change, event or occurrence which has had or would
reasonably be likely to have, individually or in the aggregate, a Parent Material Adverse Effect.
SECTION 5.9 Compliance with Law and Reporting Requirements. Parent and the Parent
Subsidiaries are not (and have not been since the Parent Balance Sheet Date) in violation of any
Law, and have not received any written notice of any violation of Law, in each case except for any
violation or possible violation that would not reasonably be expected to have, individually or in
the aggregate, a Parent Material Adverse Effect. Parent and the Parent Subsidiaries have, and are
(and have been since the Parent Balance Sheet Date) in compliance with, all permits, licenses,
authorizations, exemptions, orders, consents, approvals and franchises from Governmental
Authorities required to conduct their respective businesses as now being conducted, except for any
such permit, license, authorization, exemption, order, consent, approval or franchise the absence
of, or the non-compliance, with which would not reasonably be expected to have, individually or in
the aggregate, a Parent Material Adverse Effect.
SECTION 5.10 Litigation. There are no Actions pending or, to the knowledge of Parent,
threatened against Parent or any Parent Subsidiary or, to the knowledge of Parent, any officer,
director or employee of Parent or any Parent Subsidiary in such capacity, which would, individually
or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect. Neither
Parent nor any Parent Subsidiary is a party or subject to or in default under any material
Governmental Order.
SECTION 5.11 Financing. Attached hereto as Section 5.11 of the Parent Disclosure
Letter is a true and complete copy of the Commitment Letter dated the date hereof, between
Supervalu Inc., The Royal Bank of Scotland plc and RBS Securities Corporation (the “Financing
Commitment”), pursuant to which The Royal Bank of Scotland plc has agreed, subject to the terms
and conditions set forth therein, to lend the amounts set forth therein for the purposes of
financing the transactions contemplated hereby (the “Financing”). As of the date hereof,
the Financing Commitment has not been amended, modified, withdrawn or rescinded, and is in full
force and effect. Assuming the receipt of the proceeds of the Standalone Drug Sale, and the
consummation of the transactions contemplated by the Separation Agreement, Parent and Acquisition
Sub will have at and after the Closing funds sufficient to consummate the Emerald Merger on the
terms and conditions set forth in this Agreement.
SECTION 5.12 Brokers. No agent, broker, finder or investment banker is entitled to
any brokerage, finder’s or other fee or
commission in connection with the transactions contemplated by this Agreement based upon
arrangements made by or on behalf of Parent or Acquisition Sub for which the Company could have any
liability.
-44-
SECTION 5.13 Company Stock. Neither Parent nor Acquisition Sub is, and at no time
during the last three years has either Parent or Acquisition Sub been, an “interested stockholder”
of the Company as defined in Section 203 of the DGCL. Neither Parent nor Acquisition Sub owns
(directly or indirectly, beneficially or of record), or is a party to any agreement, arrangement or
understanding for the purpose of acquiring, holding, voting or disposing of, any shares of capital
stock of the Company (other than as contemplated by this Agreement).
SECTION 5.14 Acquisition Sub. Acquisition Sub was formed solely for the purpose of
engaging in the transactions contemplated hereby, has engaged in no business activities and has
conducted no operations.
SECTION 5.15 Fairness Opinion. Lazard Frères has delivered to the Parent Board of
Directors its written opinion (or oral opinion to be confirmed in writing) that, as of the date
hereof, the Per Share Merger Consideration to be paid by Parent is fair, from a financial point of
view, to Parent.
SECTION 5.16 Cub Stores Divestiture. Parent has closed, or simultaneously with the
execution and delivery of this Agreement will close, the sale, pursuant to the Cub Sale Agreement,
of all of Parent’s direct or indirect right, title and interest in and to all of the retail grocery
stores that, immediately prior to the date hereof, were operated directly or indirectly by Parent
in the Chicago, Illinois and Bloomington, Illinois metropolitan areas under the “Cub” or “Cub
Foods” banners. Parent has delivered to the Company correct and complete copies of the Cub Sale
Agreement and the Ancillary Agreements referred to therein, all of which constitute legal, valid
and binding obligations of Parent and its Affiliates that are parties thereto, enforceable against
them in accordance with their terms, subject to the effects of bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other similar Laws relating to or affecting creditors’
rights generally and general equitable principles (whether considered in a proceeding in equity or
at law).
ARTICLE VI
ADDITIONAL AGREEMENTS
SECTION 6.1 Conduct of Business Prior to the Closing. (a) The Company covenants and
agrees that, during the period from the date hereof until the Closing Date, except as contemplated
by this Agreement, as set forth in Section 6.1 of the Company Disclosure Letter or as required by
Law, or unless Parent shall otherwise consent in writing (which consent shall not be unreasonably
withheld, conditioned or delayed), the business of the Company and the Company Subsidiaries (in
each case, with respect to the New Diamond
Business or to the extent affecting New Diamond and/or the New Diamond Entities in a non-de
minimis respect) and the use, operation, maintenance and repair of the Owned Real Properties and
the Leased Real Properties, shall be conducted in the ordinary course of business, consistent with
past practice, and the Company shall use its reasonable best efforts to preserve substantially
intact its business organization and operations, including material insurance policies, material
Company Intellectual Property and goodwill, and to preserve its present relationships with
suppliers, lessors, licensees, distributors, wholesalers, franchisees and other Persons with which
it has material business relations. Between the date of this Agreement and the Closing Date,
subject to
-45-
applicable Law and except as otherwise contemplated by this Agreement, as set forth in
Section 6.1 of the Company Disclosure Letter or as required by Law or the Transaction Agreements
(or, with respect to clauses (vi) or (vii) below, as required by any Material Contract disclosed in
Section 4.10 of the Company Disclosure Letter), neither the Company nor any Company Subsidiary (in
each case, with respect to the New Diamond Business or to the extent affecting New Diamond and/or
the New Diamond Entities in a non-de minimis respect) shall, without the prior written consent of
Parent (which consent shall not be unreasonably withheld, conditioned or delayed):
(i) amend or otherwise change its certificate of incorporation or by-laws (or other
comparable governing documents);
(ii) issue, deliver, sell, pledge, transfer, convey, dispose of or encumber any Equity
Interests of the Company or any Company Subsidiary or securities convertible into or
exchangeable for any such Equity Interests, or any options, warrants, convertible securities
or other rights of any kind to acquire any Equity Interests of the Company or any Company
Subsidiary, or any other ownership interest or security, of the Company or any Company
Subsidiary (other than (A) the issuance of Shares (and the associated Rights) upon the
exercise of Options, the settlement of Stock Units (and dividend equivalents thereon), or
the settlement of HITS, in each case in accordance with their present terms, (B) issuances
by a wholly owned Company Subsidiary of capital stock to such Company Subsidiary’s parent,
and (C) issuances in accordance with the Rights Plan);
(iii) declare, set aside, make or pay any dividend or other distribution payable in
cash, stock, property or otherwise with respect to any Equity Interests or any options,
warrants, convertible securities or other rights to acquire any Equity Interest (except for
any dividend or distribution of cash by a wholly owned Company Subsidiary, required payments
made by the Company in respect of its HITS in accordance with their present terms, dividend
equivalents paid by the Company or accrued on Stock Units in accordance with their present
terms and regular quarterly dividends paid to holders of the Company Shares in an amount not
in excess of $0.19 per share of Common Stock);
(iv) (A) reclassify, combine, split, subdivide, redeem, purchase or otherwise acquire
any Equity Interests of the Company or any Company Subsidiary or any options, warrants,
convertible securities or other rights to acquire any Equity Interest of the Company or any
Company Subsidiary (other than the acquisition of shares tendered by directors, employees or
former employees in order to pay Taxes in connection with the exercise of Options or the
settlement of Stock Units pursuant to the terms of any of the
Stock Plans or any redemption of the Rights pursuant to the terms of the Rights Plan),
or (B) redeem, repurchase, prepay, defease or otherwise acquire any of the Company’s or the
Company Subsidiaries’ Indebtedness set forth on Section 6.1(a)(iv)(B) of the Company
Disclosure Letter;
(v) (A) acquire, lease or license from any Person (by merger, consolidation,
acquisition of stock or assets or otherwise) or sell, dispose of, abandon, encumber (other
than through the creation of a Permitted Encumbrance), lease or license (by merger,
-46-
consolidation, sale of stock or assets or otherwise) to any corporation, partnership or
other business organization or division thereof, any Equity Interests therein or any assets,
including Intellectual Property, in each case, which are material to the Company and the
Company Subsidiaries taken as a whole, other than acquisitions, leases, licenses, sales,
dispositions and encumbrances of inventory, non-merchandise supplies, media and advertising
and other assets in the ordinary course of business, (B) enter into any material joint
venture, partnership or similar agreement, (C) incur or guarantee, or modify in any material
respect, any Indebtedness or make any loans, advances or capital contributions to, or
investments in, any other Person (other than a Company Subsidiary), in each case, other than
in the ordinary course of business and consistent with past practice, (D) enter into, renew,
terminate or amend in any material respect (1) any contract or agreement which is or would
be a Material Contract, other than in the ordinary course of business consistent with past
practice, (2) any Real Property Lease which provides for rental payments over the primary
term of the lease (including percentage sales and other variable payments, as estimated by
the Company in good faith) in excess of $1,200,000 in any one year (provided, that
neither the Company nor any Company Subsidiary shall, without first consulting with Parent
in writing, enter into, renew, terminate or amend in any material respect any Real Property
Lease which provides for such rental payments in excess of $500,000 in any one year), or (3)
any Advance Contract, or (E) notwithstanding anything to the contrary set forth in Section
6.1(a)(v)(D) of the Company Disclosure Letter, authorize, or enter into any commitment to
make, any new capital expenditures which are, in the aggregate, in excess of the Company’s
capital expenditure budget insofar as it relates to the New Diamond Business set forth on
Section 6.1(a)(v)(D) of the Company Disclosure Letter or which are, individually, in excess
of $15,000,000 (provided, that neither the Company nor any Company Subsidiary shall,
without first consulting with Parent in writing, authorize, or enter into any commitment to
make, any new capital expenditures which are, individually, in excess of $10,000,000);
(vi) except (A) to the extent required under any Company Plan, or (B) as necessary to
conform to the requirements of any applicable Law that absent such conformance would impose
a penalty of an additional Tax on the Company, any Company Subsidiary or any current or
former director, officer, employee or consultant of the Company or any Company Subsidiary,
(1) increase or decrease the compensation or fringe benefits of, or pay any bonus to, any
current or former director, officer, employee or consultant of the Company or any Company
Subsidiary (except in the ordinary course of business and consistent with past practice),
(2) grant any severance or termination pay not required under any Company Plan (except in
the ordinary course of business and consistent with past practice) or grant any equity or
equity-based awards, (3) exercise any discretion to accelerate the vesting or payment or any
compensation or benefit under any
Company Plan, (4) except as required by GAAP, materially change any actuarial or other
assumption used to calculate funding obligations with respect to any Company Plan or change
the manner in which contributions to any Company Plan are made or the basis on which such
contributions are determined, (5) enter into any (A) employment agreement with any present
directors or employees, (B) consulting agreement or arrangement with any present directors
or executive officers (as defined by Rule 3b-7 of the Exchange Act) or (C) except in the
ordinary course of business consistent with past practice, consulting agreement or
arrangement or change in control or severance agreement with any present
-47-
employee, (6)
without limiting the scope of the preceding clause (5), establish, adopt, enter into any
new, or amend in any material respect or terminate any existing Company Plan, (7) without
limiting the scope of Section 6.1(a)(v)(D), enter into, renew, or materially amend any
collective bargaining or similar agreement covering in excess of 500 employees or (8)
provide any funding to any rabbi trust or similar arrangement;
(vii) enter into any transaction, agreement, arrangement or understanding between (A)
the Company or any Company Subsidiary, on the one hand, and (B) any Affiliate of the Company
(other than the Company Subsidiaries), on the other hand, of the type that would be required
to be disclosed under Item 404 of Regulation S-K;
(viii) (A) make any material Tax election (in a manner inconsistent with past
practices), change any method of accounting or make any election with respect to the Company
or any Company Subsidiary under Treasury Regulation Section 301.7701-3, (B) enter into any
settlement or compromise of any material Tax liability for an amount in excess of the amount
reserved for such Tax liability in the financial statements included in the Company SEC
Reports as of the date hereof, (C) change any annual Tax accounting period, (D) enter into
any closing agreement relating to any material Tax or (E) surrender any right to claim a
material Tax refund;
(ix) make any material changes in accounting policies or procedures other than as
required by GAAP or a Governmental Authority;
(x) subject to the fiduciary duties of the Company Board of Directors (as determined in
good faith after consultation with outside legal counsel), amend, waive, terminate or fail
to enforce its Rights Agreement or any confidentiality agreement, standstill clause or
agreement or similar agreement, arrangement or understanding;
(xi) settle any litigation or other proceedings before or threatened to be brought
before a Governmental Authority or arbitral proceeding for an amount payable by or on behalf
of the Company or any Company Subsidiary in excess of $2,500,000 (exclusive of (A) any
amounts to be received by the Company in reimbursement of such settlement amount, whether
under any insurance policy or indemnity, other than such amounts that are contested, and (B)
any amounts accrued or reserved for in respect of such matter in the financial statements
included in the Company 10-K or the Quarterly Report on Form 10-Q most recently filed prior
to the date hereof) or which would be reasonably likely to have a material adverse impact on
the operations of the Company or any Company Subsidiary or on any current or future
litigation or other proceeding of the Company or any Company Subsidiary;
(xii) except to the extent required for cash management in the ordinary course of
business consistent with past practice, enter into, perform or undergo any internal
restructuring, merger, liquidation, change in organizational status (such as conversion of
any corporation to a limited liability company), intercompany transfer of assets or
assumption or guarantee of liability, distribution, contribution, or creation, elimination,
increase or decrease in intercompany debt or liabilities;
-48-
(xiii) cause any Company Subsidiary that is a captive insurance company to underwrite
any insurance other than in respect of the New Diamond Business;
(xiv) take any action prohibited by the restrictions described in clause (5) of Section
6.8(c) of the Separation Agreement or Section 5.01(f) of the Drug Sale Agreement; or
(xv) agree to take any of the actions described in clauses (i) through (xiii) above.
(b) Parent covenants and agrees that, during the period from the date hereof until the Closing
Date, except as contemplated by this Agreement, as set forth in Section 6.1 of the Parent
Disclosure Letter or as required by Law, or unless Company shall otherwise consent in writing
(which consent shall not be unreasonably withheld, conditioned or delayed), the business of the
Parent and the Parent Subsidiaries shall be conducted in the ordinary course of business and
consistent with past practice, and Parent shall use its reasonable best efforts to preserve
substantially intact its business organization and operations, including material insurance
policies, material intellectual property and goodwill, and to preserve its present relationships
with suppliers, lessors, licensees, distributors, wholesalers, franchisees and other Persons with
which it has material business relations. Between the date of this Agreement and the Closing Date,
subject to applicable Law and except as otherwise contemplated by this Agreement, as set forth in
Section 6.1 of the Parent Disclosure Letter or as required by Law, neither Parent nor any Parent
Subsidiary shall, without the prior written consent of the Company (which consent shall not be
unreasonably withheld, conditioned or delayed):
(i) amend or otherwise change its certificate of incorporation or by-laws (or other
comparable governing documents);
(ii) declare, set aside, make or pay any dividend or other distribution payable in
cash, stock, property or otherwise with respect to any Equity Interests of Parent (except
for any dividend or distribution by a wholly owned Subsidiary of Parent, and any regular
quarterly dividend paid to holders of Parent Shares in an amount not in excess of the amount
set forth in Section 6.1(b)(ii) of the Parent Disclosure Letter);
(iii) reclassify, combine, split, subdivide or redeem, purchase or otherwise acquire
any Parent Shares or any options, warrants, convertible securities or other rights to
acquire any Parent Shares (other than (A) the acquisition of shares tendered by directors,
employees or former employees to pay Taxes in connection with the exercise of options issued
under any Parent Employee Plans and (B) open-market purchases of Parent Shares to fund
Parent Employee Plans consistent with past practice);
(iv) except for any such transactions that would not materially impair or delay the
consummation of the transactions contemplated by this Agreement, (A) acquire, lease or
license from any Person (by merger, consolidation, acquisition of stock or assets or
otherwise) or sell, dispose of, encumber (other than through the creation of a Permitted
Encumbrance), lease or license (by merger, consolidation, sale of stock or assets or
otherwise) any corporation, partnership or other business organization or division thereof,
-49-
any Equity Interests therein or any assets, including Intellectual Property, in each case,
which are material to the Parent and Parent Subsidiaries taken as a whole, other than
acquisitions, leases, licenses, sales, dispositions and encumbrances of inventory,
non-merchandise supplies, media and advertising and other assets in the ordinary course of
business and consistent with past practice, (B) incur or guarantee, or modify in any
material respect, any Indebtedness or make any loans, advances or capital contributions to,
or investments in, any other Person (other than a Parent Subsidiary), in each case, other
than loans, advances and indebtedness incurred in the ordinary course of business and
consistent with past practice, or (C) enter into, renew or amend in any material respect any
material contract, other than in the ordinary course of business and consistent with past
practice;
(v) enter into any transaction, agreement, arrangement or understanding between (A)
Parent or any Parent Subsidiary, on the one hand, and (B) any Affiliate of Parent (other
than the Parent Subsidiaries), on the other hand, of the type that would be required to be
disclosed under Item 404 of Regulation S-K;
(vi) make any material changes in accounting policies or procedures other than as
required by GAAP or a Governmental Authority; or
(vii) agree to take any of the actions described in clauses (i) through (vi), above.
(c) The Company will not, without the prior written consent of Parent, agree to any
modification of any term or condition of, or give any consent or waiver or exercise any right of
termination under, the Standalone Drug Sale Agreement, if such modification, consent, waiver or
exercise would reasonably be expected to adversely affect, or impose any cost or liability on,
Parent or its Subsidiaries (including their interests following the consummation of the
transactions contemplated by the Standalone Drug Sale Agreement) or adversely affect the ability to
consummate the transactions contemplated hereby in a timely manner. The Company shall comply with
the terms of the Standalone Drug Sale Agreement in all material respects. The Company will use
reasonable best efforts to cause the conditions to the consummation of the Standalone Drug Sale to
be satisfied (or waived by the other party thereto).
(d) The Company agrees that between the date hereof and the Closing Date it will take all
actions it has affirmatively committed to take pursuant to Section 6.1(a)(v) or Section 6.1(a)(vi)
of the Company Disclosure Letter.
SECTION 6.2 Stockholders Meetings.
(a) As soon as reasonably practicable following the date of this Agreement (and subject to the
Company’s using its reasonable best efforts to hold the Company Stockholders Meeting on the same
day as the Parent Stockholders Meeting), the Company, acting through the Company Board of
Directors, and in accordance with applicable Law, shall (i) duly call, give notice of, convene and
hold a meeting of its stockholders for the purpose of (A) approving an amendment (the “Charter
Amendment”) to the Company’s restated certificate of incorporation providing for appraisal
rights to holders of Company Shares for the Diamond Merger if the
-50-
Effective Time occurs and (B)
with respect to the Diamond Merger, adopting this Agreement (the “Company Stockholders
Meeting”) to be held as soon as reasonably practicable after such notice, and (ii) (A) include
in the Proxy Statement/Prospectus the Company Board of Directors’ determination that the terms of
this Agreement are fair to and in the best interest of the stockholders of the Company, the Company
Board of Directors’ determination that this Agreement is advisable, and the Company Board of
Directors’ recommendation that the stockholders of the Company, with respect to the Diamond Merger,
vote in favor of the adoption of this Agreement (collectively, the “Company Board
Recommendation”) and the Company Board of Directors’ recommendation that the stockholders of
the Company vote in favor of the adoption of the Charter Amendment and (B) use its reasonable best
efforts to obtain the necessary approval of the transactions contemplated by this Agreement by the
stockholders of the Company and New Diamond, as applicable; provided, that if the Company
Board of Directors determines in good faith, after consultation with outside counsel, that any of
the foregoing actions in clause (ii) would be inconsistent with their fiduciary duties under
applicable Law, the Company Board of Directors may fail to take any of such actions and/or may
withdraw, modify or change in a manner adverse to Parent all or any portion of the Company Board
Recommendation. The Company shall call and hold the Company Stockholders Meeting in accordance
with clause (i) of the preceding sentence regardless of any failure to make the Company Board
Recommendation pursuant to clause (ii), and regardless of any change in the Company Board
Recommendation; provided, however, that nothing in this sentence shall affect the
Company’s right to terminate the agreement in accordance with Section 8.1. In the event that the
Requisite Company Stockholder Vote is obtained, the Company, as sole stockholder of New Diamond,
shall, prior to the Initial Effective Time, adopt this Agreement in favor of the Emerald Merger.
(b) As soon as reasonably practicable following the date of this Agreement (and subject to
Parent’s using its reasonable best efforts to hold the Parent Stockholders Meeting on the same day
as the Company Stockholders Meeting), Parent, acting through the Parent Board of Directors, and in
accordance with applicable Law, shall (i) duly call, give notice of, convene and hold a meeting of
its stockholders for the purpose of adopting this Agreement (the “Parent Stockholders
Meeting”) to be held as soon as reasonably practicable after such notice and (ii)(A) include in
the Proxy Statement/Prospectus the Parent Board of Directors’ recommendation that Parent’s
stockholders approve the issuance of Parent Shares pursuant to this Agreement (the “Parent
Board Recommendation”) and (B) use its reasonable best efforts to obtain the necessary approval
of the transactions contemplated by this Agreement by the stockholders of Parent provided,
that if the Parent Board of Directors determines in good faith, after consultation with outside
counsel, that any of the foregoing actions in clause (ii) would be inconsistent with their
fiduciary duties under applicable Law, the Parent Board of Directors may fail to take any of
such actions and/or may withdraw, modify or change in a manner adverse to the Company all or any
portion of the Parent Board Recommendation. Parent shall call and hold the Parent Stockholders
Meeting in accordance with clause (i) of the preceding sentence regardless of any failure to make
the Parent Board Recommendation pursuant to clause (ii), and regardless of any change in the Parent
Board Recommendation made at any time prior to the meeting.
-51-
SECTION 6.3 Proxy Statement.
(a) As promptly as reasonably practicable following the date of this Agreement, (i) the
Company and Parent shall prepare a proxy statement to be sent to the stockholders of the Company
and Parent in connection with the Company Stockholder Meeting and the Parent Stockholder Meeting
(such proxy statement, as amended or supplemented, the “Proxy Statement/Prospectus”), and
(ii) Parent (and, if necessary, New Diamond) shall prepare and file with the SEC a registration
statement on Form S-4 (together with all amendments thereto, the “Form S-4”), in which the
Proxy Statement/Prospectus will be included as a prospectus, in connection with the registration
under the Securities Act of the New Diamond shares to be issued to the stockholders of the Company
in connection with the Diamond Merger and the Parent Shares to be issued to the stockholders of New
Diamond in connection with the payment of the aggregate Stock Consideration. Parent, New Diamond
and the Company will cooperate with each other in the preparation of the Proxy Statement/Prospectus
and Form S-4. Without limiting the generality of the foregoing, each of Parent, New Diamond and
the Company will provide the other with a reasonable opportunity to review drafts of, and revisions
to, the Proxy Statement/Prospectus and Form S-4 prepared by such party, and shall use its
reasonable best efforts to furnish to the other party information relating to it and its affiliates
as necessary to prepare the Proxy Statement/Prospectus and Form S-4. All of the parties hereto
shall cause the Proxy Statement/Prospectus and Form S-4 to comply as to form and substance as to
such party in all material respects with the applicable requirements of (i) the Exchange Act, (ii)
the Securities Act and (iii) the rules and regulations of the NYSE and the PCX. The Company or New
Diamond, as appropriate, shall provide audited financial statements for inclusion in the Proxy
Statement/Prospectus and Form S-4 as and to the extent required under applicable Law and SEC
regulations.
(b) Each of the Company and Parent shall use reasonable best efforts to have the Form S-4
declared effective under the Securities Act as promptly as practicable after such filing and to
maintain the effectiveness of the Form S-4 through the Effective Time and to ensure that it
complies in all material respects with the applicable provisions of the Exchange Act and the
Securities Act until such time. The Company shall use its reasonable best efforts to cause the
Proxy Statement/Prospectus to be mailed to the Company’s stockholders, and Parent shall use its
reasonable best efforts to cause the Proxy Statement/Prospectus to be mailed to Parent’s
stockholders, in each case as promptly as practicable after the Form S-4 is declared effective
under the Securities Act. Parent and New Diamond shall also take any action required to be taken
under any applicable state securities laws in connection with the issuance of New Diamond Shares in
the Diamond Merger and Parent Shares in the Emerald Merger, as applicable, and the Company shall
furnish all information concerning the Company and the holders of the Company Shares as may be
reasonably requested in connection with any such action.
(c) No filing of, or amendment or supplement to, the Form S-4 will be made by New Diamond or
Parent, and no filing of, or amendment or supplement to the Proxy Statement/ Prospectus will be
made by the Company or Parent, in each case, without providing the other party and its respective
counsel a reasonable opportunity to review and comment thereon.
(d) Each of the parties agrees that none of the information supplied or to be supplied by it
for inclusion or incorporation by reference in the Proxy Statement/Prospectus or the Form
-52-
S-4 will,
at the date such document is first mailed to the stockholders of the relevant party and at the time
of such party’s meeting of stockholders relating to the Mergers, contain any untrue statement of a
material fact or omit to state any material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they are made,
not misleading. For purposes of the foregoing, it is understood and agreed that information
concerning or related to the Company or any Company Subsidiary will be deemed to have been supplied
by the Company and information concerning or related to Parent or Acquisition Sub will be deemed to
have been supplied by Parent.
(e) Each of Parent and the Company agree to correct any information provided by it for use in
the Proxy Statement/Prospectus or Form S-4 which shall have become false or misleading. The
parties shall as soon as reasonably practicable notify each other of the receipt of any comments
from or other correspondence with the SEC staff with respect to the Proxy Statement/Prospectus or
Form S-4 and any request by the SEC for any amendment to the Proxy Statement/Prospectus or Form S-4
or for additional information (and promptly deliver a copy of such comments, correspondence or
request to each other). Parent will advise the Company, promptly after it receives notice thereof,
of the time when the Form S-4 has become effective, the issuance of any stop order or the
suspension of the qualification of the Parent Shares issuable in connection with the Mergers for
offering or sale in any jurisdiction.
(f) Each of the Company and Parent shall use its reasonable best efforts to cause to be
delivered to the other party a letter of its independent auditors, dated (i) the date on which the
Form S-4 shall become effective and (ii) the Closing Date, and addressed to the other party, in
form and substance customary for “comfort” letters delivered by independent public accountants in
connection with registration statements similar to the Form S-4.
SECTION 6.4 Access to Information.
(a) During the period from the date of this Agreement through the earlier of the termination
of this Agreement pursuant to its terms and the Closing, the Company shall, and shall cause each
Company Subsidiary to, subject to reasonable restrictions imposed from time to time upon advice of
counsel respecting applicable Law or the Confidentiality Agreements, afford representatives of
Parent, following notice from Parent to the Company in accordance with this Section 6.4(a),
reasonable access during normal business hours to all properties, offices, books, contracts,
commitments and records and such financial (including all working papers) and operating data of the
Company and the Company Subsidiaries and all other information concerning its business, properties,
personnel, vendors, landlords/sublandlords, tenants, licensees and franchisees as Parent may
reasonably request. Notwithstanding the foregoing, neither Parent nor any of its representatives
shall (i) contact or have any discussions with any of the Company’s
employees, agents, or representatives, unless in each case Parent obtains the prior written
consent of the Company, which shall not be unreasonably withheld, conditioned or delayed, (ii)
contact or have any discussions with any of the vendors, landlords/sublandlords,
tenants/subtenants, licensees or franchisees of the Company or the Company Subsidiaries, unless in
each case Parent obtains the prior written consent of the Company, which shall not be unreasonably
withheld, conditioned or delayed, (iii) damage any property or any portion thereof, or (iv) perform
any onsite procedure or investigation (including any onsite environmental investigation or study)
without the Company’s prior written consent. Parent shall schedule and coordinate all
-53-
inspections
with the Company and shall give the Company at least three Business Days prior written notice
thereof, setting forth the inspection or materials that Parent or its representatives intend to
conduct. The Company shall be entitled to have representatives present at all times during any
such inspection. Notwithstanding the foregoing, neither the Company nor any Company Subsidiary
shall be required to provide access to or to disclose information where such access or disclosure
would jeopardize the attorney-client privilege of the Company or any Company Subsidiary or
contravene any Law or binding agreement entered into prior to the date of this Agreement. All
information obtained pursuant to this Section 6.4(a) shall continue to be governed by the
Confidentiality Agreements.
(b) During the period from the date of this Agreement through the earlier of the termination
of this Agreement pursuant to its terms and the Closing, Parent shall, and shall cause each Parent
Subsidiary to, subject to reasonable restrictions imposed from time to time upon advice of counsel
respecting applicable Law, afford representatives of the Company, following notice from Company to
the Parent in accordance with this Section 6.4(b), reasonable access during normal business hours
to all properties, offices, books, contracts, commitments and records and such financial (including
all working papers) and operating data of Parent and the Parent Subsidiaries and all other
information concerning its business, properties, personnel, vendors, landlords/sublandlords,
tenants, licensees and franchisees as the Company may reasonably request. Notwithstanding the
foregoing, neither the Company nor any of its representatives shall (i) contact or have any
discussions with any of Parent’s or the Parent Subsidiaries’ employees, agents, or representatives,
unless in each case the Company obtains the prior written consent of Parent, which shall not be
unreasonably withheld, conditioned or delayed, (ii) contact or have any discussions with any of the
vendors, landlords/sublandlords, tenants/subtenants, licensees or franchisees of Parent or the
Parent Subsidiaries, unless in each case the Company obtains the prior written consent of Parent,
which shall not be unreasonably withheld, conditioned or delayed, (iii) damage any property or any
portion thereof, or (iv) perform any onsite procedure or investigation (including any onsite
environmental investigation or study) without Parent’s prior written consent. The Company shall
schedule and coordinate all inspections with Parent and shall give Parent at least three Business
Days prior written notice thereof, setting forth the inspection or materials that the Company or
its representatives intend to conduct. Parent shall be entitled to have representatives present at
all times during any such inspection. Notwithstanding the foregoing, neither Parent nor any Parent
Subsidiary shall be required to provide access to or to disclose information where such access or
disclosure would jeopardize the attorney-client privilege of Parent or any Parent Subsidiary or
contravene any Law or binding agreement entered into prior to the date of this Agreement. The
Company will keep confidential all non-public information provided to it pursuant to this Section
6.4(b), except for disclosures required by applicable Law.
SECTION 6.5 Acquisition Proposals.
(a) Each of the Company and Parent shall not, and shall not permit its Subsidiaries to, and
shall direct its and its Subsidiaries’ directors, officers, investment bankers, financial advisors,
attorneys, accountants and other representatives not to, (A) directly or indirectly, initiate or
solicit or knowingly encourage or facilitate any inquiries or the making or submission of any
proposal or offer with respect to a tender offer or exchange offer, merger, reorganization, share
exchange, consolidation or other business combination involving it or any proposal or offer
-54-
to
acquire in any manner 20% or more of its Equity Interests, or the assets, securities or other
ownership interests of or in it or any Subsidiary representing 20% or more of the consolidated
assets, revenues or earnings of the Company and the Company Subsidiaries or of the Parent and the
Parent Subsidiaries, as the case may be, other than the transactions contemplated by the
Transaction Agreements and the Standalone Drug Sale Agreement (any such proposal or offer being
hereinafter referred to as an “Acquisition Proposal”) or (B) directly or indirectly, engage
in any negotiations or discussions concerning, or provide any confidential information or data to,
any Person relating to an Acquisition Proposal or execute or enter into any agreement,
understanding, letter of intent or arrangement with respect to any Acquisition Proposal (other than
a confidentiality agreement described below). Subject to Section 6.5(b), neither the Company nor
Parent, nor the Company Board of Directors nor the Parent Board of Directors (each, a “Board of
Directors”) nor any committee thereof shall recommend to its stockholders any Acquisition
Proposal or approve any agreement with respect to an Acquisition Proposal. Notwithstanding the
foregoing, nothing contained in this Agreement shall prevent either of the Company or Parent or its
Board of Directors from (i) taking and disclosing to its stockholders a position contemplated by
Rule 14d-9 and Rule 14e-2(a) promulgated under the Exchange Act or from making any other legally
required disclosure to stockholders with regard to an Acquisition Proposal (provided that neither
the Company nor the Parent nor the Board of Directors thereof may recommend any Acquisition
Proposal unless permitted by Section 6.5(b) below and may not fail to include or make, or withdraw,
modify or change in a manner adverse to the other party all or any portion of, the Company Board
Recommendation or Parent Board Recommendation, as the case may be, unless permitted by Section 6.2
(in which case Parent or the Company shall have the right to terminate this Agreement as set forth
in Section 8.1(e)(ii) or Section 8.1(d)(ii), as applicable), and provided further that,
notwithstanding anything herein to the contrary, any “stop-look-and-listen” communication to its
stockholders pursuant to Rule 14d-9(f) promulgated under the Exchange Act shall not be considered a
failure to make, or a withdrawal, modification or change in any manner adverse to the other party
of, all or a portion of the Company Board Recommendation or the Parent Board Recommendation, as
applicable) or (ii) (A) prior to obtaining the requisite vote of its stockholders at the Company
Stockholders Meeting, in the case of a Company Proposal, providing access to its properties, books
and records and providing information or data in response to a request therefor by a Person who has
made a bona fide, unsolicited Acquisition Proposal that does not involve an intentional, material
breach of this Section 6.5(a), if (1) the Board of Directors receives from the Person so requesting
such information an executed confidentiality agreement on terms substantially similar to those
contained in the Confidentiality Agreements (except for such changes specifically necessary in
order for such party to be able to comply with its obligations under this Agreement and it being
understood that either party may enter into a confidentiality agreement without a standstill
provision or with a standstill provision less favorable to it if it waives or similarly modifies
the standstill provision in the relevant Confidentiality Agreement in favor of the other party),
and (2) in the case of a Parent Proposal, such Parent Proposal is, or is reasonably likely to
result in, a Qualifying Parent Proposal, or (B) prior to obtaining
the requisite vote of its
stockholders at the Company Stockholders Meeting, in the case of a Company Proposal, engaging in
any negotiations or discussions with any Person who has made a bona fide unsolicited Acquisition
Proposal that does not involve an intentional, material breach of this Section 6.5(a) and, in
addition, in the case of a Parent Proposal, such Parent Proposal is a Qualifying Parent Proposal,
if and only to the extent, in the case of a Company Proposal, that prior to taking any of the
-55-
actions set forth in clauses (A) or (B) of clause (ii), the Company Board of Directors shall have
determined in good faith (after consultation with its outside legal and financial advisors) that
such Acquisition Proposal constitutes or is reasonably likely to result in a Superior Proposal from
the Person that made the applicable Acquisition Proposal, and the Company shall have informed
Parent promptly following (and in no event later than 24 hours after) the taking by it of any such
action. A “Superior Proposal” means, with respect to a Company Proposal, an Acquisition
Proposal (with all percentages included in the definition of “Acquisition Proposal,” increased to
50% for purposes of this definition) that the Company Board of Directors determines in good faith
(taking into account such factors as it deems appropriate, including any legal, financial and
regulatory aspects of the proposal and the Person making the proposal) is reasonably capable of
being consummated and, if consummated, would result in a transaction more favorable to the
Company’s stockholders from a financial point of view than the transactions contemplated by this
Agreement.
(b) If either the Company Board of Directors or the Parent Board of Directors determines in
good faith, in response to an Acquisition Proposal, that such proposal is a Superior Proposal (in
the case of a Company Proposal) or a Qualifying Parent Proposal (in the case of a Parent Proposal),
the Company or Parent, as the case may be, shall notify the other party in writing of such
determination promptly following (and in no event later than 24 hours after) the making of such
determination. Prior to obtaining the requisite vote of its stockholders at the Company
Stockholders Meeting, in the case of a Company Proposal, the Company Board of Directors or the
Parent Board of Directors, as the case may be, may approve or recommend such Superior Proposal or
Qualifying Parent Proposal, as the case may be, to its stockholders and enter into any agreement,
understanding, letter of intent or arrangement with respect to such Superior Proposal or Qualifying
Parent Proposal, as applicable, and the Company may terminate this Agreement; provided,
however, that the Company shall not recommend any such Superior Proposal to its
stockholders, enter into any definitive agreement providing for any such Superior Proposal or
terminate this Agreement pursuant to this sentence (and any purported termination pursuant to this
sentence shall be void and of no force or effect), unless and until (1) it has given Parent prior
written notice of its intention to enter into such agreement at least two Business Days before
doing so, (2) the Company Board of Directors has considered in good faith any proposed changes to
this Agreement proposed by Parent, (3) the Company Board of Directors has determined in good faith,
after consultation with its outside legal counsel, that the failure to make such recommendation or
enter into such agreement would be inconsistent with its fiduciary duties under applicable Law, (4)
prior to entering into such agreement, it has terminated this Agreement, and (5) concurrently with
such termination pursuant to this Section 6.5(b), the Company pays to Parent the Company
Termination Fee (as defined below) payable pursuant to Section 8.2(b).
(c) Each of the Company and Parent shall immediately cease and cause to be terminated any
existing discussions or negotiations with any Persons conducted heretofore with respect to any
Acquisition Proposal. Each of the Company and Parent also shall, if it has not already done so,
promptly request, to the extent it has a contractual right to do so, that each Person, if any, that
has heretofore executed a confidentiality agreement within the 12 months prior to the date of this
Agreement in connection with its consideration of any Acquisition Proposal return or destroy all
confidential information or data heretofore furnished to it by or on behalf of the Company or
Parent, as the case may be.
-56-
(d) Each of the Company and Parent shall promptly (and in no event later than 48 hours after
receipt of an Acquisition Proposal) notify (which notice shall be provided orally and in writing
and shall identify the Person making the Acquisition Proposal and set forth in reasonable detail
its material terms and conditions) the other party after receipt of an Acquisition Proposal and
thereafter shall keep the other party reasonably informed of the status and material terms and
conditions of any proposals or offers. Each of the Company and Parent shall make available to the
other party (to the extent it has not already done so) all material non-public information made
available to any Person making an Acquisition Proposal at substantially the same time and in
substantially the same form as it provides it to such other Person.
SECTION 6.6 Further Action; Reasonable Best Efforts.
(a) Subject to the terms and conditions of this Agreement, Company and Parent will use their
reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done,
and assist and cooperate with the other parties in doing, all things necessary or desirable under
applicable Laws and regulations to consummate, in the most expeditious manner practicable, the
transactions contemplated by this Agreement.
(b) Company and Parent will use reasonable best efforts to: (i) prepare, as soon as
practicable, all filings and other presentations in connection with seeking any regulatory
approval, exemption or other authorization from any Governmental Authority necessary to consummate
the transactions contemplated hereby; (ii) prosecute such filings and other presentations with
diligence; and (iii) oppose any objections to, appeals from or petitions to reconsider or reopen
any such approval by Persons not party to this Agreement. Company and Parent will use reasonable
best efforts to facilitate obtaining any final order or orders approving such transactions,
consistent with this Agreement and/or to remove any impediment to the consummation of the
transactions contemplated hereby. Company and Parent will use reasonable best efforts to furnish
all information in connection with the approvals of or filings with any Governmental Authority and
will promptly cooperate with and furnish information in connection with any such requirements
imposed upon Parent or any of its Affiliates in connection with this Agreement and the transactions
contemplated hereby. Subject to Section 6.6(c), Parent will use reasonable best efforts to obtain
any consent, authorization, order or approval of, or any exemption by, and to remove any impediment
imposed by any Governmental Authority to allow the consummation of the transactions contemplated
hereby. Parent and Company will each advise the other party promptly of any material communication
received by such party or any of its Affiliates from the Federal Trade Commission, Department of
Justice, any state attorney general or any other Governmental Authority regarding any of the
transactions
contemplated hereby, and of any understandings, undertakings or agreements (oral or written)
such party proposes to make or enter into with the Federal Trade Commission, Department of Justice,
any state attorney general or any other Governmental Authority in connection with the transactions
contemplated hereby. Parent and Company will each consult with the other in advance of any
material meetings with the Federal Trade Commission.
(c) In furtherance and not in limitation of Sections 6.6(a) and (b), each of Parent and
Company shall make an appropriate filing of a Notification and Report Form pursuant to the HSR Act
with respect to the transactions contemplated hereby as promptly as practicable and thereafter make
any other required submissions with respect to the transactions contemplated
-57-
hereby under the HSR
Act and to take all other appropriate actions reasonably necessary, proper or advisable to cause
the expiration or termination of the applicable waiting periods under the HSR Act as soon as
practicable.
(d) Notwithstanding the foregoing, Parent shall promptly take, in order to consummate the
Transactions, all actions necessary (i) to secure the expiration or termination of any applicable
waiting period under the HSR Act (the “HSR Clearance”) and/or to resolve any objections
asserted by any Governmental Authority with respect to the Transactions under any antitrust Law or
the Federal Trade Commission Act (each, an “Objection”), and (ii) to prevent the entry of,
and to have vacated, lifted, reversed or overturned, any decree, judgment, injunction or other
order that would prevent, prohibit, restrict or delay the consummation of the Transactions, in each
case including (A) executing settlements, undertakings, consent decrees, stipulations or other
agreements with any such party and (B) selling, divesting or otherwise conveying particular assets
or categories of assets or businesses of Parent and its Affiliates and/or constituting part of the
New Diamond Assets (as such term is defined in the Separation Agreement) or New Diamond Business.
Such efforts shall include, in addition to the consummation of the transactions contemplated by the
Cub Sale Agreement and the Ancillary Agreements referred to therein, taking all additional actions
contemplated by the preceding sentence, subject only to a limitation that those additional actions
not result in a divestiture of additional assets or businesses that, in the aggregate, produce
annual revenues in excess of $4 billion. Parent shall respond to and seek to resolve as promptly
as practicable any Objections that are raised. No actions taken pursuant to this Section 6.6(d)
shall be considered for purposes of determining whether a Company Material Adverse Effect has
occurred.
(e) Notwithstanding the foregoing or any other provision of this Agreement, nothing in this
Section 6.6 shall limit a party’s right to terminate this Agreement pursuant to Section 8.1 so long
as such party has up to then complied in all material respects with its obligations under this
Section 6.6.
(f) Parent shall use reasonable best efforts to cause the Parent Shares issuable to New
Diamond’s stockholders as contemplated by this Agreement to be approved for listing on the NYSE,
subject to official notice of issuance, as promptly as practicable after the date of this
Agreement, and in any event prior to the Closing Date. The Company and New Diamond shall use
reasonable best efforts to cause the New Diamond Shares issuable to the Company’s stockholders in
the Diamond Merger as contemplated by this Agreement to be approved for listing on a national
securities exchange, subject to official notice of issuance, prior to the Initial Effective Time.
(g) The Company shall deliver to Parent prior to the Closing Date a letter identifying all
Persons who are, at the time this Agreement is submitted for adoption by the stockholders of the
Company, “affiliates” of the Company for purposes of Rule 145 of the rules and regulations
promulgated under the Securities Act. The Company shall use reasonable best efforts to cause each
such Person to deliver to Parent on or prior to the Closing Date a written affiliate letter
agreement in a form to be agreed by the parties.
(h) The Company shall provide, and shall cause the Company Subsidiaries to provide, and shall
use commercially reasonable efforts to cause the respective officers,
-58-
employees and
Representatives, including legal and accounting, of the Company and its Subsidiaries to provide,
all cooperation reasonably requested by Parent or New Diamond in connection with the Mergers and
the transactions contemplated by the Separation Agreement and Standalone Drug Sale Agreement to
effect the ultimate assumption by New Diamond of, and the release of the Company from, all of the
rights and obligations under, (i) that certain Indenture, as supplemented, dated as of May 1, 1992,
by and between the Company and U.S. Bank Trust National Association, as successor trustee, and each
series of notes issued thereunder, and (ii) (w) the HITS Purchase Contract Agreement, (x) that
certain Pledge Agreement dated as of May 7, 2004, by and between the Company and U.S. Bank Trust
National Association, as collateral agent, custodial agent, securities intermediary and purchase
contract agent (“Pledge Agreement”), (y) that certain Remarketing Agreement, dated as of
May 7, 2004, by and between the Company, Banc of America Securities LLC, as the remarketing agent,
and U.S. Bank Trust National Association, as purchase contract agent and as attorney-in-fact of the
holders of purchase contracts (the “Remarketing Agreement”), and (z) each other agreement
related thereto (the foregoing clauses (i) and (ii) together, the “Debt and Purchase Contract
Assumption”). In furtherance of the foregoing, the Company shall (1) take all necessary
corporate action to consummate the Debt and Purchase Contract Assumption immediately prior to or
substantially simultaneous with the Closing, (2) obtain any consent of Banc of America Securities
LLC required under the terms of the Remarketing Agreement to effect the assignment to and
assumption by New Diamond of the rights and obligations of the Company under the Remarketing
Agreement, and (3) prepare and deliver other required opinions, certificates, documents,
supplemental indentures, supplemental agreements and other deliverables in connection with the Debt
and Purchase Contract Assumption.
SECTION 6.7 Resignations. To the extent requested by Parent in writing at least ten
Business Days prior to the Closing Date, on the Closing Date, the Company shall cause to be
delivered to Parent duly signed resignations, effective immediately after the Closing, of the
directors of the Company Subsidiaries designated by Parent and shall take such other action as is
necessary to accomplish the foregoing.
SECTION 6.8 Directors’ and Officers’ Indemnification and Insurance.
(a) Without limiting any additional rights that any employee, officer or director may have
under any employment agreement or Company Plan or under the Company’s or New Diamond’s certificate
of incorporation or by-laws, after the Effective Time, Parent shall, and shall cause Surviving
Corporation to, indemnify and hold harmless each person who, as of the
Effective Time, is a present or former officer or director of the Company, New Diamond or any
Company Subsidiary or served as a fiduciary under or with respect to any employee benefit plan
(within the meaning of Section 3(3) of ERISA) at any time maintained or contributed to by the
Company, New Diamond or any Company Subsidiaries (the “Indemnified Directors and
Officers”), against all claims, losses, liabilities, damages, judgments, fines and reasonable
fees, costs and expenses, including attorneys’ fees and disbursements, incurred in connection with
any claim, demand, action, suit, proceeding, inquiry or investigation, whether civil, criminal,
administrative or investigative, arising out of actions taken (or failure to take action) by any of
them in their capacities as officers, directors or fiduciaries at or prior to the Effective Time
(including in connection with this Agreement or the transactions or actions contemplated hereby),
whether asserted or claimed prior to, at or after the Effective Time, to the fullest extent
-59-
permitted under applicable Law. Parent shall, and shall cause the Surviving Corporation to,
advance the cost of any expenses incurred by each Indemnified Director and Officer in the defense
of any claim, demand, action, suit, proceeding, inquiry or investigation arising out of such
Indemnified Director or Officer’s service as a director, officer or fiduciary within three Business
Days of receipt by the Surviving Corporation from the Indemnified Director or Officer of a request
therefor; provided only that any Person to whom expenses are to be advanced provides an
undertaking, if and only to the extent required by the DGCL, to repay such advances if it is
determined that such person is not entitled to indemnification in a final, nonappealable
determination by a Governmental Authority of competent jurisdiction. Neither Parent nor the
Surviving Corporation shall settle, compromise or consent to the entry of any judgment in any
actual or threatened claim, demand, action, suit, proceeding, inquiry or investigation in respect
of which indemnification has been or could be sought by such Indemnified Director or Officer
hereunder unless such settlement, compromise or judgment includes an unconditional release of such
Indemnified Director or Officer from all liability arising out of such claim, demand, action, suit,
proceeding, inquiry or investigation or such Indemnified Director or Officer otherwise consents
thereto.
(b) The certificate of incorporation and by-laws of the Surviving Corporation shall continue
to contain provisions no less favorable with respect to indemnification, advancement of expenses
and exculpation of the Indemnified Directors and Officers and former or present directors and
officers than are presently set forth in the Company’s certificate of incorporation and by-laws,
which provisions shall not be amended, repealed or otherwise modified in any manner that would
adversely affect the rights thereunder of any such individuals. The resolutions adopted by the
Company Board of Directors on October 7, 2005 relating to the indemnification of certain benefit
plan fiduciaries, which resolutions are set forth in Section 6.8(b) of the Company Disclosure
Letter, shall continue in effect and shall not be amended, repealed or otherwise modified in any
manner that would adversely affect the rights thereunder of any Fiduciary (as such term is defined
therein) and the Surviving Corporation shall, and Parent shall cause the Surviving Corporation to,
indemnify and pay any and all expenses incurred by each Fiduciary in accordance with the term of
such resolutions and otherwise honor and comply with the provisions of such resolutions.
(c) Prior to the Effective Time, the Company and/or New Diamond shall (and if it is unable to,
Parent shall cause the Surviving Corporation as of the Effective Time to) obtain and fully pay for
“tail” insurance policies (providing only for the Side A coverage for Indemnified Directors and
Officers where the existing policies also include Side B coverage for the
Company) with a claims period of at least six years from the Effective Time from an insurance
carrier with the same or better credit rating as the Company’s current insurance carrier with
respect to directors’ and officers’ liability insurance and fiduciary liability insurance with
benefits and levels of coverage at least as favorable as the Company’s existing policies as of the
date hereof with respect to matters existing or occurring at or prior to the Effective Time
(including in connection with this Agreement or the transactions or actions contemplated hereby),
provided, however, that in no event shall the Company expend for such policies an
amount in excess of the amounts set forth in Section 6.8(c) of the Company Disclosure Letter; and,
provided further that if the premiums of such insurance coverage exceeds such amount, the Company
shall obtain a policy with the greatest coverage available for a cost not exceeding such amount.
If the Company and the Surviving Corporation for any reason fail to obtain such “tail”
-60-
insurance
policies as of the Effective Time, the Surviving Corporation shall, and Parent shall cause the
Surviving Corporation to, continue to maintain in effect for a period of at least six years from
the Effective Time the directors’ and officers’ liability insurance and fiduciary liability
insurance in place as of the date hereof covering the Indemnified Directors and Officers with
benefits and levels of coverage at least as favorable as provided in the Company’s existing
policies as of the date hereof, or the Surviving Corporation shall, and Parent shall cause the
Surviving Corporation to, purchase comparable directors’ and officers’ liability insurance and
fiduciary liability insurance for such six-year period with benefits and levels of coverage at
least as favorable as provided in the Company’s existing policies as of the date hereof covering
the Indemnified Directors and Officers; provided, however, that in no event shall
the Parent or Surviving Corporation be required to expend for such policies an annual premium
amount in excess of the amounts set forth in Section 6.8(c) of the Company Disclosure Letter; and,
provided further that if the annual premiums of such insurance coverage exceed such amount, the
Surviving Corporation shall obtain a policy with the greatest coverage available for a cost not
exceeding such amount. Parent shall, and shall cause the Surviving Corporation to, honor and
perform under all indemnification agreements entered into by the Company or any Company Subsidiary
set forth in Section 6.8(c) of the Company Disclosure Letter.
(d) This covenant is intended to be for the benefit of, and shall be enforceable by, each of
the Indemnified Directors and Officers and their respective heirs and legal representatives. The
indemnification provided for herein shall not be deemed exclusive of any other rights to which an
Indemnified Director or Officer is entitled, whether pursuant to Law, contract or otherwise.
(e) In the event that Parent or the Surviving Corporation or any of its successors or assigns
(i) consolidates with or merges into any other Person and shall not be the continuing or surviving
corporation or entity of such consolidation or merger or (ii) transfers or conveys all or
substantially all of its properties and assets as an entirety in one or a series of related
transactions to any Person(s), then, and in each such case, proper provision shall be made so that
such continuing or surviving corporation or entity or such Persons(s), as the case may be, shall
assume the obligations set forth in this Section 6.8; provided that neither Parent nor the
Surviving Corporation shall be relieved from such obligation. In addition, neither Parent nor the
Surviving Corporation shall distribute, sell, transfer or otherwise dispose of any of its assets in
a manner that would reasonably be expected to render the Parent or Surviving Corporation unable to
satisfy its obligations under this Section 6.8.
SECTION 6.9 Public Announcements. The initial press release relating to this
Agreement shall be a joint press release the text of which has been agreed to by each of Parent and
the Company. Thereafter, each of Parent and Acquisition Sub, on the one hand, and the Company, New
Diamond, and New Diamond Merger Sub, on the other hand, shall consult with each other before
issuing any press release or otherwise making any public statements with respect to the Transaction
Agreements or the transactions contemplated thereby, except to the extent public disclosure is
required by applicable Law or the requirements of the NYSE or the PCX, in which case the issuing
party shall use its reasonable best efforts to consult with the other party before issuing any such
release or making any such public statement.
-61-
SECTION 6.10 Cooperation. (a) Parent shall use its commercially reasonable efforts
to obtain the Financing pursuant to the terms and conditions set forth in the Financing
Commitments. Parent shall notify the Company if at any time prior to the Closing Date the
Financing Commitment shall expire or be terminated, modified or amended for any reason. The
Company shall provide, and shall cause the Company Subsidiaries to, and shall use commercially
reasonable efforts to cause the respective officers, employees and Representatives, including legal
and accounting, of the Company and its Subsidiaries to provide, all cooperation reasonably
requested by Parent in connection with (i) the Financing, including providing such access and
documentation and taking such action as is customary for transactions such as the Financing and
(ii) the satisfaction of the conditions in the Financing Commitment that require action by the
Company, including those set forth in Section 3 of the Financing Commitment and Exhibit B thereto.
Parent shall promptly, upon request by the Company, reimburse the Company for all reasonable
out-of-pocket third party costs incurred by the Company or any of the Company Subsidiaries in
connection with such cooperation.
(b) If the Financing Commitment expires, is terminated or otherwise become unavailable prior
to the Closing, in whole or in part, for any reason, Parent shall (i) immediately notify the
Company of such expiration, termination or other unavailability and the reasons therefor and (ii)
use its reasonable best efforts promptly to arrange for alternative financing to replace the
financing contemplated by such expired, terminated or otherwise unavailable commitments or
agreements in an amount sufficient to consummate the transactions contemplated by this Agreement.
Without limiting the effect of the preceding sentence, if Parent is unable to obtain replacement
financing from alternative sources within 25 Business Days after any expiration, termination or
other unavailability of any of the Financing Commitment (provided, that in the event such
25-day period would delay the Closing, it shall be reduced to such period as would not delay the
Closing but in no event less than ten Business Days), alternative financing may be proposed for
Parent and Acquisition Sub by the Company (or, at the request of the Company, the Company’s
advisors) with one or more financing sources and Parent shall use its reasonable best efforts to
consummate such alternative financing, unless such alternative financing is on terms and conditions
that are (x) materially less favorable to Parent than the terms of the Financing Commitment that
expired, was terminated, or otherwise became unavailable or (y) not commercially reasonable.
SECTION 6.11 Notification. During the period commencing upon the execution and
delivery of this Agreement by all of the parties hereto and terminating upon the earlier to occur
of the Effective Time and the termination of this
Agreement pursuant to and in accordance with Section 8.1, the Company shall promptly notify
Parent, and Parent shall promptly notify the Company, in writing of any event, condition, fact or
circumstance that would cause any of the conditions set forth in Section 7.1, Section 7.2 or
Section 7.3 not to be met. Each such notification shall include a certification of an officer of
the Company or Parent, as applicable, that such notification is being delivered in accordance with
this Section 6.11. No such notification shall be deemed to supplement or amend the Company
Disclosure Letter or the Parent Disclosure Letter for the purpose of (i) determining the accuracy
of any of the representations and warranties made by the Company in this Agreement, or (ii)
determining whether any of the conditions set forth in Section 7.1, Section 7.2 and Section 7.3 has
been satisfied.
-62-
SECTION 6.12 Third-Party Consents. Without limiting the effect of Section 6.6, each
of the Company and Parent shall use reasonable best efforts to promptly obtain all authorizations,
consents, approvals and waivers of, and give all notices to, each third party that may be necessary
for the consummation of the Mergers and are material to such party; provided,
however, that, except as expressly contemplated hereby, neither the Company nor Parent
shall materially amend or agree to materially amend, or waive any material right or material
economic benefit under, any Material Contract in connection with obtaining such consents, approvals
and waivers without the other party’s consent (which shall not be unreasonably withheld,
conditioned or delayed); provided, further, that, in connection with obtaining such
authorizations, consents, approvals and waivers, or the giving of such notices, the Company shall
not be required to incur any out-of-pocket costs or any other obligation or liability unless de
minimis in nature and amount.
SECTION 6.13 Employment and Employee Benefits Matters; Section 16.
(a) Without limiting any additional rights that any Company Employee may have under any
Company Plan, Parent shall cause the Surviving Corporation and each of its Subsidiaries, for a
period commencing at the Effective Time and ending on December 31, 2007 (the “Benefits
Continuation Period”), to maintain the severance-related provisions of existing Company Plans
not subject to termination pursuant to the express terms hereof and to provide 100% of the
severance payments and benefits required thereunder to be provided to any Current Employee whose
employment is terminated during that period. For purposes of this Section 6.13 only, the term
“Company Employee” shall be deemed to refer to any current, former or retired employee, officer,
consultant, independent contractor or director of the Company or any Company Subsidiary, excluding
employees of the Standalone Drug Business and the Retained Business.
(b) The Company shall allow each participant in the Deferred Compensation Plans to elect,
prior to the Effective Time, to receive his or her account balances (in the case of account balance
plans) and the present value of all accrued benefits (in the case of non-account balance plans,
with the present value in the case of benefits payable pursuant to an individual agreement being
determined using the assumptions required to be used in such agreement and in all other cases being
determined by using the average yield to maturity for 30-year US Government Bonds and the unloaded
94 GAR mortality rates, blended 50% male and 50% female, projected
to 2002), upon the earlier of (1) the existing payment date under the current terms relating
to such deferred compensation (subject to any change in the existing payment date that is required
to comply with Section 409A of the Code) or (2) the later of (x) the Effective Time or (y) January
1, 2007. The Company may adopt such amendments to the Deferred Compensation Plans as it deems
necessary or appropriate to effectuate the transactions contemplated hereby.
(c) Without limiting any additional rights that any Company Employee not covered by a
collective bargaining agreement and employed by the Company or any Company Subsidiary at the
Effective Time (“Current Employee”) may have under any Company Plan, Parent shall cause the
Surviving Corporation and each of its Subsidiaries, for the Benefits Continuation Period, to
maintain for any Current Employees (i) salary or hourly wage rate, commissions and target cash
bonus opportunities under annual and long-term incentive programs (collectively,
“Compensation”), that in the aggregate are no less favorable than, and (ii) benefits
provided
-63-
under Company Plans (other than those covered by (i) above) that in the aggregate are no
less favorable than, the Compensation and benefits maintained for and provided to such Current
Employees immediately prior to the Effective Time; provided, however, subject to
the foregoing, that nothing herein shall prevent the amendment or termination of any Company Plan
or interfere with the Surviving Corporation’s right or obligation to make such changes as are
necessary to conform with applicable Law. Nothing in this Section 6.13 shall limit the right of
Parent, the Surviving Corporation or any of their Subsidiaries to terminate the employment of any
Current Employee at any time.
(d) As of and after the Effective Time, Parent will, or will cause the Surviving Corporation
to, give Current Employees full credit for purposes of eligibility and vesting (but not benefit
accruals, except for vacation and severance, if applicable, under the Company Plans), under any
employee compensation and incentive plans, benefit (including vacation) plans, programs, policies
and arrangements maintained for the benefit of Current Employees as of and after the Effective Time
by Parent, its Subsidiaries or the Surviving Corporation for the Company Employees’ service with
the Company, its Subsidiaries and their predecessor entities (each, a “Parent Plan”) to the
same extent recognized under the Company Plans immediately prior to the Effective Time, provided
that no such credit shall be granted to the extent that it would result in a duplication of
benefits or to the extent that it is not similarly granted to similarly situated employees of
Parent and its Affiliates. With respect to each Parent Plan that is a “welfare benefit plan” (as
defined in Section 3(1) of ERISA), the Parent or its Subsidiaries shall (i) cause to be waived any
pre-existing condition or eligibility limitations to the extent waived or satisfied under the
applicable Company Plan in which the Current Employee participates immediately prior to the
Effective Time and (ii) give effect, for the fiscal year in which the Closing occurs, in
determining any deductible and maximum out-of-pocket limitations, to claims incurred and amounts
paid by, and amounts reimbursed to, Current Employees under similar plans maintained by the Company
and its Subsidiaries immediately prior to the Effective Time.
(e) From and after the Effective Time, Parent will cause the Surviving Corporation and all of
its Subsidiaries to honor, in accordance with its terms (including any right to amend or
terminate), (i) each existing employment, change in control, severance and termination plan, policy
or agreement of or between the Company or any Company Subsidiary and any officer, director or
employee of that company, and (ii) bonus plans or programs, bonus deferral plans,
vested and accrued benefits under any employee benefit plan, program or arrangement of the
Company or any Company Subsidiary and similar employment compensation and benefit arrangements and
agreements in effect as of the Effective Time. Without limiting the generality of the foregoing,
in the event that the annual bonus for fiscal year 2005 is not yet paid to participants at the
Effective Time, any participant who was employed by the Company at the end of fiscal year 2005 will
be entitled to a bonus if earned pursuant to the 2005 bonus program, regardless of whether such
participant is employed at the time of the payment of 2005 bonuses.
(f) Prior to the Effective Time, (i) the Company shall take all steps reasonably necessary to
cause the transactions contemplated hereby and any other dispositions of Equity Interests of the
Company (including derivative securities), in connection with this Agreement by each individual who
is subject to the reporting requirements of Section 16(a) of the Exchange Act to be approved by the
Company Board of Directors or a committee of two or more Non-
-64-
Employee Directors of the Company (as
such term is defined in Rule 16b-3 promulgated under the Exchange Act) and (ii) Parent shall take
all steps reasonably necessary to cause the transactions contemplated hereby and any other
acquisitions of Parent equity securities (including derivative securities) in connection with this
Agreement by each individual who is subject to the reporting requirements of Section 16(a) of the
Exchange Act to be approved by Parent Board of Directors or a committee of two or more Non-Employee
Directors of Parent (as such term is defined in Rule 16b-3 promulgated under the Exchange Act).
Such approvals shall specify: (A) the name of each officer or director, (B) the number of
securities to be disposed of or acquired for each named person, and (C) that the approval is
granted for purposes of exempting the transaction under Rule 16b-3 of the Exchange Act.
(g) The parties hereto will treat the consummation of the Transactions and the Standalone Drug
Sale, both individually and collectively, and regardless of the order in which they actually occur,
as a “change in control,” “change of control” or similar event under each of the Company Plans (to
the extent such Company Plans contain provisions relating to “change in control,” “change of
control” or similar event).
(h) The parties will make good faith efforts to make equitable adjustments if necessary to
ensure that the provisions of this Section 6.13 comply with Section 409A of the Code.
(i) Without limiting the generality of Section 9.7, nothing in this Section 6.13, express or
implied, is intended to or shall confer upon any employee or service provider of Parent, the
Company, or their respective Subsidiaries any right, benefit or remedy of any nature whatsoever.
SECTION 6.14 Board Representation. Parent shall take any and all actions necessary or
appropriate to cause, effective immediately following the Effective Time, the number of directors
comprising the Parent Board of Directors to be no more than fourteen (14) and for there to be three
(3) vacancies on such board. Parent shall use its reasonable best efforts to cause three of the
independent members of the Company Board of Directors to be elected to the Parent Board of
Directors. In furtherance thereto, Parent shall refer the names of three or more mutually
agreeable nominees to the Director Affairs Committee of the Parent Board of Directors for
nomination to fill such vacancies immediately following the Effective Time and to serve on the
Parent Board of Directors, one in each of the three classes of the Parent Board of Directors.
SECTION 6.15 Available Cash. No less than two Business Days and no earlier than five
Business Days prior to the Closing Date, the Company shall provide Parent with a good faith
estimate, together with reasonable supporting documentation, of the amount of immediately available
funds, in U.S. dollars, that the Company has available to it to be used to fund Parent’s obligation
to pay the Merger Consideration without restriction.
SECTION 6.16 Coordination of Dividends. From the date of this Agreement until the
Effective Time, Parent and the Company shall coordinate with each other regarding the declaration
and payment of dividends in respect of the Company Shares and the Parent Shares and the record
dates and payment dates relating thereto, it being the intention of the parties hereto that holders
of Company Shares or Parent Shares shall not receive two dividends, or fail
-65-
to receive one
dividend, for any single calendar quarter, including the quarter in which the Effective Time
occurs, with respect to their Company Shares or Parent Shares, as the case may be. New Diamond and
New Diamond Merger Sub shall not declare or pay any dividends in respect of their Common Stock.
SECTION 6.17 The Diamond Reorganization. The parties acknowledge and agree that they
desire and intend to (i) cause the Diamond Merger and the Diamond LLC Conversion, taken together
(the “Diamond Reorganization”), to qualify as a “reorganization” within the meaning of
Section 368(a)(1)(F) of the Code (an “F Reorg”), (ii) treat the Retained Business Purchase
(other than the purchase of Lucky Stores, Inc., a Delaware corporation (“Lucky Delaware”)
and its Subsidiaries) and the Standalone Drug Sale as purchases of assets for federal income Tax
purposes, (iii) treat the purchase of Lucky Delaware as a purchase of stock for federal income Tax
purposes and (iv) effect the Separation in a manner that does not result in any gain, including any
deferred intercompany gain, for federal income Tax purposes (other than with respect to the
distribution of certain New Diamond Assets from Lucky Delaware and its Subsidiaries pursuant to the
Separation Agreement). The Company shall, and shall cause New Diamond to, (x) use best efforts to
cause the Diamond Reorganization to qualify as an F Reorg, (y) consult with Parent prior to taking
any action that could affect the qualification of the Diamond Reorganization as an F Reorg and
take, or refrain from taking, any actions reasonably requested by Emerald in order to qualify the
Diamond Reorganization as an F Reorg and (z) consult with Parent prior to taking any action in
connection with the Separation, the Retained Business Purchase or the Standalone Drug Sale and
take, or refrain from taking, any action reasonably requested by Parent in connection with the
Separation, the Retained Business Purchase or the Standalone Drug Sale in furtherance of the
intentions described above in this Section 6.17. Any capitalized term used in this paragraph, but
not defined in this Agreement, shall have the meaning ascribed to it in the Separation Agreement.
SECTION 6.18 Boise Operations and Community Involvement. Parent intends to maintain a
significant presence in Boise, Idaho for a period of not less than three years following the
Effective Time.
ARTICLE VII
CONDITIONS OF MERGER
SECTION 7.1 Mutual Conditions to Effect the Mergers. The respective obligations of
each party to consummate the Mergers shall be subject to the satisfaction or waiver at or prior to
the Closing of the following conditions:
(a) This Agreement shall have been adopted by the stockholders of the Company by the Requisite
Company Stockholder Vote in accordance with the Company’s certificate of incorporation and the DGCL
and the Share Issuance shall have been approved by the stockholders of Parent by the Requisite
Parent Stockholder Vote in accordance with the Parent’s certificate of incorporation or other
governing documents, the DGCL and applicable stock
exchange regulations;
-66-
(b) The Form S-4 shall have become effective under the Securities Act and not be the subject
of any stop order or proceedings seeking a stop order;
(c) The Parent Shares issuable to the New Diamond stockholders as contemplated by this
Agreement in connection with the payment of the aggregate Stock Consideration shall have been
approved for listing on the NYSE, subject to official notice of issuance;
(d) With respect to the Emerald Merger only, each of the Standalone Drug Sale, the Separation
and the Retained Business Purchase shall have occurred;
(e) No Law, temporary restraining order, preliminary or permanent injunction or other legal
restraint shall have been enacted, entered, promulgated or enforced and no action or decision shall
have been taken and remain in effect by any United States or state Governmental Authority, or any
Governmental Authority of the jurisdictions listed in Section 7.1(e) of the Company Disclosure
Letter, which seeks to or in fact prohibits, restrains or enjoins the consummation of the
transactions contemplated by this Agreement; and
(f) The waiting period (and any extension thereof) applicable to the transactions contemplated
by this Agreement under the HSR Act shall have been terminated or shall have expired.
SECTION 7.2 Conditions to Obligations of Parent and Acquisition Sub. The obligations
of Parent and Acquisition Sub to consummate the Mergers shall be further subject to the
satisfaction or waiver at or prior to the Closing of the following conditions:
(a) The representations and warranties of the Company contained in this Agreement
(disregarding any Company Material Adverse Effect, materiality or similar qualifiers therein)
shall be true and correct as of the date hereof and the Closing Date as though made on and as
of such date (unless any such representation or warranty is made only as of a specific date, in
which event such representation and warranty shall be true and correct as of such specified date),
except where any failure of any such representation or warranty to be so true and correct has not
had and would not reasonably be expected to have a Company Material Adverse Effect;
provided, however, that the representations and warranties of the Company in
Section 4.2 (Authority; Enforceability) shall be true in all but de minimis respects;
(b) Each of the Company, New Diamond and New Diamond Merger Sub shall have performed in all
material respects the obligations, and complied in all material respects with the agreements and
covenants, required to be performed by or complied with by it under this Agreement at or prior to
the Effective Time; provided, that the Company’s failure to comply with the notification
requirements in Section 6.11 shall not cause the condition set forth in this Section 7.2(b) to fail
to be satisfied; and
(c) Parent shall have received a certificate of the Chief Executive Officer and the Chief
Financial Officer of the Company, certifying that the conditions set forth in Sections 7.2(a) and
(b) have been satisfied.
SECTION 7.3 Conditions to Obligations of the Company, New Diamond and New Diamond Merger
Sub. The obligations of the Company, New Diamond and New Diamond
-67-
Merger Sub to consummate the
Mergers shall be further subject to the satisfaction or waiver at or prior to the Closing of the
following conditions:
(a) The representations and warranties of Parent and Acquisition Sub contained in this
Agreement (disregarding any Parent Material Adverse Effect, materiality or similar qualifiers
therein) shall be true and correct in all material respects, in each case as of the date hereof and
the Closing Date as though made on and as of such date (unless any such representation or warranty
is made only as of a specific date, in which event such representation and warranty shall be true
and correct in all material respects as of such specified date), except where any failure of any
such representation or warranty to be so true and correct has not had and would not reasonably be
expected to have a Parent Material Adverse Effect; provided, however, that the
representations and warranties of Parent in Section 5.2 (Authority; Enforceability) shall be true
in all but de minimis respects;
(b) Each of Parent and Acquisition Sub shall have performed in all material respects the
material obligations, and complied in all material respects with the material agreements and
covenants, required to be performed by or complied with by it under this Agreement at or prior to
the Effective Time; provided, that the Parent’s failure to comply with the notification
requirements in Section 6.11 shall not cause the condition set forth in this Section 7.3(b) to fail
to be satisfied;
(c) The New Diamond Shares issuable to the Company’s stockholders as contemplated by this
Agreement in connection with the Diamond Merger shall have been approved for listing on a national
securities exchange, subject to official notice of issuance; provided, that the obligations
of the Company, New Diamond and New Diamond Merger Sub to
consummate the Mergers shall be subject to the condition in this Section 7.3(c) only if (i)
the Company and New Diamond have complied in all respects with Section 6.6(f) and (ii) it is
reasonably likely that the Emerald Merger will not be consummated; and
(d) The Company shall have received a certificate of the Chief Executive Officer and the Chief
Financial Officer of Parent, certifying that the conditions set forth in Sections 7.3(a) and (b)
have been satisfied.
ARTICLE VIII
TERMINATION, AMENDMENT AND WAIVER
SECTION 8.1 Termination. This Agreement may be terminated and the transactions
contemplated hereby may be abandoned at any time prior to the Closing, whether before or after
adoption of this Agreement by stockholders of the Company or of New Diamond:
(a) by mutual written consent of each party hereto;
(b) by Parent or the Company if any United States or state Governmental Authority shall have
issued a final order, decree or ruling or taken any other final action permanently restraining,
enjoining or otherwise prohibiting the transactions contemplated by this Agreement and such
decision, order, decree, ruling or other action is or shall have become final and nonappealable;
-68-
(c) by Parent or the Company if the Closing shall not have occurred on or before September 22,
2006 (the “Termination Date”); provided, that the right to terminate this Agreement
pursuant to this Section 8.1(c) shall not be available to the party seeking to terminate if any
action of such party or the failure of such party to perform any of its obligations under this
Agreement required to be performed at or prior to the Closing has been the cause of, or resulted
in, the failure of the Closing to occur on or before the applicable termination date and such
action or failure to perform constitutes a breach of this Agreement; provided,
further, that the right to terminate this Agreement pursuant to this Section 8.1(c) shall
not be available to the Company if neither the Company nor CVS shall have exercised its termination
right under Section 12.01(b) of the Standalone Drug Sale Agreement;
(d) by the Company
(i) if there shall have been a material failure of any representation or warranty of Parent or
Acquisition Sub to be true, or a material breach of any covenant or agreement of Parent or
Acquisition Sub contained in this Agreement such that the condition set forth in Section 7.3(a) or
7.3(b) would not be satisfied and which shall not have been cured (if curable) prior to the earlier
of (A) 20 Business Days following notice of such breach (it being understood that such 20 Business
Day period shall not be applicable to covenants or agreements that by their terms are intended to
be satisfied at the Closing) and (B) the Termination Date;
(ii) if the Parent Board of Directors (A) shall have failed to include or make or shall have
publicly withdrawn, modified or changed (it being understood and agreed that any
“stop-look-and-listen” communication by the Parent Board of Directors to the stockholders of the
Parent pursuant to Rule 14d-9(f) of the Exchange Act shall not be deemed to constitute a
withdrawal, modification or change of its recommendation of this Agreement), in a manner adverse to
Company, the Parent Board Recommendation either (1) due in any meaningful respect to antitrust
concerns or (2) for any other reason, or (B) shall have recommended to the stockholders of Parent
an Acquisition Proposal other than the transactions contemplated by this Agreement;
(iii) if Parent fails to duly call or convene the Parent Stockholders Meeting in accordance
with Section 6.2; or
(iv) prior to obtaining the requisite vote of its stockholders at the Company Stockholders
Meeting, in accordance with, and subject to the terms and conditions of, Section 6.5(b);
(e) by Parent
(i) if there shall have been a material failure of any representation or warranty of the
Company to be true, or a material breach of any covenant or agreement of the Company contained in
this Agreement such that the condition set forth in Section 7.2(a) or 7.2(b) would not be satisfied
and which shall not have been cured (if curable) prior to the earlier of (A) 20 Business Days
following notice of such breach (it being understood that such 20 Business Day period shall not be
applicable to covenant or agreements that by their terms are intended to be satisfied at the
Closing) and (B) the Termination Date;
-69-
(ii) if the Company Board of Directors (A) shall have failed to include or make or shall have
publicly withdrawn, modified or changed (it being understood and agreed that any
“stop-look-and-listen” communication by the Company Board of Directors to the stockholders of the
Company pursuant to Rule 14d-9(f) of the Exchange Act shall not be deemed to constitute a
withdrawal, modification or change of its recommendation of this Agreement), in a manner adverse to
Parent, the Company Board Recommendation, or (B) shall have recommended to the stockholders of the
Company an Acquisition Proposal other than the transactions contemplated by this Agreement; or
(iii) if the Company fails to duly call or convene the Company Stockholders Meeting in
accordance with Section 6.2;
(f) by Parent or the Company if, (i) upon a vote thereon at the Company Stockholders Meeting
or any postponement or adjournment thereof, this Agreement shall not have been adopted by the
Requisite Company Stockholder Vote, or (ii) upon a vote thereon at the Parent Stockholders Meeting
or any postponement or adjournment thereof, the Share Issuance shall not have been approved by the
Requisite Parent Stockholder Vote; or
(g) by Parent or the Company if the Separation Agreement or the Standalone Drug Sale Agreement
shall have been terminated in accordance with the terms thereof.
SECTION 8.2 Effect of Termination.
(a) In the event of the termination of this Agreement pursuant to Section 8.1, this Agreement
shall forthwith become void and there shall be no liability or obligation on the part of any party
hereto, except with respect to Section 6.4(b), this Section 8.2, Section 8.3, or Article IX, which
shall survive such termination; provided, however, that nothing herein shall
relieve any party from liability for any willful or intentional material breach hereof.
(b) The Company shall pay Parent, by wire transfer of immediately available funds to such
accounts as Parent may designate, the sum of $276,000,000 (the “Company Termination Fee”)
if this Agreement is terminated as follows:
(i) if Parent shall terminate this Agreement pursuant to Section 8.1(e)(iii), then the
Company shall pay the Company Termination Fee on the business day following such
termination;
(ii) if the Company shall terminate this Agreement pursuant to Section 8.1(d)(iv), the
Company shall pay the Company Termination Fee concurrently with such termination;
(iii) if (A) either party shall terminate this Agreement pursuant to Section 8.1(f)(i)
and (B) at any time after the date hereof and at or before the date of the Company
Stockholders Meeting there shall have been a Public Proposal with respect to the Company,
and if (C) within twelve months of the date of such termination of this Agreement, the
Company or any of the Company Subsidiaries enters into any definitive agreement with respect
to, or consummates, any Acquisition Proposal (provided that, in this instance, all
percentages included in the definition of “Acquisition Proposal” shall be
-70-
increased to 50%),
then the Company shall pay the Company Termination Fee upon the date of such execution or
consummation, whichever is earlier;
(iv) if (A) either party shall terminate this Agreement pursuant to Section 8.1(c) and
(B) at any time after the date hereof and before such termination there shall have been a
Public Proposal with respect to the Company, and if (C) within twelve months of the date of
such termination of this Agreement, the Company or any of the Company Subsidiaries enters
into any definitive agreement with respect to, or consummates, any Acquisition Proposal
(provided that, in this instance, all percentages included in the definition of
“Acquisition Proposal” shall be increased to 50%), then the Company shall pay the Company
Termination Fee upon the date of such execution or consummation, whichever is earlier; and
(v) if Parent shall terminate this Agreement pursuant to Section 8.1(e)(ii) within 10
calendar days following the occurrence of the event giving rise to such termination right,
then the Company shall pay the Company Termination Fee on the Business Day following such
termination.
Notwithstanding anything in this Agreement to the contrary, if the Company fails to pay all
amounts due to Parent on the dates specified, then the Company shall pay all costs and
expenses (including legal fees and expenses) incurred by Parent in connection with any action
or proceeding (including the filing of any lawsuit) taken by it to collect such unpaid amounts,
together with interest on such unpaid amounts at the prime lending rate prevailing at such time, as
published in The Wall Street Journal, from the date such amounts were required to be paid until the
date actually received by Parent.
(c) Parent shall pay the Company, by wire transfer of immediately available funds to such
accounts as the Company may designate, the sum of $135,000,000 (the “Parent Termination
Fee”) if this Agreement is terminated as follows:
(i) if the Company shall terminate this Agreement pursuant to Section 8.1(d)(iii) then
Parent shall pay the Parent Termination Fee on the business day following such termination;
(ii) if (A) either party shall terminate this Agreement pursuant to Section 8.1(f)(ii)
and (B) at any time after the date hereof and before such termination there shall have been
a Public Proposal with respect to the Parent, and if (C) within twelve months of the date of
such termination of this Agreement, Parent or any of Parent Subsidiaries enters into any
definitive agreement with respect to, or consummates, any Acquisition Proposal
(provided that, in this instance, all percentages included in the definition of
“Acquisition Proposal” shall be increased to 50%), then Parent shall pay the Parent
Termination Fee upon the date of such execution or consummation, whichever is earlier;
(iii) if (A) either party shall terminate this Agreement pursuant to Section 8.1(c),
except in the circumstances described in Section 8.2(d)(i), and (B) at any time after the
date hereof and before such termination there shall have been a Public Proposal with respect
to the Parent, and if (C) within twelve months of the date of such termination
-71-
of this
Agreement, Parent or any of Parent Subsidiaries enters into any definitive agreement with
respect to, or consummates, any Acquisition Proposal (provided that, in this
instance, all percentages included in the definition of “Acquisition Proposal” shall be
increased to 50%), then Parent shall pay the Parent Termination Fee upon the date of such
execution or consummation, whichever is earlier; and
(iv) if the Company shall terminate this Agreement pursuant to Section 8.1(d)(ii)
within 10 calendar days following the occurrence of the event giving rise to such
termination right, except in the circumstances described in Section 8.2(d)(ii), then Parent
shall pay the Parent Termination Fee on the Business Day following such termination.
Notwithstanding anything in this Agreement to the contrary, if Parent fails to pay all amounts
due to the Company on the dates specified, then Parent shall pay all costs and expenses (including
legal fees and expenses) incurred by the Company in connection with any action or proceeding
(including the filing of any lawsuit) taken by it to collect such unpaid amounts, together with
interest on such unpaid amounts at the prime lending rate prevailing at such time, as published in
The Wall Street Journal, from the date such amounts were required to be paid until the date
actually received by the Company.
(d) Parent shall pay the Company by wire transfer of immediately available funds to such
accounts as the Company may designate, the sum of $250,000,000 (the “Regulatory Termination
Fee”), and shall not pay the Company the Parent Termination Fee, if this Agreement is
terminated as follows:
(i) if (A) either party shall terminate this Agreement pursuant to Section 8.1(c), (B)
as of the date of such termination the HSR Clearance shall not have occurred or any decree,
judgment, injunction, or other order (in each case that relates to antitrust Laws) that
prevents, prohibits or delays the consummation of the Transactions exists or is in effect,
(C) immediately prior to such termination, the conditions set forth in Sections 7.1(a) (to
the extent relating to the Requisite Company Stockholder Vote), 7.1(b) and 7.2(a) shall have
been satisfied, and (D) each of the Company, New Diamond and New Diamond Merger Sub shall
have performed in all material respects the obligations, and complied in all material
respects with the agreements and covenants, required to be performed by or complied with by
it under this Agreement prior to such termination (other than obligations, agreements and
covenants set forth in Section 6.11), then Parent shall pay the Regulatory Termination Fee
on the business day following such termination; provided, that if (1) this Agreement
is terminated pursuant to Section 8.1(g) and (2) at the time of such termination this
Agreement may also be terminated pursuant to Section 8.1(c), then for purposes of this
Section 8.2(d)(i) this Agreement shall be deemed to have been terminated pursuant to Section
8.1(c); and
(ii) if the Company shall terminate this Agreement pursuant to Section 8.1(d)(ii)(A)(1)
within 10 calendar days following the occurrence of the event giving rise to such
termination right, Parent shall pay the Regulatory Termination Fee on the business day
following such termination,
-72-
Notwithstanding anything in this Agreement to the contrary, if Parent fails to pay all amounts
due to the Company on the dates specified, then Parent shall pay all costs and expenses (including
legal fees and expenses) incurred by the Company in connection with any action or proceeding
(including the filing of any lawsuit) taken by it to collect such unpaid amounts, together with
interest on such unpaid amounts at the prime lending rate prevailing at such time, as published in
The Wall Street Journal, from the date such amounts were required to be paid until the date
actually received by the Company.
SECTION 8.3 Expenses. Except as otherwise specifically provided in this Agreement,
each party shall bear its own expenses in connection with this Agreement and the transactions
contemplated hereby; provided, that expenses incurred in connection with the filing fee for
the Proxy Statement/Prospectus and printing and mailing the Proxy Statement/Prospectus shall be
shared equally by Parent and the Company.
SECTION 8.4 Amendment. Subject to applicable Law, this Agreement may be amended by
the parties hereto by action taken by or on behalf of their respective boards of directors, at any
time prior to the Closing Date, whether before or after adoption of this Agreement by the
stockholders of the Company, New Diamond
and Acquisition Sub. This Agreement may not be amended except by an instrument in writing
signed by the parties hereto.
SECTION 8.5 Waiver. At any time prior to the Effective Time, any party hereto may (i)
extend the time for the performance of any of the obligations or other acts of the other parties
hereto, (ii) waive any inaccuracies in the representations and warranties contained herein or in
any document delivered pursuant hereto, and (iii) subject to the requirements of applicable Law,
waive compliance with any of the agreements or conditions contained herein. Any such extension or
waiver shall be valid only if set forth in an instrument in writing signed by the party or parties
to be bound thereby.
ARTICLE IX
GENERAL PROVISIONS
SECTION 9.1 Non-Survival of Representations, Warranties and Agreements. None of the
representations, warranties, covenants and agreements in this Agreement or in any instrument
delivered pursuant to this Agreement, and the other agreements and documents contemplated to be
delivered in connection herewith, including any rights arising out of any breach of such
representations, warranties, covenants and agreements, shall, in the event Closing occurs, survive
the Effective Time, except for (i) those covenants and agreements contained herein that by their
terms apply or are to be performed in whole or in part at or after the Effective Time (including
Section 6.8) and (ii) this Article IX.
SECTION 9.2 Company Disclosure Letter; Parent Disclosure Letter. There may have been
included in the Company Disclosure Letter and the Parent Disclosure Letter and may be included
elsewhere in this Agreement items which are not “material,” and such inclusion shall not be deemed
to be an acknowledgment or agreement by the Company or the Parent, as appropriate, that such items
are “material” or to affect the interpretation of such term for purposes of this Agreement.
Disclosures included in any Section of the Company Disclosure
-73-
Letter or the Parent Disclosure
Letter shall be considered to be made for purposes of all other Sections of the Company Disclosure
Letter or of the Parent Disclosure Letter, as appropriate, to the extent that the relevance of any
such disclosure to any other Section of the Company Disclosure Letter or the Parent Disclosure
Letter, as appropriate, is reasonably apparent from the text of such disclosure. The inclusion of
any items or information in the Company Disclosure Letter or the Parent Disclosure Letter shall not
be construed as an admission that such item or information (or any non-disclosed item or
information of comparable or greater significance) is material or otherwise required to be
scheduled as an exception from any representation, warranty or covenant. Matters reflected in the
Company Disclosure Letter or the Parent Disclosure Letter are not necessarily limited to matters
required by the Agreement to be disclosed in the Company Disclosure Letter or the Parent Disclosure
Letter.
SECTION 9.3 Notices. Any and all notices or other communications or deliveries
required or permitted to be provided hereunder shall be in writing and shall be deemed given and
effective on the earliest of (i) the date of
transmission, if such notice or communication is delivered via facsimile at the facsimile
telephone number specified in this Section 9.3 prior to 5:00 p.m. (New York time) on a Business
Day, (ii) the Business Day after the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile telephone number specified in this Agreement later than
5:00 p.m. (New York time) on any date and earlier than 11:59 p.m. (New York time) on such date,
(iii) when received, if sent by nationally recognized overnight courier service, or (iv) upon
actual receipt by the party to whom such notice is required to be given. The address for such
notices and communications shall be as follows:
(a) if to the Company, New Diamond Merger Sub, or New Diamond:
Xxxxxxxxx’x, Inc.
000 Xxxx Xxxxxxxxxx Xxxxxxxxx
Xxxxx, Xxxxx 00000
Facsimile: (000) 000-0000
Attention: Corporate Secretary
000 Xxxx Xxxxxxxxxx Xxxxxxxxx
Xxxxx, Xxxxx 00000
Facsimile: (000) 000-0000
Attention: Corporate Secretary
with a copy to (which shall not constitute notice):
Xxxxx Day
Xxxxx Xxxxx
000 Xxxxxxxx Xxxxxx
Xxxxxxxxx, Xxxx 00000
Facsimile: (000) 000-0000
Attention: Xxxx X. Xxxxxx, Esq.
Xxxxx Xxxxx
000 Xxxxxxxx Xxxxxx
Xxxxxxxxx, Xxxx 00000
Facsimile: (000) 000-0000
Attention: Xxxx X. Xxxxxx, Esq.
and to:
-74-
Xxxxx Day | ||||
0000 Xxxxx Xxxxxxx Xxxxxx | ||||
Xxxxxx, Xxxxx 00000 | ||||
Facsimile: (000) 000-0000 | ||||
Attention: Xxxx X. Xxxxxx, Esq. | ||||
and to: | ||||
Xxxxxxxx & Xxxxxxxx LLP | ||||
000 Xxxxx Xxxxxx | ||||
Xxx Xxxx, Xxx Xxxx 00000 | ||||
Facsimile: | (000) 000-0000 | |||
Attention: | Xxxxx X. Xxxxxx, Esq. | |||
Xxxxx X. Xxxxx, Esq. |
(b) if to Parent, Acquisition Sub or the Surviving Corporation:
SUPERVALU INC. | ||||
00000 Xxxxxx Xxxx Xxxx | ||||
Xxxx Xxxxxxx, XX 00000 | ||||
Facsimile: | (000) 000-0000 | |||
Attention: | Corporate Secretary | |||
with a copy to (which shall not constitute notice): | ||||
Wachtell, Lipton, Xxxxx & Xxxx | ||||
00 Xxxx 00xx Xxxxxx | ||||
Xxx Xxxx, Xxx Xxxx 00000 | ||||
Facsimile: | (000) 000-0000 | |||
Attention: | Xxxxxx X. Xxxxxxxxxx, Esq. | |||
Xxxx Xxxxxx, Esq. |
SECTION 9.4 Severability. Whenever possible, each provision of this Agreement shall
be interpreted in such manner as to be valid, legal and enforceable under applicable Law. If any
provision of this Agreement or the application of any such provision to any Person or circumstance
shall be held invalid, illegal or unenforceable in any respect by a court of competent
jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision
hereof, and this Agreement shall be reformed, construed and enforced as if such invalid, illegal or
unenforceable provision had never been contained herein and there had been contained herein instead
such valid, legal and enforceable provisions as would most nearly accomplish the intent and purpose
of such invalid, illegal or unenforceable provision.
SECTION 9.5 Entire Agreement. This Agreement, the Company Disclosure Letter, the
Parent Disclosure Letter, the Coordination Agreement and the Confidentiality Agreements constitute
the entire agreement of the parties hereto with respect to the subject matter hereof and supersede
all prior agreements and undertakings, both written and oral, between the parties hereto with
respect to the subject matter hereof.
-75-
SECTION 9.6 Assignment. This Agreement may not be assigned by any party or by
operation of law or otherwise without the prior written consent of each of the other parties (which
consent may be granted or withheld in the sole discretion of such other party). Any attempted
assignment in violation of this Section 9.6 shall be void.
SECTION 9.7 No Third Party Beneficiaries. Except for Section 6.8, this Agreement
shall be binding upon and inure solely to the benefit of the parties hereto and their permitted
assigns and nothing herein, express or implied, is intended to or shall confer upon any other
Person any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason
of this Agreement. The representations and warranties in this Agreement are the product of
negotiations among the
parties hereto and are for the sole benefit of the parties hereto. Any inaccuracies in such
representations and warranties are subject to waiver by the parties hereto in accordance with
Section 8.5 without notice or liability to any other Person. In some instances, the
representations and warranties in this Agreement may represent an allocation among the parties
hereto of risks associated with matters as to which the party making such representations and
warranties has no knowledge or only incomplete knowledge. Consequently, Persons other than the
parties hereto may not rely upon the representations and warranties in this Agreement as
characterizations of actual facts or circumstances as of the date of this Agreement or as of any
other date.
SECTION 9.8 No Responsibility for Other Parties. Each party to each of the
Transaction Agreements shall be responsible only for its own representations, warranties,
covenants, actions or omissions under each of the Transaction Agreements. The Company, New
Diamond, New Diamond Merger Sub, Parent and Acquisition Sub each acknowledges that none of the
other parties shall be held liable in any way for any representation, warrant, covenant, action or
omission of any other party to the Transaction Agreements. Notwithstanding anything to the
contrary in this Section 9.8, however, (i) Parent shall be responsible for the representations,
warranties, covenants, actions and omissions under each of the Transaction Agreements of
Acquisition Sub, and (ii) the Company shall be responsible for the representations, warranties,
covenants, actions and omissions, in each case prior to the Effective Time, under each of the
Transaction Agreements of New Diamond and New Diamond Merger Sub.
SECTION 9.9 Governing Law. This Agreement shall be governed by, and construed in
accordance with, the laws of the State of Delaware (without giving effect to choice of law
principles thereof).
SECTION 9.10 Specific Performance; Jurisdiction. The parties agree that irreparable
damage would occur in the event that any of the provisions of this Agreement were not performed in
accordance with their specific terms or were otherwise breached. It is accordingly agreed that the
parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and
to enforce specifically the terms and provisions of this Agreement in the Court of Chancery of the
State of Delaware, this being in addition to any other remedy to which such party is entitled at
law or in equity. In addition, each of the parties hereto (i) consents to submit itself to the
personal jurisdiction of the Court of Chancery of the State of Delaware (and, with respect to
claims in which the exclusive subject matter jurisdiction of such claims is federal, the federal
district court for the District of Delaware) in the event any dispute arises out of this
-76-
Agreement
or any of the transactions contemplated by this Agreement, (ii) agrees that it will not attempt to
deny or defeat such personal jurisdiction by motion or other request for leave from such court,
(iii) agrees that it will not bring any action relating to this Agreement or any of the
transactions contemplated by this Agreement in any court other than the Court of Chancery of the
State of Delaware (or, with respect to claims in which the exclusive subject matter jurisdiction of
such claims is federal, the federal district court for the District of Delaware) and (iv) to the
fullest extent permitted by Law, consents to service being made through the notice procedures set
forth in Section 9.3. Each party hereto hereby agrees that, to the fullest extent permitted by
Law, service of any process, summons, notice or document by U.S. registered mail to the respective
addresses set forth in
Section 9.3 shall be effective service of process for any suit or proceeding in connection
with this Agreement or the transactions contemplated hereby.
SECTION 9.11 Waiver of Jury Trial. EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY
CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT OR THE SEPARATION AGREEMENT IS LIKELY TO INVOLVE
COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE, IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES
ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY
ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE SEPARATION AGREEMENT AND ANY OF THE AGREEMENTS
DELIVERED IN CONNECTION HEREWITH OR THEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.
EACH PARTY HERETO CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY
OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT
OF LITIGATION, SEEK TO ENFORCE EITHER OF SUCH WAIVERS, (II) IT UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF SUCH WAIVERS, (III) IT MAKES SUCH WAIVERS VOLUNTARILY, AND (IV) IT HAS BEEN INDUCED
TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS
SECTION 9.11.
SECTION 9.12 Interpretation. When reference is made in this Agreement to a Section,
such reference shall be to a Section of this Agreement unless otherwise indicated. The table of
contents and headings contained in this Agreement are for convenience of reference purposes only
and shall not affect in any way the meaning or interpretation of this Agreement. Whenever the
words “include,” “includes” or “including” are used in this Agreement, they shall be deemed to be
followed by the words “without limitation.” This Agreement shall be construed without regard to
any presumption or rule requiring construction or interpretation against the party drafting or
causing any instrument to be drafted. The meanings given to terms defined herein shall be equally
applicable to both the singular and plural forms of such terms.
SECTION 9.13 Counterparts. This Agreement may be executed in one or more
counterparts, and by the different parties hereto in separate counterparts, each of which when
executed shall be deemed to be an original but all of which taken together shall constitute one and
the same agreement.
-77-
IN WITNESS WHEREOF, the Company, New Diamond, New Diamond Merger Sub, Acquisition Sub and
Parent have caused this Agreement to be executed as of the date first written above by their
respective officers thereunto duly authorized.
XXXXXXXXX’X, INC. | |||||||||
By: | /s/ Xxxx X. Xxxx | ||||||||
Name: | Xxxx X. Xxxx | ||||||||
Title: | Executive Vice President and | ||||||||
General Counsel | |||||||||
NEW ALOHA CORPORATION | |||||||||
By: | /s/ Xxxx X. Xxxxx | ||||||||
Name: | Xxxx X. Xxxxx | ||||||||
Title: | President | ||||||||
NEW DIAMOND SUB, INC. | |||||||||
By: | /s/ Xxxx X. Xxxxx | ||||||||
Name: | Xxxx X. Xxxxx | ||||||||
Title: | President | ||||||||
SUPERVALU INC. | |||||||||
By: | /s/ Xxxx Xxxxxx | ||||||||
Name: | Xxxx Xxxxxx | ||||||||
Title: | Chairman & CEO | ||||||||
EMERALD ACQUISITION SUB, INC. | |||||||||
By: | /s/ Xxxxx Xxxxxxx | ||||||||
Name: | Xxxxx Xxxxxxx | ||||||||
Title: | President |
-78-